Annotation Detail for PTGS2
Basic Information Top
| Gene Symbol: | PTGS2 ( COX-2,COX2,GRIPGHS,PGG/HS,PGHS-2,PHS-2,hCox-2 ) |
|---|---|
| Gene Full Name: | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
| Band: | 1q31.1 |
| Quick Links | Entrez ID:5743; OMIM: 600262; Uniprot ID:PGH2_HUMAN; ENSEMBL ID: ENSG00000073756; HGNC ID: 9605 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Pathway ID | Pathway Name |
|---|---|
| PWY66-374 | prostanoid biosynthesis |
| Pathway ID | Pathway Name |
|---|---|
| hsa00590 | Arachidonic acid metabolism |
| hsa05140 | Leishmaniasis |
| hsa05222 | Small cell lung cancer |
| hsa04370 | VEGF signaling pathway |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Hormone biosynthesis | |
| Metabolism of lipids and lipoproteins | |
| Biological oxidations |
| Pathway ID | Pathway Name |
|---|---|
| 200039 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 200130 | C-MYB transcription factor network |
| 200154 | Signaling mediated by p38-alpha and p38-beta |
| 200159 | Calcium signaling in the CD4+ TCR pathway |
| 200071 | S1P1 pathway |
| Pathway ID | Pathway Name |
|---|---|
| P00019 | Endothelin signaling pathway |
| P00054 | Toll receptor signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| 500770 | Prostanoid metabolism |
| 500205 | COX reactions |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| Cancers of the digestive system | |
| Cancers of the urinary system and male genital organs | |
| H00017 | Esophageal cancer |
| H00025 | Penile cancer |
| H00046 | Cholangiocarcinoma |
| Desease ID | Desease Name |
|---|---|
| 1709 | Parkinson disease |
| 1731 | Growth retardation |
| 1739 | Oral cancer |
| 1740 | Alzheimer's disease |
| 1781 | Rheumatoid arthritis |
| 1803 | Periodontitis |
| 1842 | Sickle cell disease |
| 1876 | Gouts |
| 1878 | Ischemia |
| 1901 | Endometriosis |
| 1918 | Atherosclerosis |
| 1934 | Cancer |
| 1946 | Thyroid gland disease |
| 1954 | Stroke |
| 2025 | Polyarthritis |
| 1997 | Dental plaque |
| 2003 | Metaplastic polyp |
| 2074 | Asthma |
| 2095 | Vulvar disease |
| 2216 | Chronic fatigue syndrome |
| 2244 | Prion disease |
| Desease Name |
|---|
| cardiovascular disease |
| placental malperfusion pregnancy complications |
| colorectal cancer |
| CARDIOVASCULAR |
| myocardial infarct |
| prostate cancer |
| Alzheimer's disease |
| skin cancer, non-melanoma |
| CANCER |
| Carcinoma, Squamous Cell |
| stomach cancer |
| analgesic response |
| PHARMACOGENOMIC |
| Esophageal Neoplasms |
| bladder cancer |
| breast cancer |
| colon cancer |
| IMMUNE |
| NEUROLOGICAL |
| knee osteoarthritis |
| METABOLIC |
| Myocardial Infarction |
| lung cancer |
| REPRODUCTION |
| diabetes, type 2 |
| cervical cancer |
| sarcoidosis |
| stroke, atherothrombotic |
| Desease Name |
|---|
| Knee osteoarthritis |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C025603 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| C420084 | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 16818512 |
| C090859 | 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole | 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in decreased activity of PTGS2 protein | decreases activity | 14633654 |
| C090859 | 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole | 1-((4-methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole results in decreased activity of PTGS2 protein | decreases activity | 15964185 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in decreased expression of PTGS2 mRNA | decreases expression | 16399772 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in decreased expression of PTGS2 protein | decreases expression | 16399772 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in decreased activity of PTGS2 protein | decreases activity | 10753194 |
| C046760 | 15-acetyldeoxynivalenol | 15-acetyldeoxynivalenol results in increased expression of PTGS2 mRNA | increases expression | 14514436 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12604364 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PTGS2 | increases expression | 15254749 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15641079 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15641079 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 10866999 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 results in increased expression of PTGS2 protein | increases expression | 10866999 |
| C477819 | 15-deoxyprostaglandin J2 | 15-deoxyprostaglandin J2 affects the expression of PTGS2 protein | affects expression | 16912651 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15905586 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine promotes the reaction [Calcimycin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA | increases expression | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 protein | increases expression | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | BN 50730 inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | BN 50730 inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | Calcium promotes the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 9375567 |
| C053479 | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine | Dactinomycin inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| C400184 | 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine | 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of PTGS2 mRNA | increases expression | 16386258 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of PTGS2 mRNA | increases expression | 19933214 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C038764 | 2,2'-biphenol | 2,2'-biphenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 19528508 |
| C019273 | 2,2-bis(4-glycidyloxyphenyl)propane | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 20032081 |
| C002462 | 2,2-di(4-methacryloxyphenyl)propane | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15264312 |
| C002462 | 2,2-di(4-methacryloxyphenyl)propane | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15264312 |
| C003585 | 22-hydroxycholesterol | 22-hydroxycholesterol results in increased expression of PTGS2 mRNA | increases expression | 19426978 |
| C070055 | 2,3',4,4',5-pentachlorobiphenyl | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C035976 | 2,4,2',4'-tetrachlorobiphenyl | 2,4,2',4'-tetrachlorobiphenyl results in increased expression of and results in increased activity of PTGS2 protein | increases activity|increases expression | 15673847 |
| C035976 | 2,4,2',4'-tetrachlorobiphenyl | 2,4,2',4'-tetrachlorobiphenyl results in increased expression of PTGS2 mRNA | increases expression | 15673847 |
| C081766 | 2,4,4'-trichlorobiphenyl | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C548544 | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19934399 |
| C548544 | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2] | decreases reaction|increases activity|increases chemical synthesis | 19934399 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of PTGS2 mRNA | increases expression | 20713471 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in increased expression of PTGS2 mRNA | increases expression | 20406850 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | PTGS2 protein results in increased metabolism of 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | increases metabolic processing | 11159734 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | PTGS2 protein results in increased metabolism of 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | increases metabolic processing | 11159734 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | PTGS2 protein results in increased metabolism of 2-amino-3-methylimidazo(4,5-f)quinoline | increases metabolic processing | 11159734 |
| C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 |
| C109986 | 2-aminoethoxydiphenyl borate | [Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [ciglitazone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16417216 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [ciglitazone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16417216 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 20032081 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16417216 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [[IL1B protein co-treated with rosiglitazone] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12897060 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12897060 |
| C034047 | 2-cresol | 2-cresol results in decreased activity of PTGS2 protein | decreases activity | 15664436 |
| C001390 | 2-hydroxyestradiol | [2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 18480072 |
| C001390 | 2-hydroxyestradiol | Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| C001390 | 2-hydroxyestradiol | Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| C001390 | 2-hydroxyestradiol | BAY 11-7085 inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| C001390 | 2-hydroxyestradiol | BAY 11-7085 inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| C001390 | 2-hydroxyestradiol | Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|increases expression|increases reaction | 18480072 |
| C017910 | 2-methoxycinnamaldehyde | 2-methoxycinnamaldehyde inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 17077517 |
| C017910 | 2-methoxycinnamaldehyde | 2-methoxycinnamaldehyde inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17077517 |
| C102563 | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone results in decreased activity of PTGS2 protein | decreases activity | 11910360 |
| C102563 | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone results in increased expression of PTGS2 mRNA | increases expression | 12586211 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 19056653 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19056653 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19056653 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane results in decreased expression of PTGS2 mRNA | decreases expression | 19056653 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C027309 | 3,4,5,3',4',5'-hexachlorobiphenyl | [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C023035 | 3,4,5,3',4'-pentachlorobiphenyl | [3,4,3',4'-tetrachlorobiphenyl co-treated with 3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474181 |
| C501048 | 3-(4-methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole | 3-(4-methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole results in decreased activity of PTGS2 protein | decreases activity | 16391822 |
| C106592 | 3,9-bis((ethylthio)methyl)-K-252a | 3,9-bis((ethylthio)methyl)-K-252a results in decreased expression of PTGS2 mRNA | decreases expression | 15294995 |
| C043247 | 3-acetyldeoxynivalenol | 3-acetyldeoxynivalenol results in increased expression of PTGS2 mRNA | increases expression | 14514436 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19372248 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19372248 18388244 19147701 |
| C091768 | 3'-methoxy-4'-nitroflavone | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| C110453 | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 15517878 |
| C110453 | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 20434301 |
| C110453 | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 12891558 |
| C027439 | 4,4'-dihydroxybiphenyl | [4,4'-dihydroxybiphenyl co-treated with Lipopolysaccharides] results in increased expression of PTGS2 | affects cotreatment|increases expression | 19528508 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16880258 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] | affects cotreatment|decreases expression|increases reaction | 16322342 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | PTGS2 protein affects the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased expression of YWHAE protein] | affects reaction|decreases expression | 17409426 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16322342 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 17766677 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 10484518 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases activity|decreases chemical synthesis | 10484518 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased expression of PTGS2 protein | increases expression | 10484518 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12428691 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased expression of PTGS2 protein | increases expression | 12428691 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 12837940 15876570 12428691 10484518 |
| C006757 | 4-biphenylamine | PTGS2 protein results in increased metabolism of 4-biphenylamine | increases metabolic processing | 11159734 |
| C006757 | 4-biphenylamine | PTGS2 protein results in increased metabolism of 4-biphenylamine | increases metabolic processing | 11159734 |
| C032171 | 4-coumaric acid | 4-coumaric acid results in decreased expression of PTGS2 protein | decreases expression | 15841493 |
| C014036 | 4-hydroxyestradiol-17 beta | [2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 18480072 |
| C014036 | 4-hydroxyestradiol-17 beta | Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| C014036 | 4-hydroxyestradiol-17 beta | Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| C014036 | 4-hydroxyestradiol-17 beta | BAY 11-7085 inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| C014036 | 4-hydroxyestradiol-17 beta | BAY 11-7085 inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| C014036 | 4-hydroxyestradiol-17 beta | Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|increases expression|increases reaction | 18480072 |
| C059539 | 4'-N-benzoylstaurosporine | 4'-N-benzoylstaurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 14613874 |
| C478738 | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester results in decreased expression of PTGS2 mRNA | decreases expression | 16172162 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased activity of PTGS2 protein | increases activity | 15762874 |
| C002202 | 4-oxoretinoic acid | 4-oxoretinoic acid results in decreased expression of PTGS2 mRNA | decreases expression | 15982314 |
| C075773 | 4-phenylbutyric acid | 4-phenylbutyric acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17709599 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of PTGS2 mRNA | increases expression | 18571826 |
| C039465 | 5-dimethylamiloride | 5-dimethylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| C052026 | 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole | 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 7575673 |
| C111855 | 6-formylindolo(3,2-b)carbazole | 6-formylindolo(3,2-b)carbazole results in increased expression of PTGS2 mRNA | increases expression | 18938131 |
| C080122 | 7-nitroindazole | 7-nitroindazole results in decreased expression of PTGS2 protein | decreases expression | 10894794 |
| C080122 | 7-nitroindazole | Cyclic GMP inhibits the reaction [7-nitroindazole results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 10894794 |
| C080122 | 7-nitroindazole | 7-nitroindazole affects the reaction [Sodium affects the expression of PTGS2 mRNA] | affects expression|affects reaction | 10894794 |
| C080122 | 7-nitroindazole | 7-nitroindazole inhibits the reaction [Sodium results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 10894794 |
| C080122 | 7-nitroindazole | 7-nitroindazole results in decreased expression of PTGS2 mRNA | decreases expression | 10894794 10691779 |
| C075750 | 8-epi-prostaglandin F2alpha | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of 8-epi-prostaglandin F2alpha | decreases activity|decreases chemical synthesis | 8621535 |
| C075750 | 8-epi-prostaglandin F2alpha | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha | increases chemical synthesis|increases expression | 8621535 |
| C075750 | 8-epi-prostaglandin F2alpha | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha | increases chemical synthesis|increases expression | 8621535 |
| C006014 | 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate | 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| C046938 | 9,11-linoleic acid | 9,11-linoleic acid results in decreased expression of PTGS2 mRNA | decreases expression | 15778275 |
| D000079 | Acetaldehyde | Acetaldehyde results in increased expression of PTGS2 mRNA | increases expression | 19110045 17050345 |
| D000079 | Acetaldehyde | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19110045 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| D000082 | Acetaminophen | Acetaminophen promotes the reaction [IL1B protein results in increased activity of PTGS2 protein] | increases activity|increases reaction | 15705740 |
| D000082 | Acetaminophen | Acetaminophen results in decreased activity of PTGS2 protein | decreases activity | 11113024 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PTGS2 mRNA | increases expression | 17175104 |
| D000082 | Acetaminophen | tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] | decreases reaction|increases activity|increases reaction | 15705740 |
| D000082 | Acetaminophen | Acetaminophen inhibits the reaction [Diclofenac results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15626590 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of PTGS2 mRNA | increases expression | 12051698 11743745 |
| D000082 | Acetaminophen | [Acetaminophen results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 11743745 |
| D000082 | Acetaminophen | [Acetaminophen results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Prostaglandin D2 | increases chemical synthesis|increases expression | 11743745 |
| D000082 | Acetaminophen | [celecoxib results in decreased activity of PTGS2 protein] which results in increased susceptibility to Acetaminophen | decreases activity|increases response to substance | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of DNAJA1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSP90AA1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSP90AB1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSP90B1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSPA1A mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSPA8 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSPB1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein affects the reaction [Acetaminophen results in increased expression of HSPH1 mRNA] | affects reaction|increases expression | 11743745 |
| D000082 | Acetaminophen | PTGS2 protein results in decreased susceptibility to Acetaminophen | decreases response to substance | 11743745 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of PTGS2 mRNA | decreases expression | 16172162 |
| D000082 | Acetaminophen | Acetaminophen results in decreased activity of PTGS2 protein | decreases activity | 17606472 |
| D019342 | Acetic Acid | PTGS2 protein affects the susceptibility to Acetic Acid | affects response to substance | 16674937 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17244722 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18414395 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [dentinol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15576159 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17255567 |
| D000111 | Acetylcysteine | Acetylcysteine results in decreased expression of PTGS2 mRNA | decreases expression | 16084531 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D000119 | Acetylmuramyl-Alanyl-Isoglutamine | Acetylmuramyl-Alanyl-Isoglutamine results in increased expression of PTGS2 mRNA | increases expression | 17087994 |
| D000171 | Acrolein | Acrolein results in increased expression of PTGS2 mRNA | increases expression | 17363696 |
| D000171 | Acrolein | Acrolein results in increased expression of PTGS2 protein | increases expression | 17363696 |
| D000171 | Acrolein | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17363696 |
| D000171 | Acrolein | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17363696 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 19147701 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of PTGS2 mRNA | decreases expression | 15982314 |
| D000493 | Allopurinol | Allopurinol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17244722 |
| C006463 | allyl alcohol | allyl alcohol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11446826 |
| C006463 | allyl alcohol | allyl alcohol results in increased expression of PTGS2 mRNA | increases expression | 11446826 |
| C523074 | allylpyrocatechol | allylpyrocatechol inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 18431645 |
| C523074 | allylpyrocatechol | allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18602073 |
| C518327 | aloe emodin | aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| D013196 | Dihydrotestosterone | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16317058 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16317058 |
| D017962 | alpha-Linolenic Acid | alpha-Linolenic Acid results in increased expression of PTGS2 mRNA | increases expression | 17092368 |
| C049740 | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 12573452 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol metabolite results in decreased activity of PTGS2 protein | decreases activity | 15225597 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol results in decreased activity of PTGS2 protein | decreases activity | 15225597 |
| D000535 | Aluminum | Aluminum results in increased expression of PTGS2 mRNA | increases expression | 16928369 |
| D000535 | Aluminum | Aluminum results in increased expression of PTGS2 protein | increases expression | 16928369 |
| D000535 | Aluminum | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16928369 |
| D000535 | Aluminum | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16928369 |
| C041524 | aluminum sulfate | aluminum sulfate results in increased expression of PTGS2 mRNA | increases expression | 15961160 |
| C102609 | amarogentin | amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| C011164 | amentoflavone | amentoflavone results in decreased expression of PTGS2 mRNA | decreases expression | 12144868 |
| C011164 | amentoflavone | amentoflavone results in decreased expression of PTGS2 protein | decreases expression | 12144868 |
| C011164 | amentoflavone | [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases chemical synthesis|decreases expression | 12144868 |
| D000584 | Amiloride | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| D000638 | Amiodarone | Amiodarone results in increased expression of PTGS2 mRNA | increases expression | 19774075 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of PTGS2 mRNA | affects expression | 16483693 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in increased expression of PTGS2 mRNA | increases expression | 12558987 |
| D000667 | Ampicillin | Ampicillin inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 |
| D000894 | Anti-Inflammatory Agents, Non-Steroidal | Anti-Inflammatory Agents, Non-Steroidal results in decreased activity of PTGS2 protein | decreases activity | 17609663 12837940 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [IL1A protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12832416 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18596194 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18596194 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenite results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19808956 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 18481333 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | Sodium Selenite inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 18481333 |
| C034020 | anthracene | anthracene results in decreased activity of PTGS2 protein | decreases activity | 12163478 |
| D000968 | Antimycin A | Antimycin A results in increased expression of PTGS2 mRNA | increases expression | 19304788 |
| D047310 | Apigenin | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D047310 | Apigenin | PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D016718 | Arachidonic Acid | PTGS2 protein results in increased metabolism of Arachidonic Acid | increases metabolic processing | 10718109 |
| D016718 | Arachidonic Acid | Arachidonic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased expression of PTGS2 mRNA | increases expression | 18388244 17092368 |
| D016718 | Arachidonic Acid | Arachidonic Acid affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 19063610 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased activity of PTGS2 protein | increases activity | 11755111 |
| D016718 | Arachidonic Acid | Ibuprofen analog inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| D016718 | Arachidonic Acid | Indomethacin inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| D016718 | Arachidonic Acid | Naproxen inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| D016718 | Arachidonic Acid | PTGS2 protein affects the metabolism of Arachidonic Acid | affects metabolic processing | 12902868 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19162293 18938131 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 19063610 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| C081565 | arachidonyltrifluoromethane | arachidonyltrifluoromethane promotes the reaction [Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression|increases reaction | 19063610 |
| D001115 | Arecoline | Arecoline results in increased expression of PTGS2 | increases expression | 16311067 |
| D001151 | Arsenic | Arsenic results in increased expression of PTGS2 mRNA | increases expression | 18039032 |
| D001151 | Arsenic | Arsenic results in decreased expression of PTGS2 mRNA | decreases expression | 19654921 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of PTGS2 mRNA | increases expression | 18588940 17530438 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of PTGS2 protein | increases expression | 18588940 |
| C006632 | arsenic trioxide | CAT protein inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C006632 | arsenic trioxide | Melatonin inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C006632 | arsenic trioxide | Melatonin inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18588940 |
| C006632 | arsenic trioxide | Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C006632 | arsenic trioxide | Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18588940 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 20339114 |
| C015001 | arsenite | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenite results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19808956 |
| C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15894712 |
| C015001 | arsenite | arsenite results in decreased expression of PTGS2 mRNA | decreases expression | 15894712 |
| C015001 | arsenite | arsenite results in increased expression of PTGS2 mRNA | increases expression | 19808956 17450217 |
| C015001 | arsenite | arsenite results in increased expression of PTGS2 protein | increases expression | 17450217 19808956 |
| C015001 | arsenite | MAP3K8 protein affects the reaction [arsenite results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 19808956 |
| C015001 | arsenite | MAP3K8 protein affects the reaction [arsenite results in increased expression of PTGS2 protein] | affects reaction|increases expression | 19808956 |
| C015001 | arsenite | U 0126 inhibits the reaction [arsenite results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19808956 |
| D017638 | Asbestos, Crocidolite | Asbestos, Crocidolite results in increased expression of PTGS2 mRNA | increases expression | 18687144 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D001205 | Ascorbic Acid | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D001241 | Aspirin | Aspirin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D001241 | Aspirin | Aspirin results in decreased activity of PTGS2 protein | decreases activity | 15843042 |
| D001241 | Aspirin | PTGS2 gene SNP affects the susceptibility to Aspirin | affects response to substance | 20485159 |
| D001241 | Aspirin | Aspirin results in increased expression of PTGS2 mRNA | increases expression | 10706128 |
| D001241 | Aspirin | Aspirin results in decreased activity of PTGS2 protein | decreases activity | 18848576 |
| D001241 | Aspirin | Aspirin promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 10706128 |
| C065179 | atorvastatin | [atorvastatin co-treated with pioglitazone] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16908763 |
| C065179 | atorvastatin | atorvastatin results in increased expression of PTGS2 protein | increases expression | 16908763 |
| D001285 | Atropine | Atropine affects the reaction [Indomethacin results in increased expression of PTGS2] | affects reaction|increases expression | 16259740 |
| D001285 | Atropine | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15104355 |
| D001285 | Atropine | Atropine inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 15104355 |
| D001310 | Auranofin | [lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17034761 |
| C023663 | avarol | avarol analog results in decreased expression of PTGS2 mRNA | decreases expression | 16973179 |
| C023663 | avarol | avarol analog results in decreased expression of PTGS2 protein | decreases expression | 16973179 |
| D001397 | Azoxymethane | Azoxymethane results in increased expression of PTGS2 mRNA | increases expression | 12458338 |
| D001397 | Azoxymethane | [Curcumin co-treated with Azoxymethane] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17190766 |
| C006680 | baicalein | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18480072 |
| C416282 | BAY 11-7085 | BAY 11-7085 inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| D001514 | Bee Venoms | Bee Venoms analog results in decreased activity of PTGS2 protein | decreases activity | 12785734 |
| D001514 | Bee Venoms | Bee Venoms analog results in decreased expression of PTGS2 mRNA | decreases expression | 12785734 |
| C020710 | benzcoprine | benzcoprine results in decreased expression of PTGS2 mRNA | decreases expression | 10418820 |
| C029876 | benzidine | PTGS2 protein results in increased metabolism of benzidine | increases metabolic processing | 11159734 |
| C029876 | benzidine | PTGS2 protein results in increased metabolism of benzidine | increases metabolic processing | 11159734 |
| C017228 | benzo(a)pyrene 7,8-dihydrodiol | PTGS2 protein results in increased metabolism of benzo(a)pyrene 7,8-dihydrodiol | increases metabolic processing | 11159734 |
| C017228 | benzo(a)pyrene 7,8-dihydrodiol | PTGS2 protein results in increased metabolism of benzo(a)pyrene 7,8-dihydrodiol | increases metabolic processing | 11159734 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased activity of PTGS2 protein | decreases activity | 12163478 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 18164116 20045035 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 20045035 |
| D019324 | beta-Naphthoflavone | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| D019324 | beta-Naphthoflavone | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | increases expression | 20064835 18001219 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PTGS2 protein | increases expression | 16086235 |
| D001564 | Benzo(a)pyrene | Linoleic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001219 |
| D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15894712 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PTGS2 mRNA | increases expression | 20713471 15894712 20371670 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PTGS2 mRNA | affects expression | 20382639 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PTGS2 mRNA | increases expression | 19150397 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | DNMT3A protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PTGS2 protein modified form] | affects reaction|increases expression | 20426865 |
| D001585 | Benzoyl Peroxide | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15264312 |
| D001585 | Benzoyl Peroxide | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15264312 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [TNF protein results in increased secretion of PTGS2 protein] | decreases reaction|increases secretion | 11230753 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PTGS2 mRNA | increases expression | 18457675 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12721113 12628480 |
| C053541 | bicalutamide | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression | 16317058 |
| C541028 | bis(3-hydroxyphenyl) diselenide | bis(3-hydroxyphenyl) diselenide results in decreased expression of PTGS2 mRNA | decreases expression | 19298695 |
| C541028 | bis(3-hydroxyphenyl) diselenide | bis(3-hydroxyphenyl) diselenide results in decreased expression of PTGS2 protein | decreases expression | 19298695 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| D017438 | Bisphenol A-Glycidyl Methacrylate | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15264312 |
| D017438 | Bisphenol A-Glycidyl Methacrylate | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15264312 |
| C472777 | bisperoxovanadium | 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | bisperoxovanadium promotes the reaction [NFATC2 protein binds to PTGS2 promoter] | affects binding|increases reaction | 12493747 |
| C472777 | bisperoxovanadium | bisperoxovanadium results in increased expression of PTGS2 mRNA | increases expression | 12493747 |
| C472777 | bisperoxovanadium | Calcium affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | Cyclosporine inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | Forskolin promotes the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 12493747 |
| C472777 | bisperoxovanadium | LAT protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | LCK protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | NFATC2 protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | PTPN2 protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | PTPN6 protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | Tacrolimus inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| C472777 | bisperoxovanadium | ZAP70 protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| C006780 | bisphenol A | bisphenol A affects the expression of PTGS2 mRNA | affects expression | 20170705 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PTGS2 mRNA | increases expression | 19415476 |
| C006780 | bisphenol A | Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19415476 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PTGS2 mRNA | increases expression | 20096755 |
| C066686 | BN 50730 | BN 50730 inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| C066686 | BN 50730 | BN 50730 inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 9375567 |
| C500927 | bolinaquinone | bolinaquinone inhibits the reaction [Zymosan results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 12604694 |
| D019819 | Budesonide | Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 20061444 |
| D019819 | Budesonide | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15734790 |
| D002045 | Bupivacaine | Bupivacaine results in increased expression of PTGS2 mRNA | increases expression | 18165598 |
| D002045 | Bupivacaine | [Bupivacaine results in increased expression of PTGS2] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 18165598 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17640750 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11854442 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12872987 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12872987 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 14613874 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene results in increased expression of PTGS2 protein | increases expression | 11696405 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17067360 |
| D020122 | tert-Butylhydroperoxide | 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16417216 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] | decreases reaction|increases activity|increases reaction | 15705740 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA | increases expression | 16417216 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA | increases expression | 14729362 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased activity of PTGS2 protein | increases activity | 15604817 |
| D002087 | Butyrates | Butyrates results in decreased expression of PTGS2 mRNA | decreases expression | 16042588 |
| D020148 | Butyric Acid | Butyric Acid results in increased expression of PTGS2 mRNA | increases expression | 17928716 |
| C098384 | cacospongionolide B | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12721113 |
| D002104 | Cadmium | Quercetin inhibits the reaction [Cadmium results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16226777 |
| D000001 | Calcimycin | [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein | affects cotreatment|increases activity | 15705740 |
| D000001 | Calcimycin | tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] | decreases reaction|increases activity|increases reaction | 15705740 |
| D000001 | Calcimycin | 1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine promotes the reaction [Calcimycin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 9375567 |
| D000001 | Calcimycin | Calcimycin results in increased expression of PTGS2 mRNA | increases expression | 9375567 |
| D002118 | Calcium | Calcium affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747 |
| D002118 | Calcium | Calcium promotes the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 9375567 |
| D002136 | Calcium, Dietary | Calcium, Dietary affects the expression of PTGS2 protein | affects expression | 17182828 |
| D002136 | Calcium, Dietary | Genistein inhibits the reaction [Calcium, Dietary affects the expression of PTGS2 protein] | affects expression|decreases reaction | 17182828 |
| C459604 | candoxin | candoxin results in decreased expression of PTGS2 mRNA | decreases expression | 16309724 |
| C073718 | cannabidiol hydroxyquinone | cannabidiol hydroxyquinone results in increased expression of PTGS2 mRNA | increases expression | 16571653 |
| C110904 | capecitabine | capecitabine results in decreased expression of PTGS2 protein | decreases expression | 17904787 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of PTGS2 mRNA | decreases expression | 17719033 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTGS2 mRNA | increases expression | 17917259 16874658 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTGS2 protein | increases expression | 16539848 17917259 16874658 16508911 |
| D002251 | Carbon Tetrachloride | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17917259 |
| D002251 | Carbon Tetrachloride | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17917259 |
| D002251 | Carbon Tetrachloride | IL10 protein inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16539848 |
| D002251 | Carbon Tetrachloride | Nitroprusside inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16874658 |
| D002251 | Carbon Tetrachloride | POMC protein inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16508911 |
| D002251 | Carbon Tetrachloride | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16874658 |
| D002251 | Carbon Tetrachloride | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16874658 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the activity of PTGS2 protein | affects activity | 18420326 |
| D002251 | Carbon Tetrachloride | [Carbon Tetrachloride co-treated with Phenobarbital co-treated with Methoxamine] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 12500202 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTGS2 mRNA | increases expression | 16420518 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of PTGS2 protein | increases expression | 16420518 15876570 |
| C070053 | carbonyl 3-chlorophenylhydrazone | carbonyl 3-chlorophenylhydrazone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D002259 | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of PTGS2 mRNA | increases expression | 16039398 |
| D002351 | Carrageenan | Carrageenan inhibits the reaction [Raloxifene results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15860553 |
| D002351 | Carrageenan | Carrageenan results in increased expression of PTGS2 protein | increases expression | 15860553 |
| D002351 | Carrageenan | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14654164 |
| D002351 | Carrageenan | Quercetin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14654164 |
| D002392 | Catechin | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D002392 | Catechin | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D002392 | Catechin | Catechin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17103373 |
| D002392 | Catechin | Catechin results in decreased expression of PTGS2 mRNA | decreases expression | 10920275 |
| C105934 | celecoxib | celecoxib inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis | 16004971 |
| C105934 | celecoxib | celecoxib inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| C105934 | celecoxib | celecoxib results in decreased activity of PTGS2 protein | decreases activity | 18848576 17164136 16004971 |
| C105934 | celecoxib | [FEC protocol co-treated with celecoxib] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16507397 |
| C105934 | celecoxib | PTGS2 protein affects the reaction [celecoxib results in increased expression of DES mRNA] | affects reaction|increases expression | 18089846 |
| C105934 | celecoxib | PTGS2 protein affects the reaction [celecoxib results in increased expression of GDF15 mRNA] | affects reaction|increases expression | 18089846 |
| C105934 | celecoxib | PTGS2 protein affects the reaction [celecoxib results in increased expression of GSTP1 mRNA] | affects reaction|increases expression | 18089846 |
| C105934 | celecoxib | celecoxib results in decreased activity of PTGS2 protein alternative form | decreases activity | 11743745 |
| C105934 | celecoxib | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Mustard Gas | decreases activity|decreases response to substance | 15451306 |
| C105934 | celecoxib | [celecoxib results in decreased activity of PTGS2 protein] which results in increased susceptibility to Acetaminophen | decreases activity|increases response to substance | 11743745 |
| C105934 | celecoxib | celecoxib results in decreased expression of PTGS2 protein | decreases expression | 15570007 |
| C105934 | celecoxib | [celecoxib co-treated with sulindac sulfone] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17908994 |
| C105934 | celecoxib | celecoxib inhibits the reaction [PTGS2 protein affects the abundance of lipoxin A4] | affects abundance|decreases reaction | 15326064 |
| C105934 | celecoxib | celecoxib promotes the reaction [sulindac sulfone results in decreased expression of PTGS2 protein] | decreases expression|increases reaction | 17908994 |
| C105934 | celecoxib | celecoxib results in decreased activity of PTGS2 protein | decreases activity | 12727271 12967936 |
| C105934 | celecoxib | celecoxib results in decreased expression of PTGS2 protein | decreases expression | 12960143 17908994 |
| C105934 | celecoxib | celecoxib results in decreased activity of PTGS2 protein | decreases activity | 12902868 16052515 15700047 16707021 15964185 16357062 16369983 |
| C469298 | CEP-11004 | CEP-11004 results in decreased expression of PTGS2 mRNA | decreases expression | 15294995 |
| D002594 | Cetylpyridinium | [Triclosan co-treated with Cetylpyridinium] inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16253096 |
| D002594 | Cetylpyridinium | [Triclosan co-treated with Cetylpyridinium] inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16253096 |
| C095591 | chan su | chan su results in decreased expression of PTGS2 mRNA | decreases expression | 16012733 |
| C095591 | chan su | chan su results in decreased expression of PTGS2 protein | decreases expression | 16012733 |
| D002784 | Cholesterol | [Cholesterol co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 10964725 |
| D002784 | Cholesterol | [Estradiol co-treated with PTGS2 protein] affects the susceptibility to Cholesterol | affects cotreatment|affects response to substance | 10964725 |
| C043561 | chrysin | chrysin results in increased expression of PTGS2 mRNA | increases expression | 18457675 |
| C043561 | chrysin | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| C043561 | chrysin | PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| C043561 | chrysin | chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 21167192 |
| C039671 | ciglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [ciglitazone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16417216 |
| C039671 | ciglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [ciglitazone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16417216 |
| C039671 | ciglitazone | ciglitazone results in increased expression of PTGS2 mRNA | increases expression | 16417216 |
| C039671 | ciglitazone | ciglitazone results in increased expression of PTGS2 protein | increases expression | 16417216 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 16624280 |
| C012843 | cinnamic aldehyde | cinnamic aldehyde results in decreased expression of PTGS2 protein | decreases expression | 17486422 |
| C097256 | CNI 1493 | CNI 1493 results in decreased expression of PTGS2 protein | decreases expression | 15947118 |
| D003033 | Coal Tar | Coal Tar results in increased expression of PTGS2 mRNA | increases expression | 16882163 |
| D003035 | Cobalt | [tungsten carbide binds to Cobalt] which results in increased expression of PTGS2 mRNA | affects binding|increases expression | 20105288 |
| C018021 | cobaltous chloride | 1-Butanol inhibits the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17640750 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of PTGS2 mRNA | increases expression | 20105288 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of PTGS2 protein | increases expression | 17640750 |
| C018021 | cobaltous chloride | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | PD 169316 inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | PD 169316 inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein] | increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | Reactive Oxygen Species affects the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | affects reaction|increases expression|increases reaction | 17640750 |
| C018021 | cobaltous chloride | rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| D003300 | Copper | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 20302851 |
| D003345 | Corticosterone | Corticosterone results in increased expression of PTGS2 mRNA | increases expression | 15755911 |
| D003345 | Corticosterone | Corticosterone results in increased expression of PTGS2 protein | increases expression | 15755911 |
| C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in increased expression of PTGS2 protein | increases expression | 16116226 |
| C534043 | CR 3294 | CR 3294 results in decreased expression of PTGS2 mRNA | decreases expression | 18927491 |
| D003436 | Croton Oil | [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16517061 |
| D003436 | Croton Oil | amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| D003436 | Croton Oil | Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| D003474 | Curcumin | Curcumin analog results in decreased expression of PTGS2 mRNA | decreases expression | 17671737 19250217 |
| D003474 | Curcumin | Curcumin inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17291458 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16243823 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16243823 |
| D003474 | Curcumin | Curcumin inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 17151092 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16219905 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17291458 15489888 17640567 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNFSF11 protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15129424 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17363495 |
| D003474 | Curcumin | Curcumin inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18596194 |
| D003474 | Curcumin | Curcumin inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18596194 |
| D003474 | Curcumin | Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin promotes the reaction [Folfox protocol results in decreased phosphorylation of and results in decreased activity of PTGS2 protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D003474 | Curcumin | Curcumin results in decreased expression of PTGS2 mRNA | decreases expression | 19250217 15911101 17671737 17671742 18348204 17999991 |
| D003474 | Curcumin | Curcumin results in decreased expression of PTGS2 protein | decreases expression | 16023083 17671742 15841493 18226269 16340194 |
| D003474 | Curcumin | Curcumin results in decreased phosphorylation of and results in decreased activity of PTGS2 protein | decreases activity|decreases phosphorylation | 17918158 |
| D003474 | Curcumin | [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16340194 |
| D003474 | Curcumin | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 17640567 |
| D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in decreased expression of PTGS2 protein] | decreases expression|increases reaction | 18226269 |
| D003474 | Curcumin | Curcumin affects the expression of PTGS2 mRNA | affects expression | 18752423 |
| D003474 | Curcumin | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16934760 |
| D003474 | Curcumin | [Curcumin co-treated with gemcitabine] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17440100 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17436566 16934760 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16678799 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18200517 |
| D003474 | Curcumin | Curcumin results in decreased expression of PTGS2 protein | decreases expression | 17885582 18829502 17440100 |
| D003474 | Curcumin | [Curcumin co-treated with Azoxymethane] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17190766 |
| D003474 | Curcumin | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18368483 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Quartz results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001810 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16804969 16782535 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16804969 16782535 |
| D003474 | Curcumin | Curcumin inhibits the reaction [VIP protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17434257 |
| D003474 | Curcumin | Curcumin results in increased expression of PTGS2 mRNA | increases expression | 17190766 18001810 |
| D003474 | Curcumin | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19243473 |
| D003474 | Curcumin | Curcumin results in decreased expression of PTGS2 | decreases expression | 18462866 |
| C017154 | cyanidin | cyanidin results in decreased activity of PTGS2 protein | decreases activity | 10075763 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| D003513 | Cycloheximide | Cycloheximide promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11286988 |
| D003513 | Cycloheximide | Cycloheximide results in increased expression of PTGS2 mRNA | increases expression | 11286988 |
| D003520 | Cyclophosphamide | PTGS2 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of PTGS2 mRNA | increases expression | 15331540 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of PTGS2 mRNA | increases expression | 12388444 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of PTGS2 protein | increases expression | 12388444 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17312158 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17312158 |
| D018119 | Stavudine | Stavudine results in decreased expression of PTGS2 protein | decreases expression | 18389896 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [1-O-hexadecyl-2-N-methylcarbamylphosphatidylcholine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| D003609 | Dactinomycin | Dactinomycin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11286988 |
| D003609 | Dactinomycin | Dactinomycin results in decreased expression of PTGS2 mRNA | decreases expression | 11286988 |
| C004742 | daidzein | [daidzein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19347870 |
| C004742 | daidzein | daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| C004742 | daidzein | daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| C014347 | decitabine | decitabine affects the expression of PTGS2 mRNA | affects expression | 17145863 |
| C107676 | deguelin | deguelin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17015749 |
| C496603 | dehydrodiisoeugenol | dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17436566 |
| D015230 | Prostaglandin D2 | [Acetaminophen results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Prostaglandin D2 | increases chemical synthesis|increases expression | 11743745 |
| D013759 | Tetrahydrocannabinol | Tetrahydrocannabinol results in increased expression of PTGS2 mRNA | increases expression | 16039398 |
| C050229 | demethoxycurcumin | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| C050229 | demethoxycurcumin | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| C050718 | dentinol | Acetylcysteine inhibits the reaction [dentinol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15576159 |
| C050718 | dentinol | dentinol results in increased expression of PTGS2 mRNA | increases expression | 15576159 |
| C007262 | deoxynivalenol | deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11922776 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of PTGS2 mRNA | increases expression | 11922776 14514436 12377986 15570035 12649040 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of PTGS2 protein | increases expression | 12649040 12377986 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased stability of PTGS2 mRNA | increases stability | 12377986 |
| C007262 | deoxynivalenol | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15570035 |
| C007262 | deoxynivalenol | Indomethacin promotes the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12377986 |
| C007262 | deoxynivalenol | PD 98059 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12377986 |
| C007262 | deoxynivalenol | PD 98059 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12377986 |
| C007262 | deoxynivalenol | PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA] | affects reaction|increases expression | 12649040 |
| C007262 | deoxynivalenol | PTGS2 protein affects the reaction [deoxynivalenol results in increased expression of IL6 protein] | affects reaction|increases expression | 12649040 |
| C007262 | deoxynivalenol | SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12377986 |
| C007262 | deoxynivalenol | SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12377986 |
| C007262 | deoxynivalenol | SB 203580 inhibits the reaction [deoxynivalenol results in increased stability of PTGS2 mRNA] | decreases reaction|increases stability | 12377986 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16354411 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16354411 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19255438 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of PTGS2 protein | decreases expression | 15680906 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16880258 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 12604694 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11454666 12628480 |
| D003907 | Dexamethasone | DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression | 16880258 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16782535 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16782535 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11099482 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11099482 |
| D003907 | Dexamethasone | Dexamethasone results in decreased expression of PTGS2 mRNA | decreases expression | 12837037 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of PTGS2 mRNA | increases expression | 15652231 |
| D016264 | Dextran Sulfate | Dextran Sulfate results in increased expression of PTGS2 protein | increases expression | 16049979 |
| D016264 | Dextran Sulfate | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15652231 |
| C493686 | diacetylcurcumin | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D016190 | Carboplatin | PTGS2 protein results in decreased susceptibility to Carboplatin | decreases response to substance | 18089846 |
| D016190 | Carboplatin | wortmannin inhibits the reaction [PTGS2 protein results in decreased susceptibility to Carboplatin] | decreases reaction|decreases response to substance | 18089846 |
| C061481 | dibenzoylmethane | dibenzoylmethane results in decreased expression of PTGS2 protein | decreases expression | 17942926 |
| D002945 | Cisplatin | [Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein | affects cotreatment|affects expression | 16322294 |
| D002945 | Cisplatin | Cisplatin results in increased expression of PTGS2 mRNA | increases expression | 15846114 |
| D002945 | Cisplatin | [PTGS2 protein results in increased expression of ABCC1 protein] which results in increased susceptibility to Cisplatin | increases expression|increases response to substance | 18695918 |
| D002945 | Cisplatin | [PTGS2 protein results in increased expression of ABCC2 protein] which results in increased susceptibility to Cisplatin | increases expression|increases response to substance | 18695918 |
| D002945 | Cisplatin | PTGS2 results in decreased susceptibility to Cisplatin | decreases response to substance | 15517878 |
| D004008 | Diclofenac | Diclofenac inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| D004008 | Diclofenac | Diclofenac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D004008 | Diclofenac | Diclofenac results in decreased activity of PTGS2 protein | decreases activity | 17164136 |
| D004008 | Diclofenac | Acetaminophen inhibits the reaction [Diclofenac results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15626590 |
| D004008 | Diclofenac | Diclofenac results in decreased activity of PTGS2 protein | decreases activity | 12242329 |
| D004008 | Diclofenac | Diclofenac results in increased expression of PTGS2 protein | increases expression | 15626590 |
| D004052 | Diethylnitrosamine | CTNNB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 20583210 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of PTGS2 protein | increases expression | 20583210 |
| D004052 | Diethylnitrosamine | chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 21167192 |
| D004052 | Diethylnitrosamine | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 20302851 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 18164116 20045035 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 20045035 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of PTGS2 mRNA | increases expression | 21167192 19539802 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of PTGS2 protein | increases expression | 20405173 |
| D004052 | Diethylnitrosamine | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| D004052 | Diethylnitrosamine | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| D004052 | Diethylnitrosamine | morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19539802 |
| D004052 | Diethylnitrosamine | morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539802 |
| D004052 | Diethylnitrosamine | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 20405173 |
| D002117 | Calcitriol | Calcitriol results in increased expression of PTGS2 mRNA | increases expression | 16002434 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16517061 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16891317 |
| D015064 | 16,16-Dimethylprostaglandin E2 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 |
| C084527 | dioctanoylphosphatidic acid | dioctanoylphosphatidic acid results in increased expression of PTGS2 protein | increases expression | 11854442 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16331273 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D004221 | Disulfiram | Disulfiram results in decreased expression of PTGS2 mRNA | decreases expression | 10418820 |
| C067311 | docetaxel | docetaxel results in increased expression of PTGS2 mRNA | increases expression | 15623590 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15570035 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased expression of PTGS2 mRNA | decreases expression | 17056761 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of PTGS2 mRNA | decreases expression | 15205334 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of PTGS2 mRNA | increases expression | 15501994 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of PTGS2 protein | increases expression | 15501994 |
| D004317 | Doxorubicin | PTGS2 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 18498876 |
| D004317 | Doxorubicin | CSF3 protein inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17334414 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of PTGS2 protein | increases expression | 17334414 16449733 |
| D004317 | Doxorubicin | EPO protein inhibits the reaction [Doxorubicin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16449733 |
| D004317 | Doxorubicin | Iloprost inhibits the reaction [PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]] | decreases reaction|increases expression|increases reaction | 16617129 |
| D004317 | Doxorubicin | PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA] | increases expression|increases reaction | 16617129 |
| D004317 | Doxorubicin | PTGS2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16617129 |
| C514017 | DP 155 | DP 155 results in decreased activity of PTGS2 protein | decreases activity | 17627676 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19415476 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Estradiol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14758024 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Estradiol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 14758024 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17996413 |
| D004365 | Drugs, Chinese Herbal | Drugs, Chinese Herbal inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17996413 |
| C064874 | DuP 697 | DuP 697 results in decreased activity of PTGS2 protein | decreases activity | 12163478 |
| D004391 | Dust | Dust results in increased expression of PTGS2 mRNA | increases expression | 17805423 |
| C046770 | EGTA acetoxymethyl ester | EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19147701 18388244 |
| D015118 | Eicosapentaenoic Acid | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 12573452 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12573452 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid results in increased expression of PTGS2 mRNA | increases expression | 17092368 |
| D015118 | Eicosapentaenoic Acid | Nordihydroguaiaretic Acid inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 12573452 |
| D015118 | Eicosapentaenoic Acid | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15890784 |
| C044101 | endotoxin, Escherichia coli | Ascorbic Acid inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases reaction | 16997862 |
| C044101 | endotoxin, Escherichia coli | endotoxin, Escherichia coli results in increased expression of PTGS2 protein | increases expression | 17637181 16997862 |
| C044101 | endotoxin, Escherichia coli | eugenosedin-A inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| C044101 | endotoxin, Escherichia coli | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16997862 |
| C044101 | endotoxin, Escherichia coli | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C044101 | endotoxin, Escherichia coli | Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate promotes the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 16206353 |
| C045651 | epigallocatechin gallate | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of PTGS2 mRNA | decreases expression | 16084531 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of PTGS2 protein | increases expression | 15210717 |
| C045651 | epigallocatechin gallate | Go 6976 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C045651 | epigallocatechin gallate | Go 6976 inhibits the reaction [PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 15210717 |
| C045651 | epigallocatechin gallate | PLD1 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | increases expression|increases reaction | 15210717 |
| C045651 | epigallocatechin gallate | PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | increases expression|increases reaction | 15210717 |
| C045651 | epigallocatechin gallate | Propranolol promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | increases expression|increases reaction | 15210717 |
| C045651 | epigallocatechin gallate | SB 203580 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C045651 | epigallocatechin gallate | SB 203580 inhibits the reaction [PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 15210717 |
| C045651 | epigallocatechin gallate | 1-Butanol inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of PTGS2 protein | increases expression | 15210717 |
| C045651 | epigallocatechin gallate | Go 6976 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C045651 | epigallocatechin gallate | SB 203580 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C028044 | epoxy resin AH-26 | epoxy resin AH-26 promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| C028044 | epoxy resin AH-26 | epoxy resin AH-26 results in increased expression of PTGS2 mRNA | increases expression | 17963957 |
| C028044 | epoxy resin AH-26 | Lipopolysaccharides promotes the reaction [epoxy resin AH-26 results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| C007610 | equol | equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| C007610 | equol | equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| D004958 | Estradiol | Acetylcysteine inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| D004958 | Estradiol | BAY 11-7085 inhibits the reaction [Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 18480072 |
| D004958 | Estradiol | Estradiol affects the expression of PTGS2 mRNA | affects expression | 14699072 |
| D004958 | Estradiol | [Estradiol co-treated with ESR1 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19347870 |
| D004958 | Estradiol | [Estradiol co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19347870 |
| D004958 | Estradiol | Estradiol inhibits the reaction [NCOR1 protein binds to PTGS2 promoter] | affects binding|decreases reaction | 17872375 |
| D004958 | Estradiol | Estradiol promotes the reaction [[2-hydroxyestradiol co-treated with 4-hydroxyestradiol-17 beta] results in increased expression of PTGS2 mRNA] | affects cotreatment|increases expression|increases reaction | 18480072 |
| D004958 | Estradiol | Estradiol promotes the reaction [CREBBP protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D004958 | Estradiol | Estradiol promotes the reaction [ESR1 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D004958 | Estradiol | Estradiol promotes the reaction [ESR2 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D004958 | Estradiol | Estradiol promotes the reaction [NCOA2 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D004958 | Estradiol | Estradiol promotes the reaction [NCOA3 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D004958 | Estradiol | Estradiol results in decreased expression of PTGS2 mRNA | decreases expression | 17872375 |
| D004958 | Estradiol | Estradiol results in increased expression of PTGS2 mRNA | increases expression | 17872375 15849065 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17404688 |
| D004958 | Estradiol | Drugs, Chinese Herbal inhibits the reaction [Estradiol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14758024 |
| D004958 | Estradiol | Drugs, Chinese Herbal inhibits the reaction [Estradiol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 14758024 |
| D004958 | Estradiol | Estradiol results in increased expression of PTGS2 mRNA | increases expression | 14758024 |
| D004958 | Estradiol | Estradiol results in increased expression of PTGS2 protein | increases expression | 14758024 17549036 |
| D004958 | Estradiol | [Cholesterol co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 10964725 |
| D004958 | Estradiol | [Estradiol co-treated with PTGS2 protein] affects the susceptibility to Cholesterol | affects cotreatment|affects response to substance | 10964725 |
| D004958 | Estradiol | Estradiol results in increased expression of PTGS2 mRNA | increases expression | 17616731 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15829624 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15829624 |
| D004958 | Estradiol | [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16891317 |
| D000431 | Ethanol | Butylated Hydroxytoluene inhibits the reaction [Ethanol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17067360 |
| D000431 | Ethanol | Ethanol results in increased expression of PTGS2 mRNA | increases expression | 17067360 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of PTGS2 mRNA | affects expression | 20170705 |
| C039614 | ethylisopropylamiloride | ethylisopropylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| D017308 | Etodolac | Etodolac inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis | 16004971 |
| D017308 | Etodolac | Etodolac results in decreased activity of PTGS2 protein | decreases activity | 16004971 |
| D017308 | Etodolac | Etodolac results in decreased activity of PTGS2 protein | decreases activity | 16979129 |
| D017308 | Etodolac | Etodolac results in decreased activity of PTGS2 protein | decreases activity | 16104877 |
| C422649 | etoricoxib | etoricoxib results in decreased activity of PTGS2 protein | decreases activity | 17164136 |
| C422649 | etoricoxib | etoricoxib results in decreased activity of PTGS2 protein | decreases activity | 17225004 17931847 |
| C496985 | eugenosedin-A | eugenosedin-A inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C496985 | eugenosedin-A | eugenosedin-A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C107135 | everolimus | everolimus results in increased expression of PTGS2 mRNA | increases expression | 15937522 |
| C107135 | everolimus | everolimus results in increased expression of PTGS2 protein | increases expression | 15937522 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15710601 |
| D005231 | Fatty Acids, Unsaturated | Fatty Acids, Unsaturated inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| C052498 | FEC protocol | [FEC protocol co-treated with celecoxib] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16507397 |
| C004999 | ferulic acid | ferulic acid results in decreased expression of PTGS2 protein | decreases expression | 15841493 |
| C004999 | ferulic acid | ferulic acid analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17436566 |
| D005395 | Fish Oils | Fish Oils results in decreased expression of PTGS2 mRNA | decreases expression | 14690764 |
| D005439 | Flufenamic Acid | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 10866999 |
| D005439 | Flufenamic Acid | Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 10866999 |
| D005439 | Flufenamic Acid | [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein | increases activity|increases expression | 10866999 |
| D005439 | Flufenamic Acid | Flufenamic Acid results in increased expression of PTGS2 mRNA | increases expression | 10866999 |
| D005439 | Flufenamic Acid | Flufenamic Acid results in increased expression of PTGS2 protein | increases expression | 10866999 |
| D005472 | Fluorouracil | [Cisplatin co-treated with Fluorouracil] affects the expression of PTGS2 protein | affects cotreatment|affects expression | 16322294 |
| D005472 | Fluorouracil | Curcumin promotes the reaction [Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with Curcumin] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16340194 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of PTGS2 mRNA | decreases expression | 15205334 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of PTGS2 protein | decreases expression | 16340194 |
| D005472 | Fluorouracil | Fluorouracil results in decreased phosphorylation of and results in decreased activity of PTGS2 protein | decreases activity|decreases phosphorylation | 17918158 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of PTGS2 mRNA | increases expression | 15846114 |
| D005472 | Fluorouracil | PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP3 protein] | decreases reaction|increases activity | 12414664 |
| D005472 | Fluorouracil | PTGS2 protein inhibits the reaction [Fluorouracil results in increased activity of CASP9 protein] | decreases reaction|increases activity | 12414664 |
| D005472 | Fluorouracil | PTGS2 protein results in increased susceptibility to Fluorouracil | increases response to substance | 12414664 |
| D005475 | Flupenthixol | Flupenthixol results in decreased expression of PTGS2 protein | decreases expression | 8897462 |
| D005480 | Flurbiprofen | Flurbiprofen results in decreased activity of PTGS2 protein | decreases activity | 18848576 |
| D005480 | Flurbiprofen | Flurbiprofen results in decreased expression of PTGS2 mRNA | decreases expression | 16949054 |
| D005480 | Flurbiprofen | Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11099482 |
| D005480 | Flurbiprofen | Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11099482 |
| C410216 | Folfox protocol | Curcumin promotes the reaction [Folfox protocol results in decreased phosphorylation of and results in decreased activity of PTGS2 protein] | decreases activity|decreases phosphorylation|increases reaction | 17918158 |
| C410216 | Folfox protocol | Folfox protocol results in decreased phosphorylation of and results in decreased activity of PTGS2 protein | decreases activity|decreases phosphorylation | 17918158 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PTGS2 mRNA | increases expression | 12946449 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased expression of PTGS2 protein | increases expression | 12946449 |
| D005576 | Forskolin | Forskolin promotes the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 12493747 |
| D005576 | Forskolin | Forskolin results in increased expression of PTGS2 mRNA | increases expression | 12493747 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17407152 |
| D005576 | Forskolin | Forskolin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| D005576 | Forskolin | Forskolin results in increased expression of PTGS2 mRNA | increases expression | 15213229 |
| D005632 | Fructose | Fructose results in increased expression of PTGS2 mRNA | increases expression | 14757778 |
| D005665 | Furosemide | Furosemide affects the expression of PTGS2 mRNA | affects expression | 11961000 |
| D005665 | Furosemide | Furosemide affects the expression of PTGS2 protein | affects expression | 11961000 |
| D005665 | Furosemide | Furosemide results in increased expression of PTGS2 mRNA | increases expression | 11135058 |
| D005665 | Furosemide | Furosemide results in increased expression of PTGS2 protein | increases expression | 11135058 |
| C002469 | fusarenon-X | fusarenon-X results in increased expression of PTGS2 mRNA | increases expression | 14514436 |
| D017965 | gamma-Linolenic Acid | gamma-Linolenic Acid results in increased expression of PTGS2 mRNA | increases expression | 17092368 |
| D024504 | gamma-Tocopherol | gamma-Tocopherol results in decreased activity of PTGS2 protein | decreases activity | 15225597 |
| C419708 | gefitinib | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] | affects cotreatment|decreases expression|increases reaction | 16322342 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] | affects binding|decreases reaction|increases activity | 11133817 |
| C001277 | geldanamycin | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11133817 |
| C056507 | gemcitabine | [Curcumin co-treated with gemcitabine] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17440100 |
| D019833 | Genistein | [Genistein co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19347870 |
| D019833 | Genistein | Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| D019833 | Genistein | Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| D019833 | Genistein | Genistein inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 10783318 |
| D019833 | Genistein | Genistein results in decreased expression of PTGS2 mRNA | decreases expression | 10783318 |
| D019833 | Genistein | Genistein inhibits the reaction [Calcium, Dietary affects the expression of PTGS2 protein] | affects expression|decreases reaction | 17182828 |
| D019833 | Genistein | Genistein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D005839 | Gentamicins | Gentamicins results in increased expression of PTGS2 protein | increases expression | 18842672 |
| C478099 | gigantol | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16924582 |
| C478099 | gigantol | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16924582 |
| C007845 | gingerol | gingerol affects the expression of PTGS2 mRNA | affects expression | 17454143 |
| C007845 | gingerol | gingerol affects the expression of PTGS2 protein | affects expression | 17454143 |
| C007845 | gingerol | gingerol affects the expression of PTGS2 mRNA | affects expression | 17454143 |
| C007845 | gingerol | gingerol affects the expression of PTGS2 protein | affects expression | 17454143 |
| C007845 | gingerol | gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| C112772 | ginsenoside M1 | ginsenoside M1 results in decreased expression of PTGS2 mRNA | decreases expression | 15914323 |
| C112772 | ginsenoside M1 | ginsenoside M1 results in decreased expression of PTGS2 protein | decreases expression | 15802804 |
| D005947 | Glucose | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Catechin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | epigallocatechin gallate inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Glucose results in increased expression of PTGS2 mRNA | increases expression | 19557821 19225232 |
| D005947 | Glucose | Glucose results in increased expression of PTGS2 protein | increases expression | 19557821 |
| D005947 | Glucose | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D005947 | Glucose | Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]] | increases expression|increases reaction | 19225232 |
| D005947 | Glucose | Glucose results in increased expression of PTGS2 mRNA | increases expression | 19861503 |
| D005947 | Glucose | Glucose results in increased expression of PTGS2 protein | increases expression | 19861503 |
| D005947 | Glucose | IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19861503 |
| D005947 | Glucose | IL1RN protein inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19861503 |
| D005978 | Glutathione | Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 17640567 |
| C531349 | glycyrol | glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18666753 |
| D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17917259 |
| D019695 | Glycyrrhizic Acid | Glycyrrhizic Acid inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17917259 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 15210717 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| D006139 | Guaiacol | Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 17465205 |
| D006152 | Cyclic GMP | Cyclic GMP inhibits the reaction [7-nitroindazole results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 10894794 |
| D006152 | Cyclic GMP | Cyclic GMP results in increased expression of PTGS2 protein | increases expression | 10894794 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [VEGFA protein results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| C120099 | GW 1929 | GW 1929 inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| D019307 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18938131 |
| D019307 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D006221 | Halothane | Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11506125 |
| C020754 | herbimycin | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] | affects binding|decreases reaction|increases activity | 11133817 |
| C020754 | herbimycin | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11133817 |
| C020754 | herbimycin | herbimycin results in decreased expression of PTGS2 mRNA | decreases expression | 11133817 |
| D006569 | Hesperidin | Hesperidin inhibits the reaction [Acetaldehyde results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19110045 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539808 |
| C005499 | honokiol | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539808 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16230421 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16230421 |
| D017313 | Fenretinide | Fenretinide results in increased expression of PTGS2 mRNA | increases expression | 15958647 |
| D017313 | Fenretinide | PTGS2 protein results in decreased susceptibility to Fenretinide | decreases response to substance | 16127422 |
| D017313 | Fenretinide | [PTGS2 protein results in increased chemical synthesis of Dinoprostone] which results in decreased susceptibility to Fenretinide | decreases response to substance|increases chemical synthesis | 16127422 |
| D006851 | Hydrochloric Acid | [Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15309881 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of PTGS2 mRNA | increases expression | 15309881 12853844 |
| D006851 | Hydrochloric Acid | Hydrochloric Acid results in increased expression of PTGS2 protein | increases expression | 12853844 15309881 |
| D006854 | Hydrocortisone | Hydrocortisone inhibits the reaction [EGF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17805209 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of PTGS2 mRNA | increases expression | 11165876 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of PTGS2 protein | increases activity | 15604817 |
| D016627 | Oxidopamine | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Oxidopamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17855475 |
| D016627 | Oxidopamine | Oxidopamine results in increased expression of PTGS2 protein | increases expression | 17855475 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of PTGS2 protein | increases expression | 16105799 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D007052 | Ibuprofen | Ibuprofen results in decreased activity of PTGS2 protein | decreases activity | 18848576 17164136 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of PTGS2 mRNA | increases expression | 16678543 |
| D007052 | Ibuprofen | PTGS2 gene SNP results in increased susceptibility to Ibuprofen | increases response to substance | 16678543 |
| D007052 | Ibuprofen | tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| D007052 | Ibuprofen | Ibuprofen results in decreased activity of PTGS2 protein | decreases activity | 12242329 |
| D007052 | Ibuprofen | Ibuprofen results in decreased expression of PTGS2 mRNA | decreases expression | 15817521 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of PTGS2 protein | increases expression | 10484518 |
| D007052 | Ibuprofen | Ibuprofen analog inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16997862 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| D007052 | Ibuprofen | Ibuprofen inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16997862 |
| D007052 | Ibuprofen | Ibuprofen results in decreased expression of PTGS2 mRNA | decreases expression | 10697514 16249722 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of PTGS2 mRNA | increases expression | 18096423 |
| D016285 | Iloprost | Iloprost inhibits the reaction [PTGS2 gene mutant form promotes the reaction [Doxorubicin results in increased expression of STK17B mRNA]] | decreases reaction|increases expression|increases reaction | 16617129 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15811958 |
| C514526 | indole-5-carboxamide | indole-5-carboxamide inhibits the reaction [Ozone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18926814 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of PTGS2 protein | decreases activity | 11852909 |
| D007213 | Indomethacin | Indomethacin analog results in decreased activity of PTGS2 protein | decreases activity | 16690318 12142058 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of PTGS2 protein | decreases expression | 10866311 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PTGS2 protein | increases expression | 10866999 15482327 |
| D007213 | Indomethacin | allylpyrocatechol inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 18431645 |
| D007213 | Indomethacin | Indomethacin analog binds to and results in decreased activity of PTGS2 protein | affects binding|decreases activity | 12135387 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 18617548 |
| D007213 | Indomethacin | Indomethacin promotes the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12377986 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of PTGS2 protein | decreases activity | 12242329 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of PTGS2 protein | decreases expression | 18431645 18237397 17977527 17329845 |
| D007213 | Indomethacin | malabaricone B inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17977527 |
| D007213 | Indomethacin | malabaricone C inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17977527 |
| D007213 | Indomethacin | oren gedoku to inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17329845 |
| D007213 | Indomethacin | Plant Extracts inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 18237397 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of PTGS2 protein | decreases activity | 17397826 |
| D007213 | Indomethacin | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester inhibits the reaction [Indomethacin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 16818512 |
| D007213 | Indomethacin | Atropine affects the reaction [Indomethacin results in increased expression of PTGS2] | affects reaction|increases expression | 16259740 |
| D007213 | Indomethacin | Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15104355 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12428691 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of PTGS2 mRNA | decreases expression | 18096423 |
| D007213 | Indomethacin | Indomethacin results in increased activity of PTGS2 protein | increases activity | 16818512 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PTGS2 | increases expression | 16259740 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PTGS2 mRNA | increases expression | 15831440 15610444 15104355 16699067 |
| D007213 | Indomethacin | Indomethacin results in increased expression of PTGS2 protein | increases expression | 12428691 |
| D007213 | Indomethacin | nitroaspirin inhibits the reaction [Indomethacin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 16818512 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of PTGS2 protein | decreases activity | 10388637 16391822 12606626 10718109 |
| C489645 | indomethacin phenethylamide | indomethacin phenethylamide metabolite results in decreased activity of PTGS2 protein | decreases activity | 14709628 |
| C489645 | indomethacin phenethylamide | indomethacin phenethylamide results in decreased activity of PTGS2 protein | decreases activity | 14709628 |
| D007455 | Iodine | Iodine affects the reaction [Mustard Gas results in increased expression of PTGS2 protein] | affects reaction|increases expression | 11305779 |
| D007501 | Iron | [Copper co-treated with Diethylnitrosamine co-treated with Iron] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 20302851 |
| D015056 | 1-Methyl-3-isobutylxanthine | 1-Methyl-3-isobutylxanthine results in increased expression of PTGS2 mRNA | increases expression | 15213229 |
| C016527 | isoquercitrin | isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14654164 |
| C016527 | isoquercitrin | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| C016527 | isoquercitrin | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 20045035 |
| C006552 | kaempferol | kaempferol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 10783318 |
| C006552 | kaempferol | kaempferol results in decreased expression of PTGS2 mRNA | decreases expression | 17184768 10783318 |
| C006552 | kaempferol | kaempferol results in decreased expression of PTGS2 protein | decreases expression | 17184768 |
| C006552 | kaempferol | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C006552 | kaempferol | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| C006552 | kaempferol | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D007608 | Kainic Acid | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D007608 | Kainic Acid | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D007608 | Kainic Acid | Kainic Acid results in increased expression of PTGS2 mRNA | increases expression | 17827730 |
| C119620 | kenpaullone | kenpaullone results in increased expression of PTGS2 mRNA | increases expression | 17993264 |
| D015121 | 6-Ketoprostaglandin F1 alpha | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha | increases abundance|increases expression | 16325209 |
| D015121 | 6-Ketoprostaglandin F1 alpha | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | increases abundance|increases expression|increases reaction | 16325209 |
| D015121 | 6-Ketoprostaglandin F1 alpha | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | decreases reaction|increases abundance|increases expression | 16325209 |
| D020910 | Ketorolac | Ketorolac results in increased expression of PTGS2 mRNA | increases expression | 17175104 |
| C093700 | L 745337 | L 745337 results in decreased activity of PTGS2 protein | decreases activity | 8621535 |
| C093700 | L 745337 | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of 8-epi-prostaglandin F2alpha | decreases activity|decreases chemical synthesis | 8621535 |
| C093700 | L 745337 | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases activity|decreases chemical synthesis | 8621535 |
| C093700 | L 745337 | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Thromboxane B2 | decreases activity|decreases chemical synthesis | 8621535 |
| C505055 | L 748706 | L 748706 results in decreased activity of PTGS2 protein | decreases activity | 15878914 |
| C505055 | L 748706 | Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] | decreases activity|increases reaction | 15878914 |
| C082161 | lipopolysaccharide A | [lipopolysaccharide A co-treated with Auranofin] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17034761 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein | increases expression | 8621535 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha | increases chemical synthesis|increases expression | 8621535 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 8621535 |
| C433788 | lipopolysaccharide, E. coli 026-B6 | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases chemical synthesis|increases expression | 8621535 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | aloe emodin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA | increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein | increases expression | 17439952 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17439952 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17439952 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Ibuprofen inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | Ibuprofen inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16997862 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases reaction | 16997862 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA | increases expression | 15734790 |
| C440499 | lipopolysaccharide, Escherichia coli 0111 B4 | lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein | increases expression | 16997862 |
| D008070 | Lipopolysaccharides | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12604364 |
| D008070 | Lipopolysaccharides | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2] | decreases reaction|increases activity|increases chemical synthesis | 19934399 |
| D008070 | Lipopolysaccharides | 6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | Arachidonic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| D008070 | Lipopolysaccharides | bicalutamide inhibits the reaction [Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression | 16317058 |
| D008070 | Lipopolysaccharides | Cycloheximide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | Dihydrotestosterone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16317058 |
| D008070 | Lipopolysaccharides | Eicosapentaenoic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| D008070 | Lipopolysaccharides | Fatty Acids, Unsaturated inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15684433 |
| D008070 | Lipopolysaccharides | Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 10866999 |
| D008070 | Lipopolysaccharides | Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15047127 |
| D008070 | Lipopolysaccharides | Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15047127 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15779068 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased activity of PTGS2 protein | increases activity | 19934399 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases activity|increases chemical synthesis | 19934399 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein | increases activity|increases expression | 7575673 15964894 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases activity|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 mRNA | increases expression | 12604364 15047127 16317058 15860229 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 protein | increases expression | 16116226 19020770 10866999 15047127 |
| D008070 | Lipopolysaccharides | manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | Nordihydroguaiaretic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | scalaradial inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | scalaradial inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| D008070 | Lipopolysaccharides | [Tretinoin co-treated with Lipopolysaccharides co-treated with trichostatin A] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16959971 |
| D008070 | Lipopolysaccharides | [Tretinoin co-treated with Lipopolysaccharides] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16959971 |
| D008070 | Lipopolysaccharides | 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12872987 |
| D008070 | Lipopolysaccharides | 1-Butanol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12872987 |
| D008070 | Lipopolysaccharides | 2,2'-biphenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 19528508 |
| D008070 | Lipopolysaccharides | [4,4'-dihydroxybiphenyl co-treated with Lipopolysaccharides] results in increased expression of PTGS2 | affects cotreatment|increases expression | 19528508 |
| D008070 | Lipopolysaccharides | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | 5-dimethylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| D008070 | Lipopolysaccharides | allylpyrocatechol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18602073 |
| D008070 | Lipopolysaccharides | Amiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| D008070 | Lipopolysaccharides | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 18481333 |
| D008070 | Lipopolysaccharides | Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | arsenic trioxide promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 20339114 |
| D008070 | Lipopolysaccharides | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | bis(4-hydroxycinnamoyl)methane inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | CD14 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| D008070 | Lipopolysaccharides | chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16934760 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16934760 17436566 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16678799 |
| D008070 | Lipopolysaccharides | dehydrodiisoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17436566 |
| D008070 | Lipopolysaccharides | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | demethoxycurcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | deoxynivalenol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11922776 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | Drugs, Chinese Herbal inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17996413 |
| D008070 | Lipopolysaccharides | DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression | 16880258 |
| D008070 | Lipopolysaccharides | epoxy resin AH-26 promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| D008070 | Lipopolysaccharides | ethylisopropylamiloride inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17237260 |
| D008070 | Lipopolysaccharides | ferulic acid analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17436566 |
| D008070 | Lipopolysaccharides | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16924582 |
| D008070 | Lipopolysaccharides | gigantol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16924582 |
| D008070 | Lipopolysaccharides | glycyrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18666753 |
| D008070 | Lipopolysaccharides | Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 17465205 |
| D008070 | Lipopolysaccharides | honokiol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539808 |
| D008070 | Lipopolysaccharides | ITGAM protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| D008070 | Lipopolysaccharides | kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [epoxy resin AH-26 results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides promotes the reaction [Sealapex results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 mRNA | increases expression | 16924582 11123339 18666753 18449507 11343698 17237260 18602073 15708354 17996413 17316017 18841975 17125270 19332304 17963957 16880258 12872987 18683823 16934760 11922776 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 protein | increases expression | 18449507 18666753 18683823 16924582 19539808 11500931 17475668 18841975 15626590 11978490 16678799 17855475 18481333 19332304 17237260 17316017 12872987 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 11500931 11978490 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| D008070 | Lipopolysaccharides | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17855475 |
| D008070 | Lipopolysaccharides | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19332304 |
| D008070 | Lipopolysaccharides | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19332304 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] | affects reaction|decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12872987 |
| D008070 | Lipopolysaccharides | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | quercetin pentaacetate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17125270 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17125270 |
| D008070 | Lipopolysaccharides | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16116226 |
| D008070 | Lipopolysaccharides | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| D008070 | Lipopolysaccharides | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| D008070 | Lipopolysaccharides | Sealapex promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| D008070 | Lipopolysaccharides | Selenium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 11978490 |
| D008070 | Lipopolysaccharides | Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases expression|increases reaction | 11978490 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| D008070 | Lipopolysaccharides | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18841975 |
| D008070 | Lipopolysaccharides | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18841975 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 18481333 |
| D008070 | Lipopolysaccharides | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18481333 18279804 |
| D008070 | Lipopolysaccharides | TLR4 protein affects the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| D008070 | Lipopolysaccharides | tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12872987 |
| D008070 | Lipopolysaccharides | tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12872987 |
| D008070 | Lipopolysaccharides | vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 17465205 |
| D008070 | Lipopolysaccharides | Vaticanol B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17475668 |
| D008070 | Lipopolysaccharides | allyl alcohol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11446826 |
| D008070 | Lipopolysaccharides | Ascorbic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | Curcumin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18368483 |
| D008070 | Lipopolysaccharides | eugenosedin-A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | [Lipopolysaccharides co-treated with TNF protein co-treated with IL1B protein] results in increased expression of and results in increased activity of PTGS2 protein | affects cotreatment|increases activity|increases expression | 11826407 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 mRNA | increases expression | 18368483 11446826 17927823 18621015 18538761 18701451 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 protein | increases expression | 16300746 12022755 17637181 18621015 |
| D008070 | Lipopolysaccharides | mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18621015 |
| D008070 | Lipopolysaccharides | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18538761 |
| D008070 | Lipopolysaccharides | pimagedine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| D008070 | Lipopolysaccharides | Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 mRNA | increases expression | 17087994 |
| D008070 | Lipopolysaccharides | Curcumin analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19243473 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of PTGS2 mRNA | increases expression | 19243473 |
| C040527 | lipoxin A4 | celecoxib inhibits the reaction [PTGS2 protein affects the abundance of lipoxin A4] | affects abundance|decreases reaction | 15326064 |
| C040527 | lipoxin A4 | PTGS2 protein affects the abundance of lipoxin A4 | affects abundance | 15326064 |
| D018021 | Lithium Chloride | Lithium Chloride results in increased expression of PTGS2 mRNA | increases expression | 19797860 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15090542 |
| C059451 | lornoxicam | lornoxicam results in decreased activity of PTGS2 protein | decreases activity | 10450786 |
| D019808 | Losartan | Losartan inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased expression of PTGS2 protein] | affects binding|decreases reaction|increases expression|increases localization | 18267125 |
| D019808 | Losartan | Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17244722 |
| D019808 | Losartan | Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17244722 |
| D019808 | Losartan | Losartan results in decreased expression of PTGS2 mRNA | decreases expression | 17244722 |
| D019808 | Losartan | Losartan results in decreased expression of PTGS2 protein | decreases expression | 17244722 |
| C473384 | lumiracoxib | lumiracoxib results in decreased activity of PTGS2 protein | decreases activity | 17164136 |
| C473384 | lumiracoxib | lumiracoxib results in decreased activity of PTGS2 protein | decreases activity | 20639878 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D047311 | Luteolin | Luteolin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| C106335 | macrophage stimulatory lipopeptide 2 | macrophage stimulatory lipopeptide 2 results in increased expression of PTGS2 protein | increases expression | 16116226 |
| C071788 | malabaricone B | malabaricone B inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17977527 |
| C071787 | malabaricone C | malabaricone C inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17977527 |
| D008345 | Manganese | Manganese results in increased expression of PTGS2 mRNA | increases expression | 17175027 |
| D008345 | Manganese | Manganese results in increased expression of PTGS2 protein | increases expression | 17175027 |
| D008345 | Manganese | [Curcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| D008345 | Manganese | [diacetylcurcumin co-treated with Manganese] inhibits the reaction [Kainic Acid results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 17827730 |
| C025340 | manganese chloride | manganese chloride results in increased expression of PTGS2 mRNA | increases expression | 17175027 |
| C025340 | manganese chloride | manganese chloride results in increased expression of PTGS2 protein | increases expression | 17175027 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 15222974 |
| C501277 | Mangifera indica extract | Mangifera indica extract inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15381052 |
| C013592 | mangiferin | mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15161907 |
| C013592 | mangiferin | mangiferin affects the expression of PTGS2 mRNA | affects expression | 19026997 |
| C013592 | mangiferin | mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15381052 |
| C013592 | mangiferin | mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18621015 |
| D008351 | Mannans | Mannans results in increased expression of PTGS2 protein | increases expression | 15944324 |
| C045673 | manoalide | manoalide inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| C045673 | manoalide | manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| D008550 | Melatonin | Melatonin inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| D008550 | Melatonin | Melatonin inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18588940 |
| D008550 | Melatonin | Melatonin inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C065757 | meloxicam | meloxicam results in decreased activity of PTGS2 protein | decreases activity | 17164136 |
| C065757 | meloxicam | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16928369 |
| C065757 | meloxicam | meloxicam inhibits the reaction [Aluminum results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16928369 |
| D008694 | Methamphetamine | PTGS2 protein results in increased susceptibility to Methamphetamine | increases response to substance | 15718289 |
| D000432 | Methanol | [Methanol co-treated with IL1B protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15225597 |
| D008729 | Methoxamine | [Carbon Tetrachloride co-treated with Phenobarbital co-treated with Methoxamine] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 12500202 |
| C104810 | methyl arachidonylfluorophosphonate | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19147701 18938131 18388244 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of PTGS2 mRNA | increases expression | 20713471 |
| D008753 | Methylenebis(chloroaniline) | PTGS2 protein results in increased metabolism of Methylenebis(chloroaniline) | increases metabolic processing | 11159734 |
| C000873 | methylprednisolone acetate | methylprednisolone acetate results in decreased expression of PTGS2 mRNA | decreases expression | 15693093 |
| D016595 | Misoprostol | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12428691 |
| D016595 | Misoprostol | Indomethacin inhibits the reaction [Misoprostol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12428691 |
| D016595 | Misoprostol | Misoprostol results in increased expression of PTGS2 protein | increases expression | 12428691 |
| D016685 | Mitomycin | Mitomycin results in increased expression of PTGS2 protein | increases expression | 15793875 |
| D016685 | Mitomycin | Sulindac inhibits the reaction [Mitomycin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15793875 |
| C406082 | monomethylarsonous acid | CAT protein inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C406082 | monomethylarsonous acid | Melatonin inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of PTGS2 mRNA | increases expression | 18588940 20375083 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of PTGS2 protein | increases expression | 20375083 |
| C406082 | monomethylarsonous acid | Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C093875 | montelukast | montelukast affects the expression of PTGS2 protein | affects expression | 18059327 |
| C008548 | morin | morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19539802 |
| C008548 | morin | morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539802 |
| D009020 | Morphine | Morphine results in increased expression of PTGS2 protein | increases expression | 16325209 |
| D009020 | Morphine | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha | increases abundance|increases expression | 16325209 |
| D009020 | Morphine | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 16325209 |
| D009020 | Morphine | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | increases abundance|increases expression|increases reaction | 16325209 |
| D009020 | Morphine | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | increases abundance|increases expression|increases reaction | 16325209 |
| D009020 | Morphine | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | decreases reaction|increases abundance|increases expression | 16325209 |
| D009020 | Morphine | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | decreases reaction|increases abundance|increases expression | 16325209 |
| D009151 | Mustard Gas | Iodine affects the reaction [Mustard Gas results in increased expression of PTGS2 protein] | affects reaction|increases expression | 11305779 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of PTGS2 protein | increases expression | 11305779 |
| D009151 | Mustard Gas | [celecoxib results in decreased activity of PTGS2 protein] which results in decreased susceptibility to Mustard Gas | decreases activity|decreases response to substance | 15451306 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of PTGS2 mRNA | increases expression | 18955075 |
| D009151 | Mustard Gas | PTGS2 protein results in increased susceptibility to Mustard Gas | increases response to substance | 15451306 |
| C040015 | myricetin | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| C040015 | myricetin | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17944529 |
| C040015 | myricetin | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17944529 |
| C502260 | N-(1-methylethyl)-1,1,2-trimethylpropylamine | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17356569 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18938131 19147701 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 17407152 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 protein | decreases expression | 12857884 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16928824 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18596194 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18596194 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 14566837 17709599 11494140 18848576 15155531 15843042 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 | decreases expression | 15144595 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PTGS2 mRNA | decreases expression | 15155531 17709599 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of PTGS2 protein | increases expression | 10485483 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PTGS2 protein affects the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of CDK2 protein] | affects reaction|decreases activity | 14566837 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PTGS2 protein inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP3 protein] | decreases reaction|increases activity | 12414664 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PTGS2 protein inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CASP9 protein] | decreases reaction|increases activity | 12414664 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PTGS2 protein results in increased susceptibility to N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | increases response to substance | 12414664 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK3 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide binds to and results in decreased activity of PTGS2 protein | affects binding|decreases activity | 9024292 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased activity of PTGS2 protein | decreases activity | 19804834 12369790 11250881 11595463 15964185 15379866 10718109 17606472 15721291 16354411 |
| C528911 | N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide | N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide results in increased expression of PTGS2 mRNA | increases expression | 18287210 |
| C080418 | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Oxidopamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17855475 |
| C080418 | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | N-(4-O-glycerol-3-methoxybenzyl)nonivamide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17855475 |
| C035605 | nabumetone | nabumetone results in decreased activity of PTGS2 protein | decreases activity | 16019514 |
| D009288 | Naproxen | Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| D009288 | Naproxen | Naproxen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D009288 | Naproxen | Naproxen results in decreased activity of PTGS2 protein | decreases activity | 17164136 |
| D009288 | Naproxen | tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| D009288 | Naproxen | Naproxen inhibits the reaction [Arachidonic Acid results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 11755111 |
| C058876 | nefiracetam | nefiracetam results in increased expression of PTGS2 protein | increases expression | 16105799 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of PTGS2 mRNA | increases expression | 16780908 |
| D009543 | Nifedipine | [Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131 |
| D009543 | Nifedipine | Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 |
| D009543 | Nifedipine | arachidonyltrifluoromethane promotes the reaction [Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression|increases reaction | 19063610 |
| D009543 | Nifedipine | Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D009544 | Niflumic Acid | Niflumic Acid results in decreased activity of PTGS2 protein | decreases activity | 15964185 |
| C012655 | nimesulide | nimesulide results in decreased activity of PTGS2 protein | decreases activity | 17592669 |
| C012655 | nimesulide | nimesulide results in decreased activity of PTGS2 protein | decreases activity | 17164136 18848576 17431384 |
| C012655 | nimesulide | nimesulide results in decreased expression of PTGS2 mRNA | decreases expression | 15155531 |
| C012655 | nimesulide | nimesulide results in increased expression of PTGS2 protein | increases expression | 15482327 |
| C012655 | nimesulide | nimesulide results in decreased activity of PTGS2 protein | decreases activity | 15482327 15964185 16391822 |
| D009569 | Nitric Oxide | [Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 18976649 |
| C102148 | nitroaspirin | nitroaspirin inhibits the reaction [Indomethacin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 16818512 |
| C007350 | nitrofen | nitrofen results in increased expression of PTGS2 mRNA | increases expression | 12612200 |
| C007350 | nitrofen | nitrofen results in increased expression of PTGS2 protein | increases expression | 12612200 |
| D009599 | Nitroprusside | Nitroprusside inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16874658 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of PTGS2 mRNA | increases expression | 16510608 16777990 17616710 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of PTGS2 protein | increases expression | 16510608 |
| C014707 | nitrosobenzylmethylamine | Plant Preparations affects the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 16510608 |
| C014707 | nitrosobenzylmethylamine | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16777990 |
| C014707 | nitrosobenzylmethylamine | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16510608 |
| C013622 | nitrosobis(2-oxopropyl)amine | nitrosobis(2-oxopropyl)amine results in increased activity of PTGS2 protein | increases activity | 16820089 |
| C013622 | nitrosobis(2-oxopropyl)amine | nitrosobis(2-oxopropyl)amine results in increased expression of PTGS2 protein | increases expression | 16820089 |
| D009637 | Nordihydroguaiaretic Acid | Nordihydroguaiaretic Acid inhibits the reaction [Eicosapentaenoic Acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 12573452 |
| D009637 | Nordihydroguaiaretic Acid | Nordihydroguaiaretic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 7575673 |
| D019787 | Linoleic Acid | Linoleic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001219 |
| D019787 | Linoleic Acid | Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 18001219 |
| D019787 | Linoleic Acid | Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001219 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of PTGS2 mRNA | increases expression | 18706400 |
| C042763 | olive oil | [olive oil co-treated with Sulindac] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 15309441 |
| C042763 | olive oil | olive oil results in decreased expression of PTGS2 protein | decreases expression | 15309441 |
| C053238 | onapristone | onapristone results in increased expression of PTGS2 mRNA | increases expression | 16399999 |
| C061676 | oren gedoku to | oren gedoku to inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 17329845 |
| D016566 | Organoselenium Compounds | Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18538761 |
| C029341 | oxophenylarsine | oxophenylarsine inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased expression of PTGS2 protein] | affects binding|decreases reaction|increases expression|increases localization | 18267125 |
| D010126 | Ozone | [Ozone co-treated with Particulate Matter] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15513908 |
| D010126 | Ozone | Ozone results in decreased activity of PTGS2 protein | decreases activity | 9176252 |
| D010126 | Ozone | indole-5-carboxamide inhibits the reaction [Ozone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18926814 |
| D010126 | Ozone | NFKB1 gene mutant form inhibits the reaction [Ozone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15064226 |
| D010126 | Ozone | Ozone results in increased expression of PTGS2 mRNA | increases expression | 18926814 |
| D010126 | Ozone | Ozone results in increased expression of PTGS2 protein | increases expression | 15064226 |
| D010126 | Ozone | TTPA protein affects the reaction [Ozone results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 19555225 |
| D017239 | Paclitaxel | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16243823 |
| D017239 | Paclitaxel | Curcumin inhibits the reaction [Paclitaxel results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16243823 |
| D017239 | Paclitaxel | PTGS2 protein results in decreased susceptibility to [Platinum co-treated with Paclitaxel] | affects cotreatment|decreases response to substance | 16831230 |
| D017239 | Paclitaxel | CD14 protein affects the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| D017239 | Paclitaxel | ITGAM protein affects the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of PTGS2 mRNA | increases expression | 11123339 |
| D017239 | Paclitaxel | TLR4 protein affects the reaction [Paclitaxel results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 11123339 |
| C508075 | Pam(3)CSK(4) peptide | Pam(3)CSK(4) peptide results in increased expression of PTGS2 mRNA | increases expression | 17087994 |
| C084656 | paricalcitol | [Phosphorus co-treated with paricalcitol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17715259 |
| D017374 | Paroxetine | Paroxetine results in decreased expression of PTGS2 mRNA | decreases expression | 17499975 |
| D017374 | Paroxetine | Paroxetine results in decreased expression of PTGS2 protein | decreases expression | 17499975 |
| D052638 | Particulate Matter | 3'-methoxy-4'-nitroflavone inhibits the reaction [Particulate Matter results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19372248 |
| D052638 | Particulate Matter | [Ozone co-treated with Particulate Matter] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15513908 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of PTGS2 mRNA | increases expression | 19372248 |
| C410127 | PCB 180 | [2,4,4'-trichlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,3',4,4',5-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15808785 |
| C408604 | PD 169316 | PD 169316 inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C408604 | PD 169316 | PD 169316 inhibits the reaction [PLD2 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 16928824 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] | affects binding|decreases reaction|increases reaction | 16928824 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to TP53 protein modified form]] | affects binding|decreases reaction|increases reaction | 16928824 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18596194 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18596194 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12377986 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12377986 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| D010457 | Peptidoglycan | Peptidoglycan results in increased expression of PTGS2 mRNA | increases expression | 15860229 |
| C118309 | petrosaspongiolide m | petrosaspongiolide m inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12628480 |
| D010615 | Phenacetin | Phenacetin results in decreased activity of PTGS2 protein | decreases activity | 17606472 |
| C031181 | phenanthrene | phenanthrene results in decreased activity of PTGS2 protein | decreases activity | 12163478 |
| C058305 | phenethyl isothiocyanate | phenethyl isothiocyanate results in decreased expression of PTGS2 mRNA | decreases expression | 16373530 |
| D010628 | Phenetidine | Phenetidine results in decreased expression of and results in decreased activity of PTGS2 protein | decreases activity|decreases expression | 14592552 |
| D010634 | Phenobarbital | [Carbon Tetrachloride co-treated with Phenobarbital co-treated with Methoxamine] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 12500202 |
| C029322 | phenylbenzoquinone | phenylbenzoquinone results in increased expression of PTGS2 mRNA | increases expression | 9661217 |
| D010653 | Phenylbutazone | Phenylbutazone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D010656 | Phenylephrine | Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17244722 |
| D010656 | Phenylephrine | Losartan inhibits the reaction [Phenylephrine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17244722 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of PTGS2 mRNA | increases expression | 18701451 |
| D010712 | Phosphatidic Acids | Phosphatidic Acids results in increased expression of PTGS2 protein | increases expression | 15210717 |
| D010712 | Phosphatidic Acids | Phosphatidic Acids results in increased expression of PTGS2 mRNA | increases expression | 12872987 |
| D010758 | Phosphorus | [Phosphorus co-treated with paricalcitol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17715259 |
| C004479 | pimagedine | pimagedine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C004479 | pimagedine | pimagedine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C060836 | pioglitazone | pioglitazone results in decreased expression of PTGS2 mRNA | decreases expression | 15817521 |
| C060836 | pioglitazone | [atorvastatin co-treated with pioglitazone] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 16908763 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of PTGS2 protein | affects expression | 16912651 |
| D010894 | Piroxicam | Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19147701 |
| D010894 | Piroxicam | [Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15309881 |
| D010894 | Piroxicam | Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] | decreases activity|increases reaction | 15878914 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18841906 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 16517061 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Indomethacin results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 18237397 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19332304 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19332304 |
| D010938 | Plant Oils | Plant Oils results in increased expression of PTGS2 mRNA | increases expression | 12672646 |
| D010938 | Plant Oils | Plant Oils results in increased expression of PTGS2 protein | increases expression | 12672646 |
| D010938 | Plant Oils | Quercetin inhibits the reaction [Plant Oils results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12672646 |
| D010938 | Plant Oils | Quercetin inhibits the reaction [Plant Oils results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12672646 |
| D028321 | Plant Preparations | Plant Preparations affects the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 16510608 |
| D028321 | Plant Preparations | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16777990 |
| D028321 | Plant Preparations | Plant Preparations inhibits the reaction [nitrosobenzylmethylamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16510608 |
| D010972 | Platelet Activating Factor | Platelet Activating Factor results in increased expression of PTGS2 mRNA | increases expression | 16386258 |
| D010984 | Platinum | PTGS2 protein results in decreased susceptibility to Platinum | decreases response to substance | 16831230 |
| D010984 | Platinum | PTGS2 protein results in decreased susceptibility to [Platinum co-treated with Paclitaxel] | affects cotreatment|decreases response to substance | 16831230 |
| D011070 | Poly I-C | Poly I-C results in increased expression of PTGS2 protein | increases expression | 16116226 |
| D011070 | Poly I-C | resveratrol inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16116226 |
| D011070 | Poly I-C | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18279804 |
| D011193 | Potassium Iodide | Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| D011193 | Potassium Iodide | Potassium Iodide inhibits the reaction [arsenic trioxide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18588940 |
| D011193 | Potassium Iodide | Potassium Iodide inhibits the reaction [monomethylarsonous acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18588940 |
| C023617 | pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15322087 |
| C425843 | Prime and Bond NT | Prime and Bond NT results in increased expression of PTGS2 mRNA | increases expression | 15264312 |
| C425843 | Prime and Bond NT | Prime and Bond NT results in increased expression of PTGS2 protein | increases expression | 15264312 |
| C009042 | pristane | pristane results in increased expression of PTGS2 mRNA | increases expression | 15075356 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 17404688 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15829624 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15829624 |
| D011374 | Progesterone | Progesterone results in increased expression of PTGS2 mRNA | increases expression | 17616731 |
| D011374 | Progesterone | Progesterone results in increased expression of PTGS2 protein | increases expression | 17616731 |
| D011374 | Progesterone | Progesterone results in decreased expression of PTGS2 mRNA | decreases expression | 16399999 |
| D011433 | Propranolol | Propranolol promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | increases expression|increases reaction | 15210717 |
| D011433 | Propranolol | Propranolol promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | increases expression|increases reaction | 11854442 |
| D011433 | Propranolol | Propranolol promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12872987 |
| C027005 | prostaglandin D3 | prostaglandin D3 promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12573452 |
| D015232 | Dinoprostone | PTGS2 protein results in increased chemical synthesis of Dinoprostone | increases chemical synthesis | 10718109 |
| D015232 | Dinoprostone | [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases chemical synthesis|decreases expression | 12144868 |
| D015232 | Dinoprostone | [Bupivacaine results in increased expression of PTGS2] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 18165598 |
| D015232 | Dinoprostone | celecoxib inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis | 16004971 |
| D015232 | Dinoprostone | Etodolac inhibits the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis | 16004971 |
| D015232 | Dinoprostone | [IL1B protein results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11854442 |
| D015232 | Dinoprostone | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases activity|decreases chemical synthesis | 8621535 |
| D015232 | Dinoprostone | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 8621535 |
| D015232 | Dinoprostone | [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases activity|increases expression | 7575673 |
| D015232 | Dinoprostone | manoalide inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| D015232 | Dinoprostone | PTGS2 protein results in increased chemical synthesis of Dinoprostone | increases chemical synthesis | 16894348 |
| D015232 | Dinoprostone | [PTGS2 protein results in increased chemical synthesis of Dinoprostone] which results in decreased susceptibility to Fenretinide | decreases response to substance|increases chemical synthesis | 16127422 |
| D015232 | Dinoprostone | [PTGS2 protein results in increased chemical synthesis of Dinoprostone] which results in decreased susceptibility to Tamoxifen | decreases response to substance|increases chemical synthesis | 16127422 |
| D015232 | Dinoprostone | scalaradial inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| D015232 | Dinoprostone | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 8621535 |
| D015232 | Dinoprostone | [Acetaminophen results in increased expression of PTGS2 mRNA] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 11743745 |
| D015232 | Dinoprostone | [GPX2 protein affects the activity of PTGS2 protein] which affects the metabolism of Dinoprostone | affects activity|affects metabolic processing | 18479189 |
| D015232 | Dinoprostone | [Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 11500931 11978490 |
| D015232 | Dinoprostone | [Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 16325209 |
| D015232 | Dinoprostone | NOS2 protein promotes the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | increases abundance|increases expression|increases reaction | 16325209 |
| D015232 | Dinoprostone | Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases expression|increases reaction | 11978490 |
| D015232 | Dinoprostone | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | decreases reaction|increases abundance|increases expression | 16325209 |
| D015232 | Dinoprostone | [sulindac sulfone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases chemical synthesis|decreases expression | 11118042 |
| D015232 | Dinoprostone | [Zymosan results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11454666 |
| D015232 | Dinoprostone | [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases activity|decreases chemical synthesis | 10484518 |
| D015232 | Dinoprostone | endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases reaction | 16997862 |
| D015232 | Dinoprostone | Ibuprofen inhibits the reaction [endotoxin, Escherichia coli promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| D015232 | Dinoprostone | Ibuprofen inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]] | decreases reaction|increases chemical synthesis|increases reaction | 16997862 |
| D015232 | Dinoprostone | IL1B protein promotes the reaction [PTGS2 protein results in increased chemical synthesis of and results in increased secretion of Dinoprostone] | increases chemical synthesis|increases reaction|increases secretion | 11882577 |
| D015232 | Dinoprostone | [IL1B protein results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases activity|increases chemical synthesis|increases expression | 11530235 |
| D015232 | Dinoprostone | [IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 11286988 8662662 |
| D015232 | Dinoprostone | lipopolysaccharide, Escherichia coli 0111 B4 promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases reaction | 16997862 |
| D015232 | Dinoprostone | PTGS2 protein results in increased chemical synthesis of and results in increased secretion of Dinoprostone | increases chemical synthesis|increases secretion | 11882577 |
| D015232 | Dinoprostone | pyrrolidine dithiocarbamic acid inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis|increases expression | 8662662 11530235 |
| D015232 | Dinoprostone | Rotenone inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis|increases expression | 11530235 |
| D015232 | Dinoprostone | [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11133817 |
| D015232 | Dinoprostone | PTGS2 protein affects the chemical synthesis of Dinoprostone | affects chemical synthesis | 12902868 |
| D015232 | Dinoprostone | PTGS2 protein results in increased chemical synthesis of Dinoprostone | increases chemical synthesis | 10231640 10388637 |
| C033246 | prostaglandin E3 | prostaglandin E3 promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12573452 |
| D011464 | Epoprostenol | PTGS2 protein affects the reaction [AGT protein results in increased abundance of Epoprostenol] | affects reaction|increases abundance | 14613874 |
| C034240 | prostaglandin I3 | prostaglandin I3 promotes the reaction [IL1B protein results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12573452 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [sodium arsenite results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11835400 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 8662662 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis|increases expression | 8662662 11530235 |
| D011791 | Quartz | Curcumin inhibits the reaction [Quartz results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001810 |
| D011791 | Quartz | Quartz results in increased expression of PTGS2 mRNA | increases expression | 18001810 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Plant Oils results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12672646 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Plant Oils results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12672646 |
| D011794 | Quercetin | Quercetin inhibits the reaction [S100B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17103373 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 10783318 |
| D011794 | Quercetin | Quercetin metabolite results in decreased activity of PTGS2 protein | decreases activity | 15225597 |
| D011794 | Quercetin | Quercetin metabolite results in decreased expression of PTGS2 mRNA | decreases expression | 14988445 15225597 |
| D011794 | Quercetin | Quercetin results in decreased activity of PTGS2 protein | decreases activity | 15225597 15155531 |
| D011794 | Quercetin | Quercetin results in decreased expression of PTGS2 mRNA | decreases expression | 17184768 15225597 10783318 10920275 15155531 |
| D011794 | Quercetin | Quercetin results in decreased expression of PTGS2 protein | decreases expression | 17184768 |
| D011794 | Quercetin | Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19352036 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Cadmium results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16226777 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 14654164 |
| D011794 | Quercetin | Quercetin results in decreased expression of PTGS2 mRNA | decreases expression | 19056647 |
| C531389 | quercetin 3'-sulfate | quercetin 3'-sulfate results in decreased expression of PTGS2 mRNA | decreases expression | 14988445 |
| C435940 | quercetin pentaacetate | quercetin pentaacetate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| D020849 | Raloxifene | [Raloxifene co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19059307 |
| D020849 | Raloxifene | Raloxifene inhibits the reaction [NCOR2 protein binds to PTGS2 promoter] | affects binding|decreases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene promotes the reaction [CREBBP protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene promotes the reaction [ESR1 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene promotes the reaction [ESR2 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene promotes the reaction [NCOA2 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene promotes the reaction [NCOA3 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375 |
| D020849 | Raloxifene | Raloxifene results in decreased expression of PTGS2 mRNA | decreases expression | 17872375 |
| D020849 | Raloxifene | Raloxifene results in increased expression of PTGS2 mRNA | increases expression | 17872375 |
| D020849 | Raloxifene | Raloxifene results in increased expression of PTGS2 protein | increases expression | 17549036 |
| D020849 | Raloxifene | Carrageenan inhibits the reaction [Raloxifene results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15860553 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | affects reaction|increases expression|increases reaction | 17640750 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | affects reaction|increases expression | 19804834 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species affects the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | affects reaction|increases expression | 16024921 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in increased expression of PTGS2 protein | increases expression | 16024921 |
| C052785 | rebamipide | rebamipide results in increased expression of PTGS2 mRNA | increases expression | 15104358 |
| C052785 | rebamipide | rebamipide results in increased expression of PTGS2 protein | increases expression | 15104358 |
| C412963 | resacetophenone | resacetophenone analog results in decreased expression of PTGS2 mRNA | decreases expression | 10920275 |
| C412963 | resacetophenone | resacetophenone results in decreased expression of PTGS2 mRNA | decreases expression | 10920275 |
| C031389 | resorcinol | resorcinol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 10783318 |
| C031389 | resorcinol | resorcinol results in decreased expression of PTGS2 mRNA | decreases expression | 10783318 |
| C059514 | resveratrol | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16928824 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 16928824 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein]] | affects binding|decreases reaction|increases reaction | 16928824 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol promotes the reaction [PTGS2 protein binds to TP53 protein modified form]] | affects binding|decreases reaction|increases reaction | 16928824 |
| C059514 | resveratrol | resveratrol affects the localization of PTGS2 protein | affects localization | 17984113 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 18001219 19056653 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 10783318 |
| C059514 | resveratrol | resveratrol inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| C059514 | resveratrol | resveratrol promotes the reaction [AHR protein binds to PTGS2 promoter] | affects binding|increases reaction | 19056653 |
| C059514 | resveratrol | resveratrol promotes the reaction [JUN protein binds to PTGS2 promoter] | affects binding|increases reaction | 16928824 |
| C059514 | resveratrol | resveratrol promotes the reaction [PTGS2 protein binds to EP300 protein] | affects binding|increases reaction | 16928824 |
| C059514 | resveratrol | resveratrol promotes the reaction [PTGS2 protein binds to TP53 protein modified form] | affects binding|increases reaction | 16928824 |
| C059514 | resveratrol | resveratrol results in decreased activity of PTGS2 protein | decreases activity | 8985016 15155531 |
| C059514 | resveratrol | resveratrol results in decreased expression of PTGS2 mRNA | decreases expression | 10783318 |
| C059514 | resveratrol | resveratrol results in decreased expression of PTGS2 protein | decreases expression | 17044934 |
| C059514 | resveratrol | resveratrol results in increased expression of and affects the localization of PTGS2 protein | affects localization|increases expression | 16928824 |
| C059514 | resveratrol | Thyroxine inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| C059514 | resveratrol | resveratrol analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17125270 |
| C059514 | resveratrol | resveratrol analog results in decreased expression of PTGS2 mRNA | decreases expression | 16114095 |
| C059514 | resveratrol | resveratrol analog results in decreased expression of PTGS2 protein | decreases expression | 16114095 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17125270 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16116226 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16116226 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2] | decreases reaction|increases expression | 15630167 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474181 |
| C059514 | resveratrol | resveratrol results in decreased expression of PTGS2 protein | decreases expression | 15688382 |
| C059514 | resveratrol | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C059514 | resveratrol | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [resveratrol promotes the reaction [MAPK3 protein binds to PTGS2 protein]] | affects binding|decreases reaction|increases reaction | 17984113 |
| C059514 | resveratrol | PD 98059 inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| C059514 | resveratrol | resveratrol affects the localization of PTGS2 protein | affects localization | 17984113 |
| C059514 | resveratrol | resveratrol inhibits the reaction [APP protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16685418 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 20405173 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474422 |
| C059514 | resveratrol | resveratrol promotes the reaction [MAPK1 protein binds to PTGS2 protein] | affects binding|increases reaction | 17984113 |
| C059514 | resveratrol | resveratrol promotes the reaction [MAPK3 protein binds to PTGS2 protein] | affects binding|increases reaction | 17984113 |
| C059514 | resveratrol | resveratrol results in decreased activity of PTGS2 protein | decreases activity | 19812893 |
| C059514 | resveratrol | Thyroxine inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of PTGS2 mRNA | decreases expression | 15982314 |
| C064758 | Ro 31-8220 | Ro 31-8220 inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11854442 |
| C116926 | rofecoxib | PTGS2 promoter SNP results in increased susceptibility to rofecoxib | increases response to substance | 16678543 |
| C116926 | rofecoxib | rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 15705740 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of PTGS2 protein | decreases activity | 17164136 17070997 |
| C116926 | rofecoxib | rofecoxib results in increased expression of PTGS2 mRNA | increases expression | 16678543 |
| C116926 | rofecoxib | tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] | decreases reaction|increases activity | 15705740 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of PTGS2 protein | decreases activity | 15718289 11245490 |
| C116926 | rofecoxib | rofecoxib results in decreased expression of PTGS2 mRNA | decreases expression | 16249722 |
| C116926 | rofecoxib | rofecoxib results in decreased activity of PTGS2 protein | decreases activity | 15831440 16343605 16259740 16699067 |
| C089730 | rosiglitazone | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 20032081 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein]] | decreases reaction|increases expression | 20032081 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11343698 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [[IL1B protein co-treated with rosiglitazone] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12897060 |
| C089730 | rosiglitazone | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12897060 |
| C089730 | rosiglitazone | IL1B protein promotes the reaction [rosiglitazone results in increased expression of PTGS2 protein] | increases expression|increases reaction | 12897060 |
| C089730 | rosiglitazone | rosiglitazone results in increased expression of PTGS2 protein | increases expression | 12897060 |
| D012402 | Rotenone | Rotenone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012402 | Rotenone | Rotenone results in increased expression of PTGS2 mRNA | increases expression | 19304788 |
| D012402 | Rotenone | N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17356569 |
| D012402 | Rotenone | Rotenone inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 8662662 |
| D012402 | Rotenone | Rotenone inhibits the reaction [[IL1B protein results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases chemical synthesis|increases expression | 11530235 |
| D012402 | Rotenone | Rotenone results in increased expression of PTGS2 mRNA | increases expression | 17356569 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17363696 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Acrolein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17363696 |
| C085746 | rottlerin | rottlerin inhibits the reaction [PLD1 protein promotes the reaction [cobaltous chloride results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17640750 |
| D012431 | Rutin | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19557821 |
| D012431 | Rutin | Rutin inhibits the reaction [Glucose results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19557821 |
| D012431 | Rutin | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15652231 |
| D012431 | Rutin | Rutin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11500931 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [EDN1 protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18457675 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11854442 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [PLD2 protein promotes the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 15210717 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [VEGFA protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18596194 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [VEGFA protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18596194 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12377986 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [deoxynivalenol results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12377986 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [deoxynivalenol results in increased stability of PTGS2 mRNA] | decreases reaction|increases stability | 12377986 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [AGT protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19145780 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19145780 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [epigallocatechin gallate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15210717 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of PTGS2 protein] | affects cotreatment|decreases reaction|increases expression | 12911628 |
| C093642 | SB 203580 | SB 203580 results in decreased expression of PTGS2 mRNA | decreases expression | 17368305 |
| C093642 | SB 203580 | SB 203580 results in decreased expression of PTGS2 protein | decreases expression | 17368305 |
| C477523 | SC 514 | SC 514 results in increased expression of PTGS2 mRNA | increases expression | 17407152 |
| C115461 | SC 560 | 16,16-Dimethylprostaglandin E2 inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 |
| C115461 | SC 560 | Ampicillin inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 |
| C115461 | SC 560 | Atropine inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15610444 15104355 |
| C115461 | SC 560 | SC 560 results in increased expression of PTGS2 mRNA | increases expression | 15610444 15104355 |
| C071197 | scalaradial | scalaradial inhibits the reaction [IL1B protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 7575673 |
| C071197 | scalaradial | scalaradial inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 7575673 |
| C071197 | scalaradial | scalaradial inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | decreases reaction|increases activity|increases chemical synthesis|increases expression | 7575673 |
| C499814 | Scutellaria baicalensis extract | Scutellaria baicalensis extract results in decreased activity of PTGS2 protein | decreases activity | 17516867 |
| C055601 | Sealapex | Lipopolysaccharides promotes the reaction [Sealapex results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| C055601 | Sealapex | Sealapex promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 17963957 |
| C055601 | Sealapex | Sealapex results in increased expression of PTGS2 mRNA | increases expression | 17963957 |
| D012643 | Selenium | PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 17439952 |
| D012643 | Selenium | Selenium deficiency promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | increases expression|increases reaction | 11978490 |
| D012643 | Selenium | Selenium deficiency promotes the reaction [[Lipopolysaccharides results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone] | increases chemical synthesis|increases expression|increases reaction | 11978490 |
| D012643 | Selenium | Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17439952 |
| D020280 | Sertraline | Sertraline results in decreased expression of PTGS2 mRNA | decreases expression | 17499975 |
| D020280 | Sertraline | Sertraline results in decreased expression of PTGS2 protein | decreases expression | 17499975 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18683823 |
| C040115 | shogaol | shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| C040115 | shogaol | shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| C440975 | silybin | silybin results in decreased expression of PTGS2 protein | decreases expression | 16788158 |
| D019821 | Simvastatin | Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]] | increases expression|increases reaction | 19225232 |
| D019821 | Simvastatin | Simvastatin results in increased expression of PTGS2 mRNA | increases expression | 19225232 |
| C073734 | sinapinic acid | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18841975 |
| C073734 | sinapinic acid | sinapinic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18841975 |
| C115612 | single bond | single bond results in increased expression of PTGS2 mRNA | increases expression | 15264312 |
| C115612 | single bond | single bond results in increased expression of PTGS2 protein | increases expression | 15264312 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16874658 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium analog inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16874658 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of 6-Ketoprostaglandin F1 alpha] | decreases reaction|increases abundance|increases expression | 16325209 |
| C027744 | S-methylisothiopseudouronium | S-methylisothiopseudouronium inhibits the reaction [[Morphine results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone] | decreases reaction|increases abundance|increases expression | 16325209 |
| D012906 | Smoke | Smoke results in increased expression of PTGS2 mRNA | increases expression | 17255567 |
| C110881 | S-nitro-N-acetylpenicillamine | S-nitro-N-acetylpenicillamine results in increased expression of PTGS2 protein | increases expression | 10894794 |
| D012964 | Sodium | 7-nitroindazole affects the reaction [Sodium affects the expression of PTGS2 mRNA] | affects expression|affects reaction | 10894794 |
| D012964 | Sodium | 7-nitroindazole inhibits the reaction [Sodium results in decreased expression of PTGS2 protein] | decreases expression|decreases reaction | 10894794 |
| D012964 | Sodium | Sodium affects the expression of PTGS2 mRNA | affects expression | 10691779 10894794 |
| D012964 | Sodium | Sodium results in increased expression of PTGS2 protein | increases expression | 10894794 |
| D012964 | Sodium | thiocitrulline analog affects the reaction [Sodium affects the expression of PTGS2 mRNA] | affects expression|affects reaction | 10894794 |
| C017947 | sodium arsenite | NFATC4 protein promotes the reaction [sodium arsenite results in increased expression of PTGS2 protein] | increases expression|increases reaction | 16809336 |
| C017947 | sodium arsenite | PTGS2 protein affects the susceptibility to sodium arsenite | affects response to substance | 16809336 |
| C017947 | sodium arsenite | pyrrolidine dithiocarbamic acid inhibits the reaction [sodium arsenite results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11835400 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PTGS2 mRNA | increases expression | 11835400 12377979 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PTGS2 protein | increases expression | 16809336 11835400 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of PTGS2 mRNA | affects expression | 16507464 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PTGS2 mRNA | increases expression | 16014739 |
| D012965 | Sodium Chloride | Acetylcysteine inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | carbonyl 3-chlorophenylhydrazone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | diphenyleneiodonium inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | Reactive Oxygen Species affects the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | affects reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | Rotenone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | Sodium Chloride results in increased expression of PTGS2 protein | increases expression | 16024921 |
| D012965 | Sodium Chloride | TEMPO inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D012965 | Sodium Chloride | Thenoyltrifluoroacetone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]] | decreases reaction|increases expression|increases reaction | 18481333 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18481333 18279804 |
| D018038 | Sodium Selenite | Sodium Selenite inhibits the reaction [Poly I-C results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18279804 |
| D013311 | Streptozocin | acetovanillone inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18414395 |
| D013311 | Streptozocin | Streptozocin results in increased expression of PTGS2 protein | increases expression | 18414395 |
| D010042 | Ouabain | Ouabain results in increased expression of PTGS2 protein | increases expression | 18976649 |
| D010042 | Ouabain | [Ouabain results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Nitric Oxide | increases chemical synthesis|increases expression | 18976649 |
| D013395 | Sucrose | Sucrose inhibits the reaction [[AGT protein binds to and results in increased localization of AGTR1A protein] which results in increased expression of PTGS2 protein] | affects binding|decreases reaction|increases expression|increases localization | 18267125 |
| C016766 | sulforafan | sulforafan results in decreased expression of PTGS2 protein | decreases expression | 17942926 |
| D013467 | Sulindac | Sulindac results in decreased expression of PTGS2 protein | decreases expression | 12857884 |
| D013467 | Sulindac | Sulindac inhibits the reaction [Mitomycin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15793875 |
| D013467 | Sulindac | Sulindac inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| D013467 | Sulindac | Sulindac results in decreased expression of PTGS2 protein | decreases expression | 15793875 |
| D013467 | Sulindac | Sulindac results in increased expression of PTGS2 mRNA | increases expression | 10706128 |
| D013467 | Sulindac | [olive oil co-treated with Sulindac] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 15309441 |
| D013467 | Sulindac | Sulindac results in decreased activity of PTGS2 protein | decreases activity | 11910360 |
| D013467 | Sulindac | Sulindac results in decreased expression of PTGS2 mRNA | decreases expression | 11375891 |
| D013467 | Sulindac | Sulindac results in increased expression of PTGS2 mRNA | increases expression | 12586211 |
| D013467 | Sulindac | Sulindac promotes the reaction [PLA2G1B protein results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 10706128 |
| C025462 | sulindac sulfide | PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP3 protein] | decreases reaction|increases activity | 12414664 |
| C025462 | sulindac sulfide | PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP8 protein] | decreases reaction|increases activity | 12414664 |
| C025462 | sulindac sulfide | PTGS2 protein inhibits the reaction [sulindac sulfide results in increased activity of CASP9 protein] | decreases reaction|increases activity | 12414664 |
| C025462 | sulindac sulfide | PTGS2 protein results in increased susceptibility to sulindac sulfide | increases response to substance | 12414664 |
| C025462 | sulindac sulfide | sulindac sulfide inhibits the reaction [PTGS2 protein results in decreased expression of TNFRSF10B mRNA] | decreases expression|decreases reaction | 12208739 |
| C025462 | sulindac sulfide | sulindac sulfide inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 10866999 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased activity of PTGS2 protein | decreases activity | 11245490 |
| C025462 | sulindac sulfide | [sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein | increases activity|increases expression | 10866999 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of PTGS2 mRNA | increases expression | 11948457 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of PTGS2 protein | increases expression | 10485483 10866999 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of PTGS2 mRNA | increases expression | 11948457 |
| C025463 | sulindac sulfone | sulindac sulfone results in decreased expression of PTGS2 protein | decreases expression | 11118042 |
| C025463 | sulindac sulfone | [sulindac sulfone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone | decreases chemical synthesis|decreases expression | 11118042 |
| C025463 | sulindac sulfone | [celecoxib co-treated with sulindac sulfone] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 17908994 |
| C025463 | sulindac sulfone | celecoxib promotes the reaction [sulindac sulfone results in decreased expression of PTGS2 protein] | decreases expression|increases reaction | 17908994 |
| C025463 | sulindac sulfone | sulindac sulfone results in decreased expression of PTGS2 mRNA | decreases expression | 11375891 |
| C029222 | sym-trinitrobenzene | Eicosapentaenoic Acid analog inhibits the reaction [sym-trinitrobenzene results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15890784 |
| D013974 | Thyroxine | Thyroxine inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| D013974 | Thyroxine | Thyroxine inhibits the reaction [resveratrol affects the localization of PTGS2 protein] | affects localization|decreases reaction | 17984113 |
| D016559 | Tacrolimus | Tacrolimus inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12493747 |
| D013629 | Tamoxifen | PTGS2 protein results in decreased susceptibility to Tamoxifen | decreases response to substance | 16127422 |
| D013629 | Tamoxifen | [PTGS2 protein results in increased chemical synthesis of Dinoprostone] which results in decreased susceptibility to Tamoxifen | decreases response to substance|increases chemical synthesis | 16127422 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 19059307 19347870 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15489888 |
| C047246 | temozolomide | temozolomide inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17638900 |
| C047246 | temozolomide | temozolomide results in decreased expression of PTGS2 mRNA | decreases expression | 17638900 |
| C003959 | TEMPO | TEMPO inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| C480848 | tephrosin | tephrosin inhibits the reaction [TNF protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18841906 |
| D013749 | Tetrachlorodibenzodioxin | PTGS2 protein results in increased susceptibility to Tetrachlorodibenzodioxin | increases response to substance | 18952116 |
| D013749 | Tetrachlorodibenzodioxin | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18938131 |
| D013749 | Tetrachlorodibenzodioxin | 2-aminoethoxydiphenyl borate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 |
| D013749 | Tetrachlorodibenzodioxin | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 19056653 |
| D013749 | Tetrachlorodibenzodioxin | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19056653 |
| D013749 | Tetrachlorodibenzodioxin | 3,3'-diindolylmethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19056653 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 19147701 19372248 |
| D013749 | Tetrachlorodibenzodioxin | AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 19147701 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 19147701 |
| D013749 | Tetrachlorodibenzodioxin | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19162293 18938131 |
| D013749 | Tetrachlorodibenzodioxin | EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 19147701 |
| D013749 | Tetrachlorodibenzodioxin | Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 18001219 |
| D013749 | Tetrachlorodibenzodioxin | Linoleic Acid inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18001219 |
| D013749 | Tetrachlorodibenzodioxin | methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19147701 18938131 18388244 |
| D013749 | Tetrachlorodibenzodioxin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18938131 19147701 |
| D013749 | Tetrachlorodibenzodioxin | [Nifedipine co-treated with 2-aminoethoxydiphenyl borate] inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 18938131 |
| D013749 | Tetrachlorodibenzodioxin | Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18388244 |
| D013749 | Tetrachlorodibenzodioxin | Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19147701 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter]] | affects binding|decreases reaction|increases reaction | 19056653 18001219 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PTGS2 promoter] | affects binding|increases reaction | 19056653 18001219 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [EP300 protein binds to PTGS2 promoter] | affects binding|increases reaction | 19056653 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [HIST4H4 protein modified form binds to PTGS2 promoter] | affects binding|increases reaction | 19056653 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | increases expression | 19147701 18938131 19372248 17823287 12377990 19162293 18001219 18388244 |
| D013749 | Tetrachlorodibenzodioxin | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Arachidonic Acid affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | arachidonyltrifluoromethane promotes the reaction [Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]] | decreases reaction|increases expression|increases reaction | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Forskolin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17407152 |
| D013749 | Tetrachlorodibenzodioxin | Forskolin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Genistein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Indomethacin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 18617548 |
| D013749 | Tetrachlorodibenzodioxin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17407152 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Nifedipine inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which binds to PTGS2 promoter | affects binding | 15213229 |
| D013749 | Tetrachlorodibenzodioxin | [[Tetrachlorodibenzodioxin binds to AHR protein] which binds to PTGS2 promoter] which results in increased expression of PTGS2 mRNA | affects binding|increases expression | 15213229 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of PTGS2 protein | increases activity | 18606429 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | increases expression | 18691609 17823287 19933214 19063610 18606429 19372248 17407152 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PTGS2 protein | increases expression | 18606429 |
| D013749 | Tetrachlorodibenzodioxin | Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | Vanadates promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| D013749 | Tetrachlorodibenzodioxin | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] | affects binding|decreases reaction|increases activity | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] | affects binding|decreases reaction|increases activity | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [PTGS2 protein results in increased expression of CGA mRNA] | decreases reaction|increases expression | 12128104 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [PTGS2 protein results in increased expression of CGA protein] | decreases reaction|increases expression | 12128104 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PTGS2 mRNA | decreases expression | 12128104 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PTGS2 protein | decreases expression | 12128104 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased activity of AHR protein] which results in increased expression of PTGS2 protein | increases activity|increases expression | 17576166 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter] | affects binding|increases activity | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter] | affects binding|increases activity | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA | increases expression | 11133817 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11133817 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein | increases expression | 16797624 |
| D013755 | Tetradecanoylphorbol Acetate | baicalein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | daidzein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | equol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | Genistein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16870006 |
| D013755 | Tetradecanoylphorbol Acetate | Go 6976 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| D013755 | Tetradecanoylphorbol Acetate | GW 1929 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| D013755 | Tetradecanoylphorbol Acetate | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | affects reaction|increases expression | 19804834 |
| D013755 | Tetradecanoylphorbol Acetate | rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein] | decreases reaction|increases activity|increases expression | 20032081 |
| D013755 | Tetradecanoylphorbol Acetate | rosiglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 20032081 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of PTGS2 protein | increases activity|increases expression | 20032081 15680906 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA | increases expression | 19804834 16870006 15997105 20032081 10783318 11237475 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein | increases expression | 16870006 15843042 19804834 8621535 16417216 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of 8-epi-prostaglandin F2alpha | increases chemical synthesis|increases expression | 8621535 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Dinoprostone | increases chemical synthesis|increases expression | 8621535 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases chemical synthesis|increases expression | 8621535 |
| D013755 | Tetradecanoylphorbol Acetate | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PTGS2 mRNA | affects cotreatment|affects expression | 16979875 |
| D013755 | Tetradecanoylphorbol Acetate | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474181 |
| D013755 | Tetradecanoylphorbol Acetate | gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| D013755 | Tetradecanoylphorbol Acetate | honokiol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19539808 |
| D013755 | Tetradecanoylphorbol Acetate | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17944529 |
| D013755 | Tetradecanoylphorbol Acetate | myricetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17944529 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2] | decreases reaction|increases expression | 15630167 |
| D013755 | Tetradecanoylphorbol Acetate | resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474181 |
| D013755 | Tetradecanoylphorbol Acetate | shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18683823 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 | increases expression | 15630167 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA | increases expression | 12872987 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein | increases expression | 17944529 15122579 18683823 19539808 16474181 |
| D013755 | Tetradecanoylphorbol Acetate | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17944529 |
| D013755 | Tetradecanoylphorbol Acetate | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15122579 |
| D013755 | Tetradecanoylphorbol Acetate | Dactinomycin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 9375567 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA | increases expression | 9375567 |
| D013755 | Tetradecanoylphorbol Acetate | 4'-N-benzoylstaurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 14613874 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein | increases expression | 14613874 |
| D007978 | Levamisole | Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15047127 |
| D007978 | Levamisole | Levamisole inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15047127 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of PTGS2 protein | decreases expression | 15982930 |
| D013792 | Thalidomide | Thalidomide results in increased degradation of PTGS2 protein | increases degradation | 15982930 |
| D013804 | Thenoyltrifluoroacetone | Thenoyltrifluoroacetone inhibits the reaction [Sodium Chloride results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16024921 |
| D013853 | Thioacetamide | IL10 protein inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16126171 |
| D013853 | Thioacetamide | POMC protein alternative form inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16511523 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of PTGS2 protein | increases expression | 16511523 16126171 15158337 |
| C086715 | thiocitrulline | thiocitrulline analog affects the reaction [Sodium affects the expression of PTGS2 mRNA] | affects expression|affects reaction | 10894794 |
| D013929 | Thromboxane B2 | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2] | decreases reaction|increases activity|increases chemical synthesis | 19934399 |
| D013929 | Thromboxane B2 | [L 745337 results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of Thromboxane B2 | decreases activity|decreases chemical synthesis | 8621535 |
| D013929 | Thromboxane B2 | [lipopolysaccharide, E. coli 026-B6 results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases chemical synthesis|increases expression | 8621535 |
| D013929 | Thromboxane B2 | [Lipopolysaccharides results in increased activity of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases activity|increases chemical synthesis | 19934399 |
| D013929 | Thromboxane B2 | [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased chemical synthesis of Thromboxane B2 | increases chemical synthesis|increases expression | 8621535 |
| D014028 | Tobacco Smoke Pollution | Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution analog results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17255567 |
| D014028 | Tobacco Smoke Pollution | Curcumin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17363495 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of PTGS2 protein | increases expression | 17363495 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18449507 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 18449507 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17944529 |
| D014196 | Trazodone | Trazodone inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D014196 | Trazodone | Trazodone inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D014212 | Tretinoin | Cycloheximide inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| D014212 | Tretinoin | Dactinomycin inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| D014212 | Tretinoin | PD 98059 inhibits the reaction [Tretinoin results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16894348 |
| D014212 | Tretinoin | [Tretinoin co-treated with Lipopolysaccharides co-treated with trichostatin A] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16959971 |
| D014212 | Tretinoin | [Tretinoin co-treated with Lipopolysaccharides] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16959971 |
| D014212 | Tretinoin | Tretinoin metabolite results in increased expression of PTGS2 mRNA | increases expression | 15982314 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of PTGS2 mRNA | decreases expression | 15982314 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PTGS2 mRNA | increases expression | 16894348 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PTGS2 protein | increases expression | 16894348 |
| D014212 | Tretinoin | Tretinoin affects the activity of PTGS2 protein | affects activity | 16847438 |
| D014212 | Tretinoin | Tretinoin results in increased expression of PTGS2 protein | increases expression | 16847436 |
| C012589 | trichostatin A | [Tretinoin co-treated with Lipopolysaccharides co-treated with trichostatin A] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16959971 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PTGS2 mRNA | decreases expression | 16010430 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of PTGS2 protein | decreases expression | 16010430 |
| D014260 | Triclosan | [Triclosan co-treated with Cetylpyridinium] inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16253096 |
| D014260 | Triclosan | [Triclosan co-treated with Cetylpyridinium] inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | affects cotreatment|decreases reaction|increases expression | 16253096 |
| D014260 | Triclosan | Triclosan inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16253096 |
| D014260 | Triclosan | Triclosan inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16253096 |
| C046498 | tricyclodecane-9-yl-xanthogenate | tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 12872987 |
| C046498 | tricyclodecane-9-yl-xanthogenate | tricyclodecane-9-yl-xanthogenate inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12872987 |
| C020946 | triethylene glycol dimethacrylate | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 mRNA | affects cotreatment|increases expression | 15264312 |
| C020946 | triethylene glycol dimethacrylate | [2,2-di(4-methacryloxyphenyl)propane co-treated with triethylene glycol dimethacrylate co-treated with Bisphenol A-Glycidyl Methacrylate co-treated with Benzoyl Peroxide] results in increased expression of PTGS2 protein | affects cotreatment|increases expression | 15264312 |
| D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 18200517 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | increases expression | 15973123 18200517 |
| D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16804969 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16804969 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | resveratrol inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 16474422 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA | increases expression | 16804969 16782535 |
| D014302 | Trinitrobenzenesulfonic Acid | Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 protein | increases expression | 16474422 17276891 16782535 16804969 11698051 |
| C057693 | troglitazone | troglitazone results in increased expression of PTGS2 protein | increases expression | 15641079 10866999 |
| C002802 | tungsten carbide | [tungsten carbide binds to Cobalt] which results in increased expression of PTGS2 mRNA | affects binding|increases expression | 20105288 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [LHB protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 15459120 |
| C113580 | U 0126 | U 0126 inhibits the reaction [arsenite results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19808956 |
| D014520 | Urethane | Urethane results in increased expression of PTGS2 mRNA | increases expression | 11497255 |
| D014520 | Urethane | Urethane results in increased expression of PTGS2 protein | increases expression | 11497255 |
| D014520 | Urethane | Urethane results in decreased expression of PTGS2 mRNA | decreases expression | 11211925 |
| C406224 | valdecoxib | valdecoxib results in decreased activity of PTGS2 protein | decreases activity | 17164136 15887009 |
| C406224 | valdecoxib | valdecoxib results in decreased activity of PTGS2 protein | decreases activity | 16908763 |
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 19225232 |
| C081489 | valsartan | valsartan inhibits the reaction [AGT protein results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 19145780 |
| D014638 | Vanadates | Vanadates promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA] | increases expression|increases reaction | 19063610 |
| C034028 | vanadyl sulfate | vanadyl sulfate results in increased expression of PTGS2 mRNA | increases expression | 16330358 |
| C100058 | vanillin | vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2] | decreases reaction|increases expression | 17465205 |
| C522219 | Vaticanol B | Vaticanol B inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17475668 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased activity of PTGS2 protein | decreases activity | 12163478 |
| C030852 | vinorelbine | vinorelbine results in decreased expression of PTGS2 protein | decreases expression | 17904787 |
| C017963 | vinyl carbamate | vinyl carbamate results in decreased expression of PTGS2 mRNA | decreases expression | 17849452 |
| D002762 | Cholecalciferol | Cholecalciferol results in increased expression of PTGS2 mRNA | increases expression | 16508948 17170073 |
| C009687 | wortmannin | wortmannin inhibits the reaction [PTGS2 protein results in decreased susceptibility to Carboplatin] | decreases reaction|decreases response to substance | 18089846 |
| C104536 | xanthohumol | xanthohumol results in decreased activity of PTGS2 protein | decreases activity | 17590382 |
| D015016 | Yohimbine | Yohimbine inhibits the reaction [endotoxin, Escherichia coli results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| D015016 | Yohimbine | Yohimbine inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17637181 |
| C403304 | zerumbone | zerumbone results in decreased expression of PTGS2 mRNA | decreases expression | 16007145 |
| C403304 | zerumbone | zerumbone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 15122579 |
| D015215 | Zidovudine | Zidovudine results in decreased expression of PTGS2 protein | decreases expression | 18389896 |
| C063449 | zileuton | zileuton affects the expression of PTGS2 protein | affects expression | 18059327 |
| D015032 | Zinc | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of PTGS2 mRNA | affects cotreatment|affects expression | 16979875 |
| D015032 | Zinc | Zinc results in increased expression of PTGS2 protein | increases expression | 16584753 |
| C088658 | zoledronic acid | gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein] | affects cotreatment|decreases expression|increases reaction | 16322342 |
| C088658 | zoledronic acid | [zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of PTGS2 protein | affects cotreatment|decreases expression | 16322342 |
| D015054 | Zymosan | Zymosan analog results in increased expression of PTGS2 mRNA | increases expression | 12946449 |
| D015054 | Zymosan | Zymosan analog results in increased expression of PTGS2 protein | increases expression | 12946449 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 protein | increases expression | 15944324 |
| D015054 | Zymosan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12628480 12721113 |
| D015054 | Zymosan | bolinaquinone inhibits the reaction [Zymosan results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 12604694 |
| D015054 | Zymosan | cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12721113 |
| D015054 | Zymosan | Cyclosporine inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17312158 |
| D015054 | Zymosan | Cyclosporine inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 17312158 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased activity of PTGS2 protein] | decreases reaction|increases activity | 12604694 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11454666 12628480 |
| D015054 | Zymosan | Drugs, Chinese Herbal inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 17996413 |
| D015054 | Zymosan | petrosaspongiolide m inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 12628480 |
| D015054 | Zymosan | Zymosan results in increased activity of PTGS2 protein | increases activity | 12604694 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 mRNA | increases expression | 17312158 17996413 15708354 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 protein | increases expression | 12628480 12721113 17312158 |
| D015054 | Zymosan | [Zymosan results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone | increases abundance|increases expression | 11454666 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11099482 |
| D015054 | Zymosan | Dexamethasone inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11099482 |
| D015054 | Zymosan | Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 mRNA] | decreases reaction|increases expression | 11099482 |
| D015054 | Zymosan | Flurbiprofen inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] | decreases reaction|increases expression | 11099482 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 mRNA | increases expression | 11099482 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 protein | increases expression | 11099482 |
| D015054 | Zymosan | Zymosan results in increased expression of PTGS2 protein | increases expression | 16055675 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 7.55 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 7.55 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Capsaicin | 16.12 | 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 16.12 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 16.12 | 17676605 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 16.12 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 16.12 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 16.12 | 15322242 14514962 11752688 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Thalidomide | 16.12 | 8333272 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 3.48 | 18769834 | |
| MESH:D000038 | Abscess | Drugs, Chinese Herbal | 4.65 | 15043669 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 8.62 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 8.62 | 11192467 | |
| MESH:D000138 | Acidosis | Hydrochloric Acid | 8.62 | 20872349 15920416 19262391 11574821 16144966 12771618 | |
| MESH:D000141 | Acidosis, Renal Tubular | Hydrochloric Acid | 4.16 | 17183249 | |
| MESH:D000142 | Acidosis, Respiratory | Hydrochloric Acid | 4.16 | 20597076 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 4.62 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 11.00 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 11.00 | 18769834 16185265 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 11.00 | 20436887 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 6.46 | 9207937 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 6.46 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 3.88 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.76 | 17202136 17190629 16889938 | |
| MESH:D058186 | Acute Kidney Injury | Capsaicin | 24.83 | 18460982 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 24.83 | 12690470 15814532 17670903 | |
| MESH:D058186 | Acute Kidney Injury | Diclofenac | 24.83 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 24.83 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 24.83 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | Naproxen | 24.83 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 24.83 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 24.83 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 24.83 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Acrolein | 19.70 | 21297076 20525806 | |
| MESH:D055371 | Acute Lung Injury | Hydrochloric Acid | 19.70 | 16759491 19094174 11850527 15970105 19060228 11953099 19760209 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 19.70 | 18653653 11850527 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 19.70 | 19131640 12718980 11954676 16100012 | |
| MESH:D055371 | Acute Lung Injury | Particulate Matter | 19.70 | 12396868 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 19.70 | 18653653 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 19.70 | 17118201 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 3.85 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | marker/mechanism | 10485483 12507933 16820089 | ||
| MESH:D000230 | Adenocarcinoma | 1,4-phenylenebis(methylene)selenocyanate | 37.41 | 12844480 | |
| MESH:D000230 | Adenocarcinoma | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 37.41 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | 9,10-Dimethyl-1,2-benzanthracene | 37.41 | 10697514 12844480 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 37.41 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 37.41 | 20127859 20464547 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 37.41 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 37.41 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 37.41 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 37.41 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 37.41 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 37.41 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 37.41 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 37.41 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 37.41 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 37.41 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylenebis(chloroaniline) | 37.41 | 512554 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 37.41 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 37.41 | 18316556 | |
| MESH:D000230 | Adenocarcinoma | vinyl carbamate | 37.41 | 17363558 16247444 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Tobacco Smoke Pollution | 7.99 | 15814487 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 7.99 | 15814487 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 28.21 | 16176798 | |
| MESH:D000236 | Adenoma | 9,10-Dimethyl-1,2-benzanthracene | 28.21 | 11376689 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 28.21 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 28.21 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 28.21 | 10737359 6695378 | |
| MESH:D000236 | Adenoma | Indomethacin | 28.21 | 11497255 | |
| MESH:D000236 | Adenoma | Melatonin | 28.21 | 17195641 | |
| MESH:D000236 | Adenoma | Methylcholanthrene | 28.21 | 6695378 10545420 | |
| MESH:D000236 | Adenoma | Methylenebis(chloroaniline) | 28.21 | 512554 | |
| MESH:D000236 | Adenoma | resveratrol | 28.21 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 28.21 | 10223192 | |
| MESH:D000236 | Adenoma | Urethane | 28.21 | 10822126 11497255 6695378 10530776 16926031 17195641 17093202 | |
| MESH:D018248 | Adenoma, Liver Cell | 3,4,5,3',4'-pentachlorobiphenyl | 20.34 | 16628245 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 20.34 | 19052882 16434500 17620307 17162532 19061943 18056438 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 20.34 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 20.34 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 20.34 | 16835633 | |
| MESH:D018248 | Adenoma, Liver Cell | vinyl carbamate | 20.34 | 12371669 | |
| MESH:D011125 | Adenomatous Polyposis Coli | marker/mechanism | 17942926 | ||
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 22.72 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | dibenzoylmethane | 22.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 22.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Flurbiprofen | 22.72 | 10680582 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 22.72 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 22.72 | 11535846 15623613 12394442 16460482 11874996 17611924 19003578 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 22.72 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.05 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 8.32 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 8.32 | 16712894 17306315 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 10.38 | 21441931 | |
| MESH:D000419 | Albuminuria | Losartan | 10.38 | 12586211 | |
| MESH:D000419 | Albuminuria | Raloxifene | 10.38 | 17451421 17308373 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.66 | 15451040 15451039 | |
| MESH:D000437 | Alcoholism | Disulfiram | 3.60 | 17079463 10841824 18968458 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.43 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | marker/mechanism | 16979129 | ||
| OMIM:607154 | ALLERGIC RHINITIS | Etodolac | 4.29 | 16979129 | |
| MESH:D000505 | Alopecia | Capsaicin | 4.85 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 4.85 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.01 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | etoricoxib | 9.31 | 17225004 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 9.31 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Acrolein | 37.34 | 17570602 15207723 14715435 | |
| MESH:D000544 | Alzheimer Disease | Aluminum | 37.34 | 17662457 10721010 | |
| MESH:D000544 | Alzheimer Disease | Anti-Inflammatory Agents, Non-Steroidal | 37.34 | 16407166 14586007 15817521 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 37.34 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Copper | 37.34 | 16886094 16325427 16962711 17119284 16866297 16410023 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 37.34 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | DP 155 | 37.34 | 17627676 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 37.34 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 37.34 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 37.34 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 37.34 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 37.34 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Particulate Matter | 37.34 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 37.34 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 37.34 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 37.34 | 16183991 16162502 | |
| MESH:D000544 | Alzheimer Disease | rosiglitazone | 37.34 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 37.34 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Trazodone | 37.34 | 17897735 16856516 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 37.34 | 16410023 16580781 16325427 17119284 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | marker/mechanism | 15816863 | ||
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Copper | 6.20 | 10694572 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Tetrahydrocannabinol | 6.20 | 15204022 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Thalidomide | 6.20 | 16510725 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 10.64 | 9532969 | |
| MESH:D000707 | Anaphylaxis | Mangifera indica extract | 10.64 | 16536907 14669257 | |
| MESH:D000707 | Anaphylaxis | mangiferin | 10.64 | 14669257 16536907 | |
| MESH:D000740 | Anemia | Drugs, Chinese Herbal | 15.66 | 15504547 17963324 | |
| MESH:D000740 | Anemia | Fluorouracil | 15.66 | 17963324 15504547 16511603 | |
| MESH:D000740 | Anemia | Iron | 15.66 | 16566752 16434484 | |
| MESH:D000740 | Anemia | Phenacetin | 15.66 | 2444515 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 15.66 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 15.66 | 18664788 | |
| MESH:D000743 | Anemia, Hemolytic | Phenacetin | 5.59 | 1949026 17698508 17082564 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 5.59 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Copper | 5.51 | 16614410 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 5.51 | 16569441 17163184 17162259 17375513 17147795 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.32 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 9.12 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 9.12 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | manganese chloride | 9.12 | 16910769 | |
| MESH:D000787 | Angina Pectoris | Drugs, Chinese Herbal | 3.78 | 11477813 | |
| MESH:D000799 | Angioedema | Acetaminophen | 6.73 | 10982225 | |
| MESH:D000799 | Angioedema | montelukast | 6.73 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.22 | 15513904 | |
| MESH:D000860 | Anoxia | Hydrochloric Acid | 3.70 | 15090967 | |
| MESH:D001004 | Anus Diseases | Drugs, Chinese Herbal | 4.31 | 15043669 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 4.86 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Sertraline | 4.86 | 18822694 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 6.97 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 6.97 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 10.92 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 10.92 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 10.92 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | marker/mechanism | 19376970 | ||
| MESH:D001145 | Arrhythmias, Cardiac | Amiodarone | 6.54 | 20041841 18218290 18057881 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 6.54 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 6.54 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.20 | 12569548 16251483 18414634 16835338 | |
| MESH:D001161 | Arteriosclerosis | 9,11-linoleic acid | 15.50 | 15778275 | |
| MESH:D001161 | Arteriosclerosis | Acrolein | 15.50 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 15.50 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 15.50 | 11256880 | |
| MESH:D001161 | Arteriosclerosis | indomethacin phenethylamide | 15.50 | 15950196 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.52 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 32.66 | 18287210 | |
| MESH:D001169 | Arthritis, Experimental | Carrageenan | 32.66 | 17392412 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 32.66 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 32.66 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide | 32.66 | 18287210 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 32.66 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 32.66 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | rofecoxib | 32.66 | 16690336 | |
| MESH:D001169 | Arthritis, Experimental | Thalidomide | 32.66 | 9598899 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 32.66 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 32.66 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 32.66 | 15944321 15142272 17659584 15188379 16872482 | |
| MESH:D015210 | Arthritis, Gouty | Drugs, Chinese Herbal | 4.11 | 19655406 | |
| MESH:D001172 | Arthritis, Rheumatoid | marker/mechanism | 11978490 | ||
| MESH:D001172 | Arthritis, Rheumatoid | Auranofin | 7.16 | 16510263 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 7.16 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 7.16 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 7.16 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tobacco Smoke Pollution | 7.16 | 19898480 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 7.16 | 16292516 | |
| MESH:D001249 | Asthma | Acetaldehyde | 15.35 | 9600491 | |
| MESH:D001249 | Asthma | Budesonide | 15.35 | 10893010 15572850 18489783 12113382 15136378 12604023 20004779 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 15.35 | 16516891 | |
| MESH:D001249 | Asthma | gamma-Tocopherol | 15.35 | 17854713 19389874 | |
| MESH:D001249 | Asthma | montelukast | 15.35 | 16293801 19681236 10852428 17895592 20332717 19667530 | |
| MESH:D001249 | Asthma | Mustard Gas | 15.35 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 15.35 | 17854713 16373670 | |
| MESH:D001249 | Asthma | Tretinoin | 15.35 | 16456186 | |
| MESH:D001249 | Asthma | zileuton | 15.35 | 20332717 9620945 10181070 8598621 17944539 10764316 19214143 | |
| MESH:D001249 | Asthma | Zinc | 15.35 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | marker/mechanism | 20485159 | ||
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 5.77 | 20485159 12372130 | |
| MESH:D055963 | Asthma, Aspirin-Induced | montelukast | 5.77 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | montelukast | 6.85 | 19667531 10984370 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 6.85 | 10984370 | |
| MESH:D001254 | Astrocytoma | temozolomide | 4.86 | 15865885 | |
| MESH:D001259 | Ataxia | 1-Butanol | 4.04 | 7820390 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 7.70 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 7.70 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Acrolein | 33.23 | 16037261 16126721 17363696 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 33.23 | 12928151 19371607 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 33.23 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Cholesterol | 33.23 | 16632123 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 33.23 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 33.23 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Losartan | 33.23 | 10821809 | |
| MESH:D050197 | Atherosclerosis | Mangifera indica extract | 33.23 | 18450471 | |
| MESH:D050197 | Atherosclerosis | mangiferin | 33.23 | 18450471 | |
| MESH:D050197 | Atherosclerosis | Methylcholanthrene | 33.23 | 11922910 | |
| MESH:D050197 | Atherosclerosis | olive oil | 33.23 | 16216721 | |
| MESH:D050197 | Atherosclerosis | Plant Oils | 33.23 | 16216721 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 33.23 | 17967414 16873680 | |
| MESH:D050197 | Atherosclerosis | Tetrahydrocannabinol | 33.23 | 15815632 | |
| MESH:D001281 | Atrial Fibrillation | Amiodarone | 2.54 | 19698954 18651412 | |
| MESH:D001289 | Attention Deficit Disorder with Hyperactivity | Oxidopamine | 3.40 | 14699433 | |
| MESH:D001321 | Autistic Disorder | marker/mechanism | 18579107 | ||
| MESH:D001321 | Autistic Disorder | Acetaminophen | 3.57 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Arachidonic Acid | 3.57 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Docosahexaenoic Acids | 3.57 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 3.57 | 18929414 16917939 19267885 19056591 | |
| MESH:D001321 | Autistic Disorder | Iron | 3.57 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Linoleic Acid | 3.57 | 18582451 | |
| MESH:D001321 | Autistic Disorder | Melatonin | 3.57 | 16919138 16897403 | |
| MESH:D001321 | Autistic Disorder | pioglitazone | 3.57 | 17207275 | |
| MESH:D001321 | Autistic Disorder | Propranolol | 3.57 | 18766980 | |
| MESH:D001321 | Autistic Disorder | Sertraline | 3.57 | 18775368 | |
| MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 17.25 | 16142846 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 17.25 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 17.25 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 17.25 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 17.25 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 3.57 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 2.82 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 7.38 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 7.38 | 10684365 | |
| MESH:D001768 | Blister | Mustard Gas | 3.52 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | Amiodarone | 20.53 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 20.53 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Hydrochloric Acid | 20.53 | 15920416 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 20.53 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 20.53 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Thioacetamide | 20.53 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 20.53 | 16197459 16206674 | |
| MESH:D001836 | Body Weight Changes | 2-cresol | 6.95 | 12820538 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 6.95 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 1.52 | 15746008 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 10.99 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 10.99 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 10.99 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 5.71 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 5.71 | 17312309 16778634 16121404 19442620 11697798 15867366 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 10.39 | 11985600 | |
| MESH:D001862 | Bone Resorption | Drugs, Chinese Herbal | 10.39 | 9881647 | |
| MESH:D001862 | Bone Resorption | mangiferin | 10.39 | 9881647 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 10.39 | 16769263 11869084 18404659 8053405 18496637 15845617 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 3.71 | 11207687 | |
| MESH:D001919 | Bradycardia | Capsaicin | 8.61 | 18207255 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 8.61 | 15306635 | |
| MESH:D001919 | Bradycardia | Propranolol | 8.61 | 6740701 | |
| MESH:D001929 | Brain Edema | Indomethacin | 7.42 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 7.42 | 19309543 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.67 | 17868700 | |
| MESH:D001930 | Brain Injuries | Nitroprusside | 13.46 | 14637104 | |
| MESH:D001930 | Brain Injuries | Progesterone | 13.46 | 15665606 15380490 15845082 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 13.46 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 13.46 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Capsaicin | 23.46 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 23.46 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 23.46 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 23.46 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Morphine | 23.46 | 19211983 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 23.46 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 23.46 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 11.83 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Copper | 11.83 | 17079463 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 11.83 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 11.83 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 11.83 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | marker/mechanism | 18498876 16127422 16870006 | ||
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 66.41 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 66.41 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | 2-hydroxyestradiol | 66.41 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | 4-biphenylamine | 66.41 | 17671175 | |
| MESH:D001943 | Breast Neoplasms | 4-hydroxyestradiol-17 beta | 66.41 | 16675129 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 66.41 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 66.41 | 17127718 18840765 16153821 20435547 15565634 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 66.41 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | anthracene | 66.41 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 66.41 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 66.41 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 66.41 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Atropine | 66.41 | 12762645 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 66.41 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 66.41 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 66.41 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | capecitabine | 66.41 | 12972520 18473752 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 66.41 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Cobalt | 66.41 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Copper | 66.41 | 17079463 15986119 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 66.41 | 19250217 18593918 16243823 18462866 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 66.41 | 16978400 11325840 12006526 18234424 15093573 18323546 17020986 17388661 15136595 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 66.41 | 19208741 18320071 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 66.41 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 66.41 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 66.41 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 66.41 | 18628466 19526202 16264153 15567936 16495393 17369602 15692762 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 66.41 | 18628466 16595493 19526202 15993339 18695136 17426702 17369602 16115903 16264153 15692762 17983394 16322301 15939500 18234424 16096432 15668708 15567936 11325840 16826403 18382427 15136595 16935488 15634643 15994142 | |
| MESH:D001943 | Breast Neoplasms | equol | 66.41 | 16898868 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 66.41 | 17018787 17289903 12948864 19861407 14630087 18497071 17261762 16675129 | |
| MESH:D001943 | Breast Neoplasms | FEC protocol | 66.41 | 15970926 16682728 17145825 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 66.41 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 66.41 | 16110121 15136595 18357371 16595493 19217205 18608205 16557594 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 66.41 | 18382427 17039268 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 66.41 | 16541309 17200150 16873071 | |
| MESH:D001943 | Breast Neoplasms | gingerol | 66.41 | 17683926 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 66.41 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 66.41 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 66.41 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 66.41 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Methylenebis(chloroaniline) | 66.41 | 512554 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 66.41 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Nordihydroguaiaretic Acid | 66.41 | 18418215 | |
| MESH:D001943 | Breast Neoplasms | Organoselenium Compounds | 66.41 | 16155795 15833885 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 66.41 | 11325840 15136595 18234424 16244791 18223236 16273361 16115903 18323546 | |
| MESH:D001943 | Breast Neoplasms | Plant Preparations | 66.41 | 17398067 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 66.41 | 16175315 15562024 17614352 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 66.41 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 66.41 | 15775269 15572757 17049068 15758505 17261762 17440819 17595753 17893378 16837676 16912660 17952589 17242785 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 66.41 | 16393696 17534123 17651959 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 66.41 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 66.41 | 18984771 19115204 20859285 19066611 20005174 19221464 19084267 11161223 17049068 18855134 18425577 19244106 17261762 20544844 20390343 16273361 17440819 16818667 16873071 18351453 21138602 19189210 19289846 19189212 19487384 17893378 15668708 18815881 19288272 18821012 21152245 18629630 19103187 18997820 19410462 15565566 19200415 19059307 19142967 20135344 20065188 17242785 19011961 19155303 16202921 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 66.41 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 66.41 | 16873071 16443354 16166294 | |
| MESH:D001943 | Breast Neoplasms | vinorelbine | 66.41 | 16495393 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 66.41 | 18695136 16096432 | |
| MESH:D016535 | Bronchial Hyperreactivity | Hydrochloric Acid | 8.78 | 12378975 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 8.78 | 18315731 17626835 18417511 19059883 15516495 14754758 16777450 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 8.78 | 12794006 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 8.78 | 12794006 12388339 12654629 | |
| MESH:D001986 | Bronchial Spasm | Hydrochloric Acid | 3.83 | 15578804 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.52 | 15286001 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.32 | 17687719 10378619 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 2.96 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.77 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 6.09 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 6.09 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.69 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 11.80 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 11.80 | 15141370 15625704 11239499 16537180 | |
| MESH:D002100 | Cachexia | Ozone | 11.80 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 3.88 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.23 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 2.83 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | 16,16-Dimethylprostaglandin E2 | 15.05 | 3786805 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 15.05 | 15700767 15673190 16124888 18705752 15721981 16227642 16011737 16097048 3786805 16192424 10355542 16050911 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | ferulic acid | 15.05 | 16011737 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Melatonin | 15.05 | 15700767 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Oleanolic Acid | 15.05 | 10355542 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 11.78 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 11.78 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 11.78 | 16051944 | |
| MESH:D002277 | Carcinoma | marker/mechanism | 10485483 | ||
| MESH:D002277 | Carcinoma | Curcumin | 14.50 | 18593918 | |
| MESH:D002277 | Carcinoma | Disulfiram | 14.50 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 14.50 | 17121937 | |
| MESH:D002277 | Carcinoma | Methylcholanthrene | 14.50 | 10545420 | |
| MESH:D002277 | Carcinoma | Methylenebis(chloroaniline) | 14.50 | 512554 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 14.50 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.43 | 15504454 17687452 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 2.89 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.49 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 12024111 | ||
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 57.45 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 3-(4-methylsulfonylphenyl)-4-phenyl-5-trifluoromethylisoxazole | 57.45 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 57.45 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 57.45 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 57.45 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 57.45 | 16217749 15553829 14691202 11135700 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 57.45 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 57.45 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 57.45 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 57.45 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 57.45 | 16328049 20084675 20214788 16288022 19418558 11831363 18691550 16698587 3084413 17138121 19052882 19383236 16681979 16779866 19208518 19107877 10737359 17978847 18056438 19822196 20432363 16540662 16878318 18506893 10672840 21159647 19919837 17428255 20514400 19701751 16502159 18494052 18393292 16830150 16569478 18785209 18971187 17162532 20727157 19171122 16935385 17173139 17761372 18978308 18788625 16807293 17055752 19539802 18210153 20512989 18665156 20007298 20101231 19519916 20524982 19394651 19335982 20935162 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 57.45 | 17876044 16023760 18059187 16234567 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 57.45 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 57.45 | 18788625 15763234 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 57.45 | 16270382 17159502 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 57.45 | 17045692 18930000 17971768 16332177 17088986 16799960 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 57.45 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 57.45 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | morin | 57.45 | 19539802 | |
| MESH:D006528 | Carcinoma, Hepatocellular | nimesulide | 57.45 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 57.45 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 57.45 | 17173139 1701930 6705139 20935162 20007298 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 57.45 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 57.45 | 19519916 12508355 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 57.45 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | SC 560 | 57.45 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 57.45 | 16507464 15276417 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 57.45 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thalidomide | 57.45 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Thioacetamide | 57.45 | 17997003 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 57.45 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | vinyl carbamate | 57.45 | 12371669 | |
| MESH:D002278 | Carcinoma in Situ | marker/mechanism | 10582676 10873095 | ||
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.35 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 9.79 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 9.79 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 9.79 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.71 | 14736730 18791128 11352223 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 23.57 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 23.57 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 23.57 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 23.57 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 23.57 | 11894018 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | gefitinib | 23.57 | 15496427 19233551 18347146 17290066 20005069 16230376 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 23.57 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 23.57 | 18758305 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Tobacco Smoke Pollution | 23.57 | 11212258 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | vinorelbine | 23.57 | 18758305 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | vinyl carbamate | 23.57 | 16247446 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 23.57 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.34 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 8.93 | 19014326 | |
| MESH:D002291 | Carcinoma, Papillary | Methylenebis(chloroaniline) | 8.93 | 722185 | |
| MESH:D002292 | Carcinoma, Renal Cell | marker/mechanism | 12664575 | ||
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 10.85 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 10.85 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 10.85 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 10.85 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 10.85 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 10.85 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.62 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | marker/mechanism | 15756444 16543248 | ||
| MESH:D002294 | Carcinoma, Squamous Cell | 9,10-Dimethyl-1,2-benzanthracene | 47.62 | 11376689 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 47.62 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 47.62 | 15504454 17687452 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 47.62 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 47.62 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 47.62 | 6189445 17066447 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 47.62 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 47.62 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 47.62 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 47.62 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 47.62 | 16757204 16280240 17066447 18986760 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 47.62 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 47.62 | 12636206 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 47.62 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | nimesulide | 47.62 | 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 47.62 | 17418620 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 47.62 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 47.62 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 47.62 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tobacco Smoke Pollution | 47.62 | 11212258 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 47.62 | 16051514 16096774 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 47.62 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | marker/mechanism | 10582676 12664575 10873095 | ||
| MESH:D002295 | Carcinoma, Transitional Cell | Amiloride | 10.58 | 14644129 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 10.58 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 10.58 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 10.58 | 17572228 | |
| MESH:D006332 | Cardiomegaly | atorvastatin | 23.21 | 18360054 | |
| MESH:D006332 | Cardiomegaly | Copper | 23.21 | 17327471 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 23.21 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Losartan | 23.21 | 12586211 15969258 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 23.21 | 15728586 17287366 11754973 17124262 11179087 16170337 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 23.21 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 23.21 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 23.21 | 18670907 18850075 16120746 | |
| MESH:D006332 | Cardiomegaly | Thyroxine | 23.21 | 18093424 | |
| MESH:D006332 | Cardiomegaly | valsartan | 23.21 | 19597038 | |
| MESH:D009202 | Cardiomyopathies | marker/mechanism | 11978490 | ||
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 8.00 | 17928571 16612575 17007740 17329180 16109756 16364871 15792986 16731534 16278810 16651473 16952015 17308081 15811867 18627295 16455267 15476868 16242529 17351982 17974986 17519947 16269455 17131338 17382496 17924179 15505089 | |
| MESH:D009202 | Cardiomyopathies | Iron | 8.00 | 16640825 | |
| MESH:D009202 | Cardiomyopathies | pimagedine | 8.00 | 16612575 | |
| MESH:D009202 | Cardiomyopathies | valsartan | 8.00 | 16247790 | |
| MESH:D002310 | Cardiomyopathy, Alcoholic | Acetaldehyde | 4.82 | 10525098 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Amiodarone | 4.12 | 15710769 19225199 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.12 | 16243910 17334414 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 4.12 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 33.75 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 33.75 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 33.75 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 33.75 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 33.75 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | olive oil | 33.75 | 16216721 | |
| MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 33.75 | 12396868 | |
| MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 33.75 | 16862667 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 33.75 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 33.75 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 33.75 | 17703430 | |
| MESH:D002318 | Cardiovascular Diseases | valsartan | 33.75 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 33.75 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 2.84 | 16973168 18022660 | |
| MESH:D002341 | Carotid Artery Thrombosis | Amiodarone | 3.44 | 18974383 | |
| MESH:D016893 | Carotid Stenosis | Plant Preparations | 4.50 | 15158307 | |
| MESH:D002375 | Catalepsy | Tetrahydrocannabinol | 4.12 | 10318961 | |
| MESH:D002386 | Cataract | Acetaminophen | 10.21 | 10977129 | |
| MESH:D002386 | Cataract | Disulfiram | 10.21 | 17936468 15003327 | |
| MESH:D002386 | Cataract | pimagedine | 10.21 | 17936468 15003327 | |
| MESH:D002386 | Cataract | Simvastatin | 10.21 | 12518039 | |
| MESH:D002386 | Cataract | Tretinoin | 10.21 | 17460283 | |
| MESH:D002418 | Cattle Diseases | Levamisole | 4.81 | 14651886 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 35.89 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-biphenylamine | 35.89 | 15746073 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4-hydroxyestradiol-17 beta | 35.89 | 18566989 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 35.89 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 35.89 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Azoxymethane | 35.89 | 15705887 18075178 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 35.89 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | cinnamic aldehyde | 35.89 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 35.89 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 35.89 | 17174075 2727394 21159647 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 35.89 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 35.89 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 35.89 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | monomethylarsonous acid | 35.89 | 19716837 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 35.89 | 19524636 20056578 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 2.66 | 4080065 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 7.57 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 7.57 | 16129372 | |
| MESH:D002637 | Chest Pain | Trazodone | 4.38 | 15238202 | |
| MESH:D018281 | Cholangiocarcinoma | marker/mechanism | 16818635 | ||
| MESH:D018281 | Cholangiocarcinoma | 3,4,5,3',4'-pentachlorobiphenyl | 14.91 | 16628245 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 14.91 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 14.91 | 16835633 | |
| MESH:D018281 | Cholangiocarcinoma | Thalidomide | 14.91 | 18291259 | |
| MESH:D018281 | Cholangiocarcinoma | Thioacetamide | 14.91 | 18291259 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.52 | 11181007 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 10.93 | 19486331 | |
| MESH:D002779 | Cholestasis | Diosgenin | 10.93 | 16105132 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 10.93 | 17333356 15861022 17681005 16105132 17110522 16919318 11677210 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 10.93 | 16919318 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 10.93 | 19176532 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.49 | 16461808 | |
| MESH:D043171 | Chromosomal Instability | 4-biphenylamine | 5.35 | 17671175 | |
| MESH:D019457 | Chromosome Breakage | Sodium Selenite | 3.14 | 15894690 | |
| MESH:D002971 | Cleft Lip | Ethanol | 2.49 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 9.63 | 15513904 | |
| MESH:D002972 | Cleft Palate | Hydrocortisone | 9.63 | 15826874 | |
| MESH:D002972 | Cleft Palate | Methanol | 9.63 | 8946559 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 9.63 | 16354765 15668235 8697196 15340226 12621046 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 9.63 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 9.63 | 12810352 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 4.12 | 19462300 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.02 | 15800139 | |
| MESH:D003092 | Colitis | Amiloride | 29.63 | 12065299 | |
| MESH:D003092 | Colitis | Curcumin | 29.63 | 16804969 18200517 16782535 | |
| MESH:D003092 | Colitis | Dextran Sulfate | 29.63 | 15652231 12065299 18023891 16375993 | |
| MESH:D003092 | Colitis | resveratrol | 29.63 | 16474422 | |
| MESH:D003092 | Colitis | Rutin | 29.63 | 15652231 | |
| MESH:D003092 | Colitis | Selenium | 29.63 | 17936198 | |
| MESH:D003092 | Colitis | Thalidomide | 29.63 | 16680017 | |
| MESH:D003092 | Colitis | Tretinoin | 29.63 | 17035595 | |
| MESH:D003092 | Colitis | Trinitrobenzenesulfonic Acid | 29.63 | 16867261 11698051 17936198 16804969 17991707 16474422 16782535 18023891 18200517 | |
| MESH:D003093 | Colitis, Ulcerative | phenethyl isothiocyanate | 3.41 | 20423518 | |
| MESH:D003093 | Colitis, Ulcerative | Trinitrobenzenesulfonic Acid | 3.41 | 17276891 | |
| MESH:D003103 | Coloboma | Curcumin | 3.03 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | 1-(4-chlorobenzoyl)-5-methoxy-2-1H-indole-3-acetic acid 3-(nitrooxymethyl)phenyl ester | 50.81 | 16818512 | |
| MESH:D003110 | Colonic Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 50.81 | 10753194 | |
| MESH:D003110 | Colonic Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 50.81 | 16353153 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 50.81 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 50.81 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Azoxymethane | 50.81 | 16293270 16818512 15824018 15705887 12189186 19056647 14668109 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 50.81 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | Calcium, Dietary | 50.81 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 50.81 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | cinnamic aldehyde | 50.81 | 16343908 17510524 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 50.81 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 50.81 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 50.81 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Etodolac | 50.81 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 50.81 | 17287894 15001691 17018589 16510598 17172411 17725105 17169374 17016597 16340194 18772588 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 50.81 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 50.81 | 15637740 15625704 11260862 15936596 15786552 15963497 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 50.81 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | nitroaspirin | 50.81 | 16818512 | |
| MESH:D003110 | Colonic Neoplasms | Nordihydroguaiaretic Acid | 50.81 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | Piroxicam | 50.81 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 50.81 | 16640504 19056647 19440933 17191121 15741050 17148506 11134977 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 50.81 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | rofecoxib | 50.81 | 12902858 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 50.81 | 12902858 12458338 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 50.81 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | marker/mechanism | 10485483 11375891 12837940 | ||
| MESH:D015179 | Colorectal Neoplasms | 4-biphenylamine | 31.42 | 17671175 | |
| MESH:D015179 | Colorectal Neoplasms | Acrolein | 31.42 | 17597105 | |
| MESH:D015179 | Colorectal Neoplasms | Anti-Inflammatory Agents, Non-Steroidal | 31.42 | 12837940 18059344 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 31.42 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 31.42 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Azoxymethane | 31.42 | 11076880 10416599 | |
| MESH:D015179 | Colorectal Neoplasms | capecitabine | 31.42 | 18473752 18448328 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 31.42 | 18349538 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 31.42 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 31.42 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 31.42 | 18259882 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Etodolac | 31.42 | 11076880 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 31.42 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 31.42 | 17695437 18949393 16524972 16331619 16282729 18288408 16391804 17016601 20501625 15289873 16303861 15148649 18802399 17594712 17454858 17094418 18383874 17255274 18509181 17401013 18448328 14970324 | |
| MESH:D015179 | Colorectal Neoplasms | gefitinib | 31.42 | 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 31.42 | 11197048 17054584 12606626 18059344 | |
| MESH:D015179 | Colorectal Neoplasms | Levamisole | 31.42 | 15148649 | |
| MESH:D015179 | Colorectal Neoplasms | meloxicam | 31.42 | 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | nimesulide | 31.42 | 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 31.42 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 31.42 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 31.42 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 31.42 | 11197048 18059344 10666051 11076880 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 31.42 | 10666051 11197048 10416599 18059344 | |
| MESH:D003128 | Coma | Trazodone | 4.48 | 10836866 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 3.82 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 4.70 | 17141729 14669216 | |
| MESH:D000013 | Congenital Abnormalities | Triclosan | 4.70 | 19283420 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 7.28 | 18497527 | |
| MESH:D016510 | Corneal Neovascularization | Thalidomide | 7.28 | 9301478 | |
| MESH:D003324 | Coronary Artery Disease | marker/mechanism | 14642682 | ||
| MESH:D003324 | Coronary Artery Disease | atorvastatin | 4.62 | 16368305 | |
| MESH:D003324 | Coronary Artery Disease | Plant Preparations | 4.62 | 15158307 | |
| MESH:D003324 | Coronary Artery Disease | valsartan | 4.62 | 17719468 | |
| MESH:D003327 | Coronary Disease | Fructose | 4.49 | 18504504 | |
| MESH:D003327 | Coronary Disease | resveratrol | 4.49 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.62 | 12609071 | |
| MESH:D003329 | Coronary Vasospasm | capecitabine | 4.23 | 17465463 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.05 | 17302372 | |
| MESH:D003371 | Cough | Capsaicin | 3.56 | 10350223 | |
| MESH:D003384 | Coxsackievirus Infections | valsartan | 4.21 | 20392896 | |
| MESH:D003389 | Cranial Nerve Diseases | Thalidomide | 4.64 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | 3,4,5,3',4'-pentachlorobiphenyl | 12.22 | 17686920 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 12.22 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 12.22 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 12.22 | 10194807 19302082 15513904 11873399 15451040 11198716 15451039 | |
| MESH:D019465 | Craniofacial Abnormalities | Hydrocortisone | 12.22 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 12.22 | 9879862 18769834 | |
| MESH:D019465 | Craniofacial Abnormalities | Methanol | 12.22 | 15108243 | |
| MESH:D019465 | Craniofacial Abnormalities | nitrofen | 12.22 | 11405365 | |
| MESH:D019465 | Craniofacial Abnormalities | Reactive Oxygen Species | 12.22 | 15736158 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 12.22 | 15322242 10048152 20055451 | |
| MESH:D019465 | Craniofacial Abnormalities | Thalidomide | 12.22 | 9200351 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 12.22 | 9664655 8800419 9224671 10589399 9142499 17551590 14991402 9125849 9211117 16925845 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 12.22 | 19302082 | |
| MESH:D003424 | Crohn Disease | Thalidomide | 3.11 | 16078585 | |
| MESH:D003457 | Cryptosporidiosis | mangiferin | 4.21 | 16547730 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 2.43 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 11.25 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Docosahexaenoic Acids | 11.25 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 11.25 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | pioglitazone | 11.25 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 11.25 | 19747007 | |
| MESH:D003556 | Cystitis | Acrolein | 10.49 | 12161096 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 10.49 | 11948286 12161096 15276878 18433785 10700343 12913760 16989017 15643279 18372110 10498854 12388444 17010015 17979934 18093676 18295254 16413132 16614059 16651033 18483878 18710439 | |
| MESH:D003556 | Cystitis | Hydrochloric Acid | 10.49 | 19279288 12599022 12853844 20719367 | |
| MESH:D018856 | Cystitis, Interstitial | Hydrochloric Acid | 4.16 | 17714534 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.16 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.56 | 15213294 | |
| MESH:D003665 | Decompression Sickness | zileuton | 4.57 | 18309904 | |
| MESH:D003704 | Dementia | Trazodone | 3.94 | 11575062 12587811 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.32 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 2.76 | 19031437 | |
| MESH:D003866 | Depressive Disorder | Paroxetine | 5.82 | 17072103 15014590 | |
| MESH:D003866 | Depressive Disorder | Sertraline | 5.82 | 15014590 18822694 20305041 | |
| MESH:D003866 | Depressive Disorder | Trazodone | 5.82 | 20305041 15014590 19623435 3690436 18083778 3378227 4066620 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 8.37 | 17474826 | |
| MESH:D003865 | Depressive Disorder, Major | Sertraline | 8.37 | 16968574 | |
| MESH:D003865 | Depressive Disorder, Major | Trazodone | 8.37 | 16968574 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4-phenylenediamine | 6.09 | 11906362 16533241 19470301 11298694 18759875 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cinnamic aldehyde | 6.09 | 11042091 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 6.09 | 15059100 16823706 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 6.09 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 6.09 | 11298694 16823706 16780908 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.43 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4-phenylenediamine | 3.86 | 11531941 | |
| MESH:D002658 | Developmental Disabilities | 2,3',4,4',5-pentachlorobiphenyl | 4.20 | 19647017 | |
| MESH:D003920 | Diabetes Mellitus | marker/mechanism | 15885672 | ||
| MESH:D003920 | Diabetes Mellitus | Iron | 13.42 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | rosiglitazone | 13.42 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Sodium Selenite | 13.42 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 13.42 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 13.42 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 24.38 | 15331540 11751995 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Fructose | 24.38 | 18603373 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | mangiferin | 24.38 | 12093613 19028559 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 24.38 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 24.38 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 24.38 | 19298542 12083368 18603373 19586609 15862027 2177838 19960420 19496084 12644472 12446591 16286809 11055810 16684804 11260395 7637645 18715473 6379147 17442507 15298345 12093613 8740154 1374869 15831366 17874149 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Thromboxane B2 | 24.38 | 15831366 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | valsartan | 24.38 | 11508273 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | vanadyl sulfate | 24.38 | 16684804 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 3.98 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 3.98 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 3.98 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | alpha-Tocopherol | 26.83 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 26.83 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 26.83 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 26.83 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 26.83 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 26.83 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Fructose | 26.83 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 26.83 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 26.83 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | mangiferin | 26.83 | 9881663 11315760 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 26.83 | 12642470 16023994 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 26.83 | 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 26.83 | 19586609 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 26.83 | 17107852 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 26.83 | 16023994 | |
| MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.04 | 12601628 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.09 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 28.23 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 28.23 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | mangiferin | 28.23 | 19706694 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 28.23 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 28.23 | 15920148 17308373 17451421 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 28.23 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 28.23 | 19960420 19682444 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 28.23 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | valsartan | 28.23 | 18630688 11427623 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 2.89 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.02 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.02 | 12861449 17621415 | |
| MESH:D003967 | Diarrhea | Atropine | 11.42 | 10867622 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 11.42 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 11.42 | 11488427 7237001 10446763 | |
| MESH:D003967 | Diarrhea | Hydrocortisone | 11.42 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 11.42 | 7237001 7907874 | |
| MESH:D003967 | Diarrhea | Morphine | 11.42 | 2540324 | |
| MESH:D004283 | Dog Diseases | Allopurinol | 4.63 | 10449224 | |
| MESH:D056486 | Drug-Induced Liver Injury | therapeutic | 11743745 | ||
| MESH:D056486 | Drug-Induced Liver Injury | 16,16-Dimethylprostaglandin E2 | 28.54 | 3786805 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 28.54 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 28.54 | 12153990 2444490 10774834 15619225 14725611 16177239 16393943 16227642 16781746 15968718 11739529 19085960 19370779 19420014 18713872 19923254 12392966 11834606 11529661 14986274 12540782 12705907 19416960 17906064 11461765 16109766 17562736 11287661 19739265 12594235 10663392 19164858 14550746 10915739 16485898 17522070 11743745 16081117 12958197 18071297 11421492 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 28.54 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | allyl alcohol | 28.54 | 7440962 | |
| MESH:D056486 | Drug-Induced Liver Injury | Amiodarone | 28.54 | 18218290 15265979 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 28.54 | 15968718 19085960 19336974 10092053 3732212 10915739 7120509 17522070 9327722 21278145 15998439 15027814 11566570 4309450 6623471 7179309 3786805 6884620 16177239 2869522 7440962 16227642 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 28.54 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 28.54 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Drugs, Chinese Herbal | 28.54 | 15027814 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 28.54 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Halothane | 28.54 | 12919722 | |
| MESH:D056486 | Drug-Induced Liver Injury | lumiracoxib | 28.54 | 20639878 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 28.54 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Sodium Selenite | 28.54 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 28.54 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Thioacetamide | 28.54 | 12963478 | |
| MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 28.54 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 28.54 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 7.87 | 19426721 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Glycyrrhizic Acid | 7.87 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 17.83 | 12231392 15033597 12649298 19839026 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 17.83 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 17.83 | 11033412 15033597 | |
| MESH:D004362 | Drug Toxicity | Plant Preparations | 17.83 | 11033412 | |
| MESH:D004362 | Drug Toxicity | Stavudine | 17.83 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 17.83 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 17.83 | 15040536 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 7.83 | 18446180 18450898 16133044 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 7.83 | 18043480 18446180 12774134 16133044 17190690 16326151 | |
| MESH:D004381 | Duodenal Ulcer | marker/mechanism | 12481160 | ||
| MESH:D004381 | Duodenal Ulcer | 16,16-Dimethylprostaglandin E2 | 27.17 | 11991626 16699067 11595431 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Ampicillin | 27.17 | 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Anti-Inflammatory Agents, Non-Steroidal | 27.17 | 17157122 | |
| MESH:D004381 | Duodenal Ulcer | Atropine | 27.17 | 11595415 | |
| MESH:D004381 | Duodenal Ulcer | Capsaicin | 27.17 | 11535926 10671773 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 27.17 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 27.17 | 17329845 17202747 11991626 11595415 17151854 17351913 11535926 11595431 16699067 10671773 17045617 | |
| MESH:D004381 | Duodenal Ulcer | oren gedoku to | 27.17 | 17329845 | |
| MESH:D004381 | Duodenal Ulcer | Tacrolimus | 27.17 | 17202747 | |
| MESH:D004409 | Dyskinesia, Drug-Induced | Trazodone | 4.29 | 3690436 | |
| MESH:D004417 | Dyspnea | Budesonide | 5.69 | 20016425 | |
| MESH:D004417 | Dyspnea | Furosemide | 5.69 | 16935035 | |
| MESH:D004421 | Dystonia | Phenobarbital | 5.89 | 1851702 | |
| MESH:D004421 | Dystonia | Trazodone | 5.89 | 3700695 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 3.82 | 9068938 | |
| MESH:D004485 | Eczema | Dexamethasone | 2.90 | 12438553 | |
| MESH:D004487 | Edema | Arachidonic Acid | 71.45 | 9599246 16716910 11698051 15177302 9831321 7990266 | |
| MESH:D004487 | Edema | Aspirin | 71.45 | 17259670 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 71.45 | 18449507 | |
| MESH:D004487 | Edema | Carrageenan | 71.45 | 18841975 10653021 12787963 12798668 12083418 18621150 15860553 16100529 8985016 18449507 17259670 | |
| MESH:D004487 | Edema | demethoxycurcumin | 71.45 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 71.45 | 19703484 | |
| MESH:D004487 | Edema | Diclofenac | 71.45 | 16273134 | |
| MESH:D004487 | Edema | Furosemide | 71.45 | 11834646 | |
| MESH:D004487 | Edema | glycyrol | 71.45 | 18621150 | |
| MESH:D004487 | Edema | Indomethacin | 71.45 | 7907874 8273558 16100529 10653021 8985016 19703484 7990266 | |
| MESH:D004487 | Edema | Mangifera indica extract | 71.45 | 15177302 16716910 16273134 | |
| MESH:D004487 | Edema | Mustard Gas | 71.45 | 11428631 11402378 9260866 11428647 | |
| MESH:D004487 | Edema | Phenylbutazone | 71.45 | 8985016 | |
| MESH:D004487 | Edema | pirinixic acid | 71.45 | 12083418 | |
| MESH:D004487 | Edema | Piroxicam | 71.45 | 7907874 | |
| MESH:D004487 | Edema | Plant Extracts | 71.45 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 71.45 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 71.45 | 8985016 | |
| MESH:D004487 | Edema | rosiglitazone | 71.45 | 12083418 | |
| MESH:D004487 | Edema | scalaradial | 71.45 | 8113982 | |
| MESH:D004487 | Edema | sinapinic acid | 71.45 | 18841975 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 71.45 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 71.45 | 8113982 9599246 16716910 8273558 15177302 11698051 7812673 | |
| MESH:D004487 | Edema | Trazodone | 71.45 | 12798668 | |
| MESH:D004487 | Edema | zileuton | 71.45 | 8273558 19703484 17118201 11698051 7990266 7812673 9831321 | |
| MESH:D004487 | Edema | Zymosan | 71.45 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | 3,4,5,3',4'-pentachlorobiphenyl | 11.65 | 17686920 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 11.65 | 15322242 16714409 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 11.65 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 27.72 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 2,2-bis(4-glycidyloxyphenyl)propane | 27.72 | 16091293 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 27.72 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | ciglitazone | 27.72 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 27.72 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 27.72 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 27.72 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 27.72 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 27.72 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 8.55 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 8.55 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 2.97 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 12.50 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 12.50 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 12.50 | 18566989 19148513 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 12.50 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 12.50 | 19155303 20544844 17893378 16202921 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 12.50 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Naproxen | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Progesterone | 24.59 | 16134523 | |
| MESH:D004715 | Endometriosis | rofecoxib | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Sulindac | 24.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 24.59 | 9294722 10568697 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 8.58 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 8.58 | 15268973 | |
| MESH:D019446 | Endotoxemia | endotoxin, Escherichia coli | 25.09 | 18509659 17637181 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 25.09 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 25.09 | 18509659 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, E. coli 026-B6 | 25.09 | 8368378 | |
| MESH:D019446 | Endotoxemia | lipopolysaccharide, Escherichia coli 0111 B4 | 25.09 | 12954792 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 25.09 | 15821434 15328337 17637181 | |
| MESH:D019446 | Endotoxemia | zileuton | 25.09 | 15328337 | |
| MESH:D004751 | Enteritis | Croton Oil | 6.70 | 8982514 | |
| MESH:D004751 | Enteritis | Indomethacin | 6.70 | 17763956 10567023 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.05 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.05 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 8.52 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 8.52 | 11298111 | |
| MESH:D004802 | Eosinophilia | montelukast | 8.52 | 10335014 | |
| MESH:D004802 | Eosinophilia | zileuton | 8.52 | 8621850 10764316 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 2.53 | 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 2.28 | 11558140 3922381 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 4.68 | 20417680 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 4.68 | 19700373 19439326 | |
| MESH:D004827 | Epilepsy | Tetrahydrocannabinol | 4.68 | 821787 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 2.14 | 6401628 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 2.66 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 2.43 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 5.73 | 14972507 | |
| MESH:D007172 | Erectile Dysfunction | Trazodone | 5.73 | 7604472 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.52 | 9357497 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.45 | 16302075 | |
| MESH:D004935 | Esophageal Diseases | Capsaicin | 8.10 | 19566590 | |
| MESH:D004935 | Esophageal Diseases | Hydrochloric Acid | 8.10 | 19566590 | |
| MESH:D004938 | Esophageal Neoplasms | marker/mechanism | 15756444 16322294 12507933 16543248 | ||
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 26.91 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 26.91 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 26.91 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 26.91 | 16481741 16785472 15464296 15173087 17638652 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 26.91 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 26.91 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 26.91 | 16785472 17638652 16481741 15173087 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 26.91 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | L 748706 | 26.91 | 15878914 | |
| MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 26.91 | 15623463 15878914 16805852 15264214 15547733 16704527 15547721 16510608 15150132 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 26.91 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Piroxicam | 26.91 | 15878914 | |
| MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 26.91 | 16510608 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 26.91 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 26.91 | 16543248 | |
| MESH:D004941 | Esophagitis | Hydrochloric Acid | 4.36 | 12928072 | |
| MESH:D004942 | Esophagitis, Peptic | Hydrochloric Acid | 4.36 | 14621274 20516732 11346197 | |
| MESH:D020329 | Essential Tremor | Trazodone | 4.48 | 3296121 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.23 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.23 | 9664655 16938888 | |
| MESH:D005128 | Eye Diseases | Ketorolac | 5.44 | 11084241 | |
| MESH:D005218 | Fat Necrosis | Thioacetamide | 4.06 | 16456712 | |
| MESH:D005234 | Fatty Liver | Amiodarone | 63.45 | 14986274 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 63.45 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 63.45 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 63.45 | 12795759 17595544 12631006 16239168 19224547 16045604 61145 15959796 | |
| MESH:D005234 | Fatty Liver | Curcumin | 63.45 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 63.45 | 19224547 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 63.45 | 20387270 21071580 | |
| MESH:D005234 | Fatty Liver | Ethanol | 63.45 | 19236843 16409862 18620774 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 63.45 | 15345470 | |
| MESH:D005234 | Fatty Liver | Fish Oils | 63.45 | 18620774 | |
| MESH:D005234 | Fatty Liver | Fructose | 63.45 | 19196556 18395287 18641190 | |
| MESH:D005234 | Fatty Liver | Iron | 63.45 | 16640825 | |
| MESH:D005234 | Fatty Liver | mangiferin | 63.45 | 15975614 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 63.45 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 63.45 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 63.45 | 17473493 | |
| MESH:D005234 | Fatty Liver | rosiglitazone | 63.45 | 19196556 | |
| MESH:D005234 | Fatty Liver | Stavudine | 63.45 | 18299183 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 63.45 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 63.45 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.00 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.02 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.19 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.66 | 15451040 10194807 16946407 15513904 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 1.88 | 11858732 | |
| MESH:D005334 | Fever | Arachidonic Acid | 24.06 | 11852909 | |
| MESH:D005334 | Fever | Dinoprostone | 24.06 | 11852909 16997862 | |
| MESH:D005334 | Fever | DP 155 | 24.06 | 17627676 | |
| MESH:D005334 | Fever | endotoxin, Escherichia coli | 24.06 | 16997862 | |
| MESH:D005334 | Fever | Ibuprofen | 24.06 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 24.06 | 10431976 17627676 11852909 | |
| MESH:D005334 | Fever | lipopolysaccharide, Escherichia coli 0111 B4 | 24.06 | 16997862 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 24.06 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 7.55 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 7.55 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 10.23 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 10.23 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 10.23 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Carrageenan | 11.13 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 11.13 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 11.13 | 10962813 14633661 | |
| MESH:D005355 | Fibrosis | arsenite | 46.55 | 18296743 | |
| MESH:D005355 | Fibrosis | baicalein | 46.55 | 19474275 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 46.55 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 46.55 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 46.55 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Fructose | 46.55 | 18504504 | |
| MESH:D005355 | Fibrosis | Hydrochloric Acid | 46.55 | 18497604 | |
| MESH:D005355 | Fibrosis | Indomethacin | 46.55 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 46.55 | 19474275 | |
| MESH:D005355 | Fibrosis | Scutellaria baicalensis extract | 46.55 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 46.55 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 46.55 | 17994277 | |
| MESH:D005355 | Fibrosis | Trinitrobenzenesulfonic Acid | 46.55 | 17994277 | |
| MESH:D005355 | Fibrosis | valsartan | 46.55 | 16893502 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.52 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 3.89 | 6392382 | |
| MESH:D005596 | Fractures, Closed | montelukast | 7.83 | 19544365 | |
| MESH:D005596 | Fractures, Closed | zileuton | 7.83 | 19544365 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 3.81 | 16604332 16640825 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.69 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 7.02 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Hydrochloric Acid | 7.02 | 12378975 | |
| MESH:D005756 | Gastritis | Acetaminophen | 14.06 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 14.06 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 14.06 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 14.06 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 10.19 | 11910360 | |
| MESH:D005764 | Gastroesophageal Reflux | Hydrochloric Acid | 10.19 | 12212954 19951613 20516732 20616304 19957777 20545468 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 10.19 | 11910360 | |
| MESH:D005767 | Gastrointestinal Diseases | Anti-Inflammatory Agents, Non-Steroidal | 4.80 | 17021222 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.10 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.05 | 16452187 | |
| MESH:D005871 | Giant Lymph Node Hyperplasia | Thalidomide | 4.64 | 12701121 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 2.59 | 8708960 | |
| MESH:D005909 | Glioblastoma | Aspirin | 37.00 | 12870263 | |
| MESH:D005909 | Glioblastoma | baicalein | 37.00 | 19804834 | |
| MESH:D005909 | Glioblastoma | Capsaicin | 37.00 | 18405923 | |
| MESH:D005909 | Glioblastoma | Curcumin | 37.00 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 37.00 | 17150277 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 37.00 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 37.00 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 37.00 | 12870263 | |
| MESH:D005909 | Glioblastoma | Manganese | 37.00 | 17043766 | |
| MESH:D005909 | Glioblastoma | myricetin | 37.00 | 19804834 | |
| MESH:D005909 | Glioblastoma | Quercetin | 37.00 | 19804834 | |
| MESH:D005909 | Glioblastoma | temozolomide | 37.00 | 15865885 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 37.00 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 37.00 | 18801729 | |
| MESH:D005910 | Glioma | marker/mechanism | 15561105 | ||
| MESH:D005910 | Glioma | Anti-Inflammatory Agents, Non-Steroidal | 9.93 | 16487511 | |
| MESH:D005910 | Glioma | Fluorouracil | 9.93 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 9.93 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Quercetin | 9.93 | 17643826 | |
| MESH:D005910 | Glioma | temozolomide | 9.93 | 16327979 10871815 | |
| MESH:D005910 | Glioma | Thalidomide | 9.93 | 16327979 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 3.87 | 11389073 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.60 | 15173396 16524712 | |
| MESH:D015432 | Glomerulonephritis, Membranoproliferative | valsartan | 3.96 | 16928621 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 5.55 | 11849393 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 5.55 | 16687628 | |
| MESH:D018149 | Glucose Intolerance | Fructose | 3.77 | 19165636 | |
| MESH:D044882 | Glucose Metabolism Disorders | Mangifera indica extract | 5.09 | 16273134 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 2.93 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.71 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 7.12 | 15172196 16376943 11014644 | |
| MESH:D006086 | Graft vs Host Disease | Tacrolimus | 7.12 | 16376943 | |
| MESH:D006130 | Growth Disorders | Amiloride | 6.87 | 19703807 | |
| MESH:D006130 | Growth Disorders | Tacrolimus | 6.87 | 11041285 | |
| MESH:D006130 | Growth Disorders | Zinc | 6.87 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 9.03 | 15240983 | |
| MESH:D006261 | Headache | Nitric Oxide | 9.03 | 11554966 11284996 | |
| MESH:D006261 | Headache | Plant Oils | 9.03 | 19121572 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 19.72 | 15464296 15102660 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 19.72 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 19.72 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 19.72 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 19.72 | 15102660 18337622 15162350 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 19.72 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | nimesulide | 19.72 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 19.72 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 8.24 | 19898482 | |
| MESH:D034381 | Hearing Loss | Furosemide | 8.24 | 17868369 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 8.24 | 19130971 17868369 18024279 15968427 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.49 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 2.97 | 15464296 | |
| MESH:D006356 | Heartburn | Capsaicin | 8.10 | 19566590 | |
| MESH:D006356 | Heartburn | Hydrochloric Acid | 8.10 | 19566590 | |
| MESH:D006330 | Heart Defects, Congenital | 3,4,3',4'-tetrachlorobiphenyl | 13.86 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | 3,4,5,3',4'-pentachlorobiphenyl | 13.86 | 17686920 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 13.86 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 13.86 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | nitrofen | 13.86 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 13.86 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 13.86 | 9664655 14991402 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 9.82 | 16707910 16144979 16244372 18006777 14766674 17875725 18674790 16244371 16330681 12587719 16495754 17888722 16879835 | |
| MESH:D006331 | Heart Diseases | mangiferin | 9.82 | 12093613 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 9.82 | 11110106 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 9.82 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 9.82 | 16046796 | |
| MESH:D006333 | Heart Failure | atorvastatin | 23.55 | 16360360 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 23.55 | 17481944 | |
| MESH:D006333 | Heart Failure | Furosemide | 23.55 | 16845234 12660669 16011733 | |
| MESH:D006333 | Heart Failure | Losartan | 23.55 | 10979640 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 23.55 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 23.55 | 18097624 | |
| MESH:D006333 | Heart Failure | Propranolol | 23.55 | 20082655 | |
| MESH:D006333 | Heart Failure | Selenium | 23.55 | 17162251 | |
| MESH:D006333 | Heart Failure | valsartan | 23.55 | 19027736 | |
| MESH:D006333 | Heart Failure | Zinc | 23.55 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.11 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 3.01 | 17241300 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 4.92 | 15692506 | |
| MESH:D006394 | Hemangiosarcoma | Methylenebis(chloroaniline) | 4.92 | 512554 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 3.17 | 12579204 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.13 | 16640825 16604332 16574947 17236123 17053826 17255318 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 2.78 | 15720958 | |
| MESH:D006461 | Hemolysis | allyl alcohol | 4.61 | 2222504 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 2.89 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.68 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 1.83 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.57 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 5.87 | 15633222 | |
| MESH:D006501 | Hepatic Encephalopathy | Thioacetamide | 5.87 | 18665440 15929193 17276928 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 3.88 | 14986274 | |
| MESH:D006505 | Hepatitis | allyl alcohol | 13.17 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 13.17 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Drugs, Chinese Herbal | 13.17 | 18339527 | |
| MESH:D006505 | Hepatitis | Thioacetamide | 13.17 | 16456712 | |
| MESH:D006505 | Hepatitis | Zymosan | 13.17 | 19110552 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.11 | 15135802 | |
| MESH:D006521 | Hepatitis, Chronic | Copper | 6.65 | 17338147 | |
| MESH:D006521 | Hepatitis, Chronic | Diclofenac | 6.65 | 14986274 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 3.82 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Copper | 9.48 | 17109627 19888908 16607473 17276780 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 9.48 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 9.48 | 17276780 | |
| MESH:D006529 | Hepatomegaly | Amiodarone | 17.09 | 15265979 | |
| MESH:D006529 | Hepatomegaly | Iron | 17.09 | 16890145 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 17.09 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 17.09 | 16221962 19176532 18467677 19772884 | |
| MESH:D006529 | Hepatomegaly | Propranolol | 17.09 | 16371745 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 17.09 | 12621046 16120746 15340226 | |
| MESH:D006529 | Hepatomegaly | zileuton | 17.09 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.43 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 4.28 | 16490937 16863852 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 4.28 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | nitrofen | 4.28 | 11685700 10898224 11584395 12904592 10370016 11051153 10898222 7576705 8863223 17618886 11076806 9698600 11329586 15764645 12194112 17270546 16490937 16473863 12021965 16080930 15793718 10541330 16720372 11588001 15756563 12547725 15578192 16863852 15707848 9473106 17245593 18280291 10693666 12759764 12407540 16292651 15136996 9575882 15185205 12746050 15088113 11409163 18280292 10646786 7760232 9476886 12505043 18958481 9859898 7520565 10370017 10359170 11057544 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.37 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Flupenthixol | 13.88 | 1682908 | |
| MESH:D006561 | Herpes Simplex | Mangifera indica extract | 13.88 | 10715843 | |
| MESH:D006561 | Herpes Simplex | mangiferin | 13.88 | 10715843 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 13.88 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 13.88 | 16876885 | |
| MESH:D015658 | HIV Infections | Iron | 5.98 | 16597321 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 5.98 | 12878215 | |
| MESH:D015658 | HIV Infections | Stavudine | 5.98 | 11141242 | |
| MESH:D015658 | HIV Infections | Zidovudine | 5.98 | 11363243 20032539 17358032 11698656 11141242 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 5.97 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 5.97 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 5.97 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 5.97 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 11.35 | 17088409 | |
| MESH:D019584 | Hot Flashes | Paroxetine | 11.35 | 14716179 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 11.35 | 16566672 14716179 17454163 | |
| MESH:D019584 | Hot Flashes | Trazodone | 11.35 | 19711746 | |
| MESH:D006816 | Huntington Disease | Sertraline | 4.41 | 18403212 | |
| MESH:D006869 | Hydronephrosis | Lithium Chloride | 7.56 | 19797860 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 7.56 | 16959395 16354765 18606429 15340226 8697196 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.10 | 15240983 | |
| MESH:D006930 | Hyperalgesia | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 29.11 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 29.11 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Capsaicin | 29.11 | 17434803 17043245 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 29.11 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 29.11 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 29.11 | 12727271 | |
| MESH:D006930 | Hyperalgesia | rosiglitazone | 29.11 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Trazodone | 29.11 | 12790215 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 29.11 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Yohimbine | 29.11 | 12727271 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 29.11 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.05 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 2.90 | 16899240 | |
| MESH:D006934 | Hypercalcemia | Furosemide | 6.23 | 17652376 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 6.23 | 18089816 19622757 | |
| MESH:D053565 | Hypercalciuria | Furosemide | 8.05 | 17652376 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 8.05 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | Amiodarone | 12.85 | 8137927 9751232 | |
| MESH:D006937 | Hypercholesterolemia | atorvastatin | 12.85 | 11583720 | |
| MESH:D006937 | Hypercholesterolemia | Cholesterol | 12.85 | 16933029 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 12.85 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 12.85 | 17188708 | |
| MESH:D006940 | Hyperemia | Hydrochloric Acid | 11.95 | 12646421 | |
| MESH:D006940 | Hyperemia | Indomethacin | 11.95 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 11.95 | 11156591 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 2.96 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 7.23 | 18262572 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 7.23 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 7.23 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Catechin | 5.08 | 17292331 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 5.08 | 16484555 | |
| MESH:D006946 | Hyperinsulinism | Fructose | 5.67 | 14757778 18360027 19008412 18563319 15752949 | |
| MESH:D006946 | Hyperinsulinism | mangiferin | 5.67 | 9881663 11315760 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 2.95 | 17050553 | |
| MESH:D006948 | Hyperkinesis | Methamphetamine | 3.90 | 17658665 | |
| MESH:D006949 | Hyperlipidemias | Fish Oils | 20.12 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Fructose | 20.12 | 15752949 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 20.12 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | mangiferin | 20.12 | 15975614 | |
| MESH:D006949 | Hyperlipidemias | Oleanolic Acid | 20.12 | 8847885 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 20.12 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 20.12 | 16873680 | |
| MESH:D006951 | Hyperlipoproteinemias | Fatty Acids, Unsaturated | 4.64 | 18435438 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | atorvastatin | 5.77 | 16238680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 5.77 | 16238680 | |
| MESH:D006962 | Hyperparathyroidism, Secondary | Furosemide | 4.22 | 15086907 | |
| MESH:D006967 | Hypersensitivity | Butylated Hydroxytoluene | 6.52 | 17604070 | |
| MESH:D006967 | Hypersensitivity | Mangifera indica extract | 6.52 | 16536907 | |
| MESH:D006967 | Hypersensitivity | mangiferin | 6.52 | 16536907 | |
| MESH:D006968 | Hypersensitivity, Delayed | Fish Oils | 3.86 | 11484837 | |
| MESH:D006973 | Hypertension | marker/mechanism | 14757778 | ||
| MESH:D006973 | Hypertension | Amiloride | 36.12 | 18524855 19344079 15174897 | |
| MESH:D006973 | Hypertension | Arsenic | 36.12 | 11953799 9931084 16076760 | |
| MESH:D006973 | Hypertension | atorvastatin | 36.12 | 17042910 | |
| MESH:D006973 | Hypertension | Cobalt | 36.12 | 17039479 | |
| MESH:D006973 | Hypertension | Cyclosporine | 36.12 | 10903974 | |
| MESH:D006973 | Hypertension | daidzein | 36.12 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 36.12 | 17042910 | |
| MESH:D006973 | Hypertension | Fructose | 36.12 | 14568997 14633139 14573337 16843071 19008412 | |
| MESH:D006973 | Hypertension | Losartan | 36.12 | 10090350 12512695 14597852 12586211 15969258 | |
| MESH:D006973 | Hypertension | Nifedipine | 36.12 | 20102058 | |
| MESH:D006973 | Hypertension | Ouabain | 36.12 | 18976649 | |
| MESH:D006973 | Hypertension | Phenylephrine | 36.12 | 8949925 12717712 | |
| MESH:D006973 | Hypertension | Quercetin | 36.12 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 36.12 | 17577099 15787275 | |
| MESH:D006973 | Hypertension | Sodium Chloride | 36.12 | 11507004 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 36.12 | 18850075 18670907 | |
| MESH:D006973 | Hypertension | valsartan | 36.12 | 16475468 20102058 10903974 12850387 12692753 18344623 18390891 11427623 | |
| MESH:D006974 | Hypertension, Malignant | valsartan | 4.75 | 11560862 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 6.12 | 15338365 | |
| MESH:D006975 | Hypertension, Portal | Hydrochloric Acid | 6.12 | 16984587 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Furosemide | 3.69 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | Epoprostenol | 10.84 | 15302794 | |
| MESH:D006976 | Hypertension, Pulmonary | gefitinib | 10.84 | 18424623 | |
| MESH:D006976 | Hypertension, Pulmonary | Hydrochloric Acid | 10.84 | 19262391 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 10.84 | 15838368 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 10.84 | 14726295 | |
| MESH:D015228 | Hypertriglyceridemia | Fructose | 3.59 | 19342510 19799862 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 5.86 | 16672835 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 5.86 | 12791704 18502941 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 2.82 | 17488730 | |
| MESH:D017380 | Hypertrophy, Right Ventricular | gefitinib | 4.60 | 18424623 | |
| MESH:D006987 | Hypesthesia | Arsenic | 3.89 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.53 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 3.08 | 16640825 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Amiloride | 4.22 | 19822448 | |
| MESH:C537153 | Hypomagnesemia primary | Furosemide | 8.21 | 11041285 | |
| MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 8.21 | 11041285 | |
| MESH:D007019 | Hypoproteinemia | Furosemide | 4.22 | 16096441 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 2.21 | 16945680 16569931 | |
| MESH:D007022 | Hypotension | Furosemide | 9.39 | 11041285 | |
| MESH:D007022 | Hypotension | Hydrochloric Acid | 9.39 | 11574821 | |
| MESH:D007022 | Hypotension | Propranolol | 9.39 | 6740701 | |
| MESH:D007022 | Hypotension | Tacrolimus | 9.39 | 11041285 | |
| MESH:D007024 | Hypotension, Orthostatic | Furosemide | 7.29 | 15811171 | |
| MESH:D007024 | Hypotension, Orthostatic | Trazodone | 7.29 | 15811171 | |
| MESH:D007035 | Hypothermia | Tetrahydrocannabinol | 4.34 | 10318961 | |
| MESH:D007037 | Hypothyroidism | Amiodarone | 6.38 | 17991464 18020914 | |
| MESH:D007037 | Hypothyroidism | Iron | 6.38 | 16640825 | |
| MESH:D007077 | Ileal Diseases | 1-Methyl-3-isobutylxanthine | 7.26 | 18306037 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 7.26 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.71 | 10651667 10647630 16133968 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 7.97 | 16076520 | |
| MESH:D007154 | Immune System Diseases | mangiferin | 7.97 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 8.72 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 8.72 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 10.34 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 10.34 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 10.34 | 19309543 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 1.94 | 12013081 | |
| MESH:D007248 | Infertility, Male | 2,2',3',4,4',5-hexachlorobiphenyl | 9.84 | 12948891 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 9.84 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | decitabine | 9.84 | 17581917 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 9.84 | 17937319 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 9.84 | 15346721 12646999 | |
| MESH:D007248 | Infertility, Male | Triclosan | 9.84 | 20821571 | |
| MESH:D007249 | Inflammation | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid | 150.44 | 19934399 | |
| MESH:D007249 | Inflammation | aloe emodin | 150.44 | 19352036 | |
| MESH:D007249 | Inflammation | Aluminum | 150.44 | 16052892 | |
| MESH:D007249 | Inflammation | Amiloride | 150.44 | 17237260 | |
| MESH:D007249 | Inflammation | Anti-Inflammatory Agents, Non-Steroidal | 150.44 | 3291741 14586007 16684565 | |
| MESH:D007249 | Inflammation | Arachidonic Acid | 150.44 | 17371808 15177302 9831321 | |
| MESH:D007249 | Inflammation | atorvastatin | 150.44 | 16908763 | |
| MESH:D007249 | Inflammation | bolinaquinone | 150.44 | 12604694 | |
| MESH:D007249 | Inflammation | Bupivacaine | 150.44 | 18165598 | |
| MESH:D007249 | Inflammation | cacospongionolide B | 150.44 | 12721113 | |
| MESH:D007249 | Inflammation | Capsaicin | 150.44 | 16956363 | |
| MESH:D007249 | Inflammation | Carrageenan | 150.44 | 19934399 12787963 12428691 12798668 16100529 10653021 7907874 8985016 18295198 | |
| MESH:D007249 | Inflammation | Curcumin | 150.44 | 16956363 18403477 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 150.44 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Diclofenac | 150.44 | 16273134 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 150.44 | 18785209 | |
| MESH:D007249 | Inflammation | epoxy resin AH-26 | 150.44 | 17963957 | |
| MESH:D007249 | Inflammation | ethylisopropylamiloride | 150.44 | 17237260 | |
| MESH:D007249 | Inflammation | Flurbiprofen | 150.44 | 11099482 | |
| MESH:D007249 | Inflammation | honokiol | 150.44 | 19539808 | |
| MESH:D007249 | Inflammation | Hydrochloric Acid | 150.44 | 11574821 | |
| MESH:D007249 | Inflammation | Ibuprofen | 150.44 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 150.44 | 7812673 12568917 3291741 | |
| MESH:D007249 | Inflammation | Iodine | 150.44 | 16001271 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 150.44 | 17963957 12878042 17255318 9205823 17237260 | |
| MESH:D007249 | Inflammation | Losartan | 150.44 | 12586211 | |
| MESH:D007249 | Inflammation | Mangifera indica extract | 150.44 | 15222974 15177302 | |
| MESH:D007249 | Inflammation | mangiferin | 150.44 | 15222974 | |
| MESH:D007249 | Inflammation | montelukast | 150.44 | 18059327 | |
| MESH:D007249 | Inflammation | Mustard Gas | 150.44 | 8975870 11428647 9357497 11428620 17524151 9260866 11428631 11402378 16001271 | |
| MESH:D007249 | Inflammation | Naproxen | 150.44 | 3291741 | |
| MESH:D007249 | Inflammation | nimesulide | 150.44 | 11438310 | |
| MESH:D007249 | Inflammation | Oleanolic Acid | 150.44 | 8847885 | |
| MESH:D007249 | Inflammation | petrosaspongiolide m | 150.44 | 12628480 | |
| MESH:D007249 | Inflammation | pioglitazone | 150.44 | 16908763 | |
| MESH:D007249 | Inflammation | Plant Extracts | 150.44 | 16366677 19332304 12787963 15997105 | |
| MESH:D007249 | Inflammation | Plant Oils | 150.44 | 10432208 | |
| MESH:D007249 | Inflammation | Progesterone | 150.44 | 15869954 | |
| MESH:D007249 | Inflammation | Quartz | 150.44 | 11306444 | |
| MESH:D007249 | Inflammation | resveratrol | 150.44 | 16366677 | |
| MESH:D007249 | Inflammation | rosiglitazone | 150.44 | 12083418 | |
| MESH:D007249 | Inflammation | Sealapex | 150.44 | 17963957 | |
| MESH:D007249 | Inflammation | Sulindac | 150.44 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 150.44 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 150.44 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 150.44 | 8273558 7562506 15177302 11698051 7812673 | |
| MESH:D007249 | Inflammation | Thalidomide | 150.44 | 16134734 | |
| MESH:D007249 | Inflammation | Tobacco Smoke Pollution | 150.44 | 18590791 | |
| MESH:D007249 | Inflammation | Trazodone | 150.44 | 12798668 | |
| MESH:D007249 | Inflammation | Triclosan | 150.44 | 9584910 20507366 | |
| MESH:D007249 | Inflammation | zileuton | 150.44 | 7812673 18309904 18295198 9831321 8621850 18059327 8960868 17118201 | |
| MESH:D007249 | Inflammation | Zymosan | 150.44 | 11289658 8014878 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 8.43 | 18200517 18596194 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Dextran Sulfate | 8.43 | 15339030 20423518 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Rutin | 8.43 | 15652231 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Trinitrobenzenesulfonic Acid | 8.43 | 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 8.43 | 15339030 | |
| MESH:D007251 | Influenza, Human | Nordihydroguaiaretic Acid | 18.05 | 18473937 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 18.05 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 18.05 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 18.05 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 18.05 | 16624496 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 15.26 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 15.26 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | Fructose | 15.26 | 17133782 19008412 18057795 18981581 19342510 19586609 19799862 18563319 14757778 14633139 14573337 | |
| MESH:D007333 | Insulin Resistance | mangiferin | 15.26 | 11315760 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 15.26 | 16306350 | |
| MESH:D007333 | Insulin Resistance | rosiglitazone | 15.26 | 16306350 | |
| MESH:D007333 | Insulin Resistance | Sodium Selenite | 15.26 | 14714311 | |
| MESH:D007410 | Intestinal Diseases | Hydrochloric Acid | 26.54 | 11574821 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 26.54 | 15831440 17329856 11686837 10210152 17994277 18236018 11855677 11713966 15610444 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 26.54 | 11574821 10210152 11713966 | |
| MESH:D007410 | Intestinal Diseases | pimagedine | 26.54 | 11713966 | |
| MESH:D007410 | Intestinal Diseases | rebamipide | 26.54 | 11686837 | |
| MESH:D007410 | Intestinal Diseases | rofecoxib | 26.54 | 15831440 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 26.54 | 17994277 | |
| MESH:D007410 | Intestinal Diseases | Trinitrobenzenesulfonic Acid | 26.54 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 14.99 | 10753194 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 14.99 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Piroxicam | 14.99 | 10213222 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 14.99 | 12628509 12351151 12584176 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 14.99 | 12351151 10213222 12663524 10223192 12628509 12584176 | |
| MESH:D007417 | Intestinal Polyps | marker/mechanism | 11245490 11507063 10753194 | ||
| MESH:D007417 | Intestinal Polyps | 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone | 10.19 | 11507063 | |
| MESH:D007417 | Intestinal Polyps | rofecoxib | 10.19 | 11245490 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 10.19 | 11245490 12394442 | |
| MESH:D002532 | Intracranial Aneurysm | Reactive Oxygen Species | 3.54 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 3.71 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 6.43 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 6.43 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.20 | 17553498 | |
| MESH:D007511 | Ischemia | Mangifera indica extract | 13.04 | 16273134 | |
| MESH:D007511 | Ischemia | mangiferin | 13.04 | 16806951 | |
| MESH:D007511 | Ischemia | morin | 13.04 | 16806951 | |
| MESH:D007511 | Ischemia | Zinc | 13.04 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 8.42 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 8.42 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 8.42 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | 1-Methyl-3-isobutylxanthine | 7.26 | 18306037 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 7.26 | 10574470 16133968 18306037 | |
| MESH:D007627 | Keloid | Quercetin | 3.34 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 2.78 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.36 | 12749816 16930632 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.00 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 7.85 | 15464296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 7.85 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 38.72 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Acrolein | 38.72 | 12488133 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 38.72 | 16962696 16322080 16226777 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 38.72 | 12231392 18289764 15190930 12649298 19839026 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 38.72 | 8314463 10903974 18776723 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 38.72 | 15369732 16775033 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 38.72 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Furosemide | 38.72 | 11041285 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 38.72 | 19349640 18289764 17934191 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 38.72 | 17190690 | |
| MESH:D007674 | Kidney Diseases | mangiferin | 38.72 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 38.72 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 38.72 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 38.72 | 12093613 | |
| MESH:D007674 | Kidney Diseases | Tacrolimus | 38.72 | 11041285 | |
| MESH:D007674 | Kidney Diseases | valsartan | 38.72 | 16893502 10903974 12164870 | |
| MESH:D007674 | Kidney Diseases | Zinc | 38.72 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Copper | 15.40 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 15.40 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 15.40 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 15.40 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 15.40 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | marker/mechanism | 12664575 | ||
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 13.73 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 13.73 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 13.73 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 13.73 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | gefitinib | 13.73 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 13.73 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 13.73 | 12579204 | |
| MESH:D007681 | Kidney Papillary Necrosis | nefiracetam | 6.06 | 16105799 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Calcium | 10.41 | 16316344 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 10.41 | 11231351 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 10.41 | 11231351 | |
| MESH:D007818 | Laryngeal Diseases | Hydrochloric Acid | 4.70 | 16498863 | |
| MESH:D007826 | Laryngismus | Hydrochloric Acid | 4.70 | 11510729 | |
| MESH:D007859 | Learning Disorders | Cholesterol | 10.20 | 17134702 | |
| MESH:D007859 | Learning Disorders | Copper | 10.20 | 17134702 | |
| MESH:D007859 | Learning Disorders | Ethanol | 10.20 | 15451040 | |
| MESH:D007859 | Learning Disorders | mangiferin | 10.20 | 19182383 | |
| MESH:D007889 | Leiomyoma | Curcumin | 6.01 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 6.01 | 16973256 | |
| MESH:D007890 | Leiomyosarcoma | marker/mechanism | 18645019 | ||
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 3.26 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Allopurinol | 8.37 | 9314461 12207774 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 8.37 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.37 | 12228301 10320625 11703811 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Sodium Chloride | 8.37 | 9499605 | |
| MESH:D007898 | Leishmaniasis, Visceral | Allopurinol | 5.78 | 7498017 10449224 11332679 | |
| MESH:D007898 | Leishmaniasis, Visceral | amarogentin | 5.78 | 10590280 | |
| MESH:D007898 | Leishmaniasis, Visceral | Thalidomide | 5.78 | 16514283 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 17.73 | 15070760 | |
| MESH:D007938 | Leukemia | Curcumin | 17.73 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 17.73 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 17.73 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Genistein | 17.73 | 17468513 18980019 | |
| MESH:D007938 | Leukemia | kaempferol | 17.73 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 17.73 | 17468513 | |
| MESH:D007938 | Leukemia | temozolomide | 17.73 | 17500047 | |
| MESH:D007938 | Leukemia | Tretinoin | 17.73 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 8.75 | 16085563 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 8.75 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | marker/mechanism | 16314473 | ||
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 6.51 | 17008537 18172266 18587576 17802794 17296974 17658394 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 6.51 | 17026967 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Drugs, Chinese Herbal | 6.51 | 15802533 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | honokiol | 6.51 | 15802533 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 14.52 | 12560223 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 14.52 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Docosahexaenoic Acids | 14.52 | 17077332 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 14.52 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 14.52 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 14.97 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 14.97 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 14.97 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 14.97 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 11.79 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 11.79 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 11.79 | 15631656 10785260 16572323 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | mangiferin | 11.79 | 15498116 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 11.79 | 19823023 19503090 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 7.29 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 7.29 | 17236224 19117987 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 7.29 | 16482212 16932348 19285840 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 5.68 | 16968895 20471514 19850784 17050201 16467208 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 5.68 | 19387464 18460780 18206229 19010910 18704418 17679729 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 5.68 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Thalidomide | 5.68 | 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 5.68 | 19850784 16294345 17596541 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 5.68 | 18206229 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 3.80 | 18055864 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 7.59 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 7.59 | 16891316 9834237 19075265 19642359 16330433 17217047 15336539 17107899 19225113 11468182 12679006 19035177 15622746 12018890 16331271 17649720 16966277 16823087 11161223 12712474 15748426 17712046 15213294 16112521 17869043 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 7.59 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 7.59 | 16331271 17217047 17339181 19029980 19642359 16140955 16766008 17301526 19035177 16935935 17294898 19075265 16823087 19225113 9834237 16891316 17712046 12679006 17649720 17506722 16788101 17361223 17107899 15748426 17368321 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 6.47 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 6.47 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.71 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.05 | 17980183 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 6.39 | 10052129 11830472 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 6.39 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.38 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 3.81 | 16563566 | |
| MESH:D056929 | Liddle Syndrome | Amiloride | 4.36 | 19344079 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 8.53 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 8.53 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Thalidomide | 8.53 | 10473037 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 8.53 | 9224671 | |
| MESH:D008064 | Lipidoses | Amiodarone | 5.58 | 17567588 15342952 | |
| MESH:D008064 | Lipidoses | Sertraline | 5.58 | 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 5.58 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.27 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.05 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 21.75 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 21.75 | 16221502 11903743 17334410 16943688 21278145 11408273 16239168 17174718 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 21.75 | 18522880 19638242 18665156 20032147 18407596 | |
| MESH:D008103 | Liver Cirrhosis | Drugs, Chinese Herbal | 21.75 | 17163593 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 21.75 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Hydrochloric Acid | 21.75 | 16984587 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 21.75 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 21.75 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 21.75 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Thalidomide | 21.75 | 17174718 16943688 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.46 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 2.99 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | marker/mechanism | 17565644 | ||
| MESH:D008106 | Liver Cirrhosis, Experimental | 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide | 62.09 | 12891558 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | 62.09 | 15876570 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | allyl alcohol | 62.09 | 18564211 11063159 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | atorvastatin | 62.09 | 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Bee Venoms | 62.09 | 20821823 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 62.09 | 14716496 12958196 14620537 15931870 15818738 16136751 12389079 15650968 13678700 17922224 18156304 17721639 15673190 15893842 18006644 18263696 12445418 18429990 18187930 12609069 17766677 18279442 15925388 16638106 15730626 17976157 12632514 12741479 14512876 15052691 18054572 18277467 15338365 14724832 17805973 16033810 12546737 20821823 12898905 12586293 16248980 11481614 15876570 18472094 17640975 18472332 18418968 14716833 16192424 16097048 17823541 16011737 17698563 15123356 18376398 15362042 16015684 17869086 12667390 18339082 12632512 18205269 17761835 18481824 17714472 17900296 17708605 18166357 17525996 18395095 18251166 17481882 18395914 10355542 15370692 15057751 18210741 18705752 12445421 18420326 17557913 16116963 17631135 12649538 12666154 18317297 18412020 16027843 17944888 17565644 14748882 15996030 15959796 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 62.09 | 18006644 18705752 17355460 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 62.09 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 62.09 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 62.09 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Drugs, Chinese Herbal | 62.09 | 15641146 12632512 17881167 15339415 15763062 18371158 17348192 18567088 18237412 15754396 15849816 15383259 15864749 15744066 17666798 18606216 17629604 15818738 17036385 16610055 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 62.09 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 62.09 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 62.09 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | ferulic acid | 62.09 | 16011737 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 62.09 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 62.09 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 62.09 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Losartan | 62.09 | 17900296 15573910 12445418 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Melatonin | 62.09 | 15298665 16703270 15925388 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | morin | 62.09 | 18629640 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Oleanolic Acid | 62.09 | 10355542 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 62.09 | 15052691 16484506 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 62.09 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 62.09 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 62.09 | 17724770 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Poly I-C | 62.09 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 62.09 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 62.09 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rofecoxib | 62.09 | 17565644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 62.09 | 17347453 15980055 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | silybin | 62.09 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 62.09 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 62.09 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thalidomide | 62.09 | 15465738 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Thioacetamide | 62.09 | 18615449 15316131 11481614 16097051 16489207 17355460 12531686 12891558 12557150 12085344 15288473 18032466 15075984 16343077 15465738 15716488 16511523 18606216 17629604 15158331 18416461 11172339 16098781 18380797 18263696 17292413 15334695 15288472 14739098 16248980 15474484 15078482 11682029 16126171 15095483 10677585 12175628 18458672 18395095 18031379 12679928 15362042 18295389 17050028 17127702 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 62.09 | 18397230 16248980 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | valsartan | 62.09 | 16872305 15619341 15504291 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 30.07 | 16611625 19014921 12969438 16610002 19784758 19460945 12587719 11587558 | |
| MESH:D008107 | Liver Diseases | Arsenic | 30.07 | 11134558 | |
| MESH:D008107 | Liver Diseases | Capsaicin | 30.07 | 16956363 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 30.07 | 17285989 16246199 16964402 15830285 15720792 | |
| MESH:D008107 | Liver Diseases | Curcumin | 30.07 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diclofenac | 30.07 | 14566034 16867024 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 30.07 | 17034775 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 30.07 | 15816358 | |
| MESH:D008107 | Liver Diseases | Docosahexaenoic Acids | 30.07 | 17056761 | |
| MESH:D008107 | Liver Diseases | Drugs, Chinese Herbal | 30.07 | 17207593 | |
| MESH:D008107 | Liver Diseases | Naproxen | 30.07 | 16867024 | |
| MESH:D008107 | Liver Diseases | nimesulide | 30.07 | 16867024 | |
| MESH:D008107 | Liver Diseases | Oleanolic Acid | 30.07 | 8847885 15720792 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 30.07 | 19363144 | |
| MESH:D008107 | Liver Diseases | Piroxicam | 30.07 | 16867024 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 30.07 | 17034775 | |
| MESH:D008107 | Liver Diseases | Sulindac | 30.07 | 14986274 16867024 | |
| MESH:D008107 | Liver Diseases | Thioacetamide | 30.07 | 15158337 16337175 18374380 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 6.20 | 17347304 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 6.20 | 16737972 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 6.54 | 15123358 | |
| MESH:D017093 | Liver Failure | Stavudine | 6.54 | 18299183 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 14.95 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 14.95 | 14706259 16899240 | |
| MESH:D017114 | Liver Failure, Acute | Epoprostenol | 14.95 | 15633222 | |
| MESH:D017114 | Liver Failure, Acute | Thioacetamide | 14.95 | 15633222 15313186 12479984 17276928 | |
| MESH:D017114 | Liver Failure, Acute | Trazodone | 14.95 | 19857765 | |
| MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 66.50 | 16835634 18644402 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 66.50 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 66.50 | 16353153 | |
| MESH:D008113 | Liver Neoplasms | 4-biphenylamine | 66.50 | 15761837 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 66.50 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 66.50 | 9643874 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 66.50 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 66.50 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 66.50 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 66.50 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Butylated Hydroxytoluene | 66.50 | 18177683 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 66.50 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Copper | 66.50 | 20302851 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 66.50 | 20137499 2422723 19499222 20101389 20583210 19812893 19426721 20501860 19690152 19551842 19833225 18978307 21167192 19642983 16942905 18648771 19073162 19294768 12112319 21071580 19638242 2862719 20434301 18644402 19996281 20118626 19427195 19254457 19850985 18754104 12771043 19090486 21047994 18977376 15885732 15175105 19256749 20452335 10737359 20492335 21278145 9163691 20405173 19255062 | |
| MESH:D008113 | Liver Neoplasms | Drugs, Chinese Herbal | 66.50 | 18339527 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 66.50 | 15113037 17045692 16603448 18383874 | |
| MESH:D008113 | Liver Neoplasms | Glycyrrhizic Acid | 66.50 | 19426721 | |
| MESH:D008113 | Liver Neoplasms | Iron | 66.50 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Methylenebis(chloroaniline) | 66.50 | 512554 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 66.50 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 66.50 | 8742319 21047994 15975961 19073162 19812893 19482888 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 66.50 | 20007298 16377806 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 66.50 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 66.50 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 66.50 | 20405173 19073162 19321006 19812893 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 66.50 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 66.50 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 66.50 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 66.50 | 17559639 16391232 17093202 | |
| MESH:D008113 | Liver Neoplasms | zerumbone | 66.50 | 20452335 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 29.70 | 2876786 6135515 2876784 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4-biphenylamine | 29.70 | 11376689 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 29.70 | 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 29.70 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 29.70 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 29.70 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 29.70 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 29.70 | 21159647 2563599 17942915 18775883 18253720 19009564 18093689 9362446 18164116 19004024 17854601 17174075 18308698 16267830 19126423 19539802 19519916 18079962 3124819 18544905 16842330 18282651 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 29.70 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 29.70 | 1399818 598648 | |
| MESH:D008114 | Liver Neoplasms, Experimental | morin | 29.70 | 19539802 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Organoselenium Compounds | 29.70 | 16170372 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 29.70 | 17172636 6150874 1399818 2563599 18308698 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 29.70 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 29.70 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | Amiodarone | 5.80 | 15350150 11989578 17391786 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 5.80 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Trazodone | 5.80 | 18167038 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 24.46 | 12815614 | |
| MESH:D008171 | Lung Diseases | Acrolein | 24.46 | 11504702 | |
| MESH:D008171 | Lung Diseases | Aluminum | 24.46 | 16052892 | |
| MESH:D008171 | Lung Diseases | Amiodarone | 24.46 | 12587719 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 24.46 | 16863852 | |
| MESH:D008171 | Lung Diseases | Hydrochloric Acid | 24.46 | 16784557 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 24.46 | 18702808 18161513 | |
| MESH:D008171 | Lung Diseases | nitrofen | 24.46 | 9614859 9859898 17245593 16863852 | |
| MESH:D008171 | Lung Diseases | Ozone | 24.46 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 24.46 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Amiodarone | 2.85 | 18516814 | |
| MESH:D008173 | Lung Diseases, Obstructive | Cobalt | 4.26 | 6434250 | |
| MESH:D055370 | Lung Injury | Asbestos, Crocidolite | 18.61 | 17365036 | |
| MESH:D055370 | Lung Injury | Hydrochloric Acid | 18.61 | 18497604 15607125 21114838 15044056 20597076 18573544 17627322 19262391 21311175 11395602 19644408 18339021 15090967 16129981 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 18.61 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 18.61 | 11395602 | |
| MESH:D055370 | Lung Injury | Ozone | 18.61 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 18.61 | 16129981 | |
| MESH:D055370 | Lung Injury | S-methylisothiopseudouronium | 18.61 | 18573544 | |
| MESH:D008175 | Lung Neoplasms | 2-amino-3-methylimidazo(4,5-f)quinoline | 91.37 | 16353153 | |
| MESH:D008175 | Lung Neoplasms | 4-biphenylamine | 91.37 | 17671175 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 91.37 | 14755239 16401635 18508827 17139156 19931552 15893417 15172992 12438228 18813816 9255578 16061637 | |
| MESH:D008175 | Lung Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 91.37 | 11376689 | |
| MESH:D008175 | Lung Neoplasms | Acetaldehyde | 91.37 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 91.37 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | alpha-Tocopherol | 91.37 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 91.37 | 17976673 17306315 19168569 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 91.37 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 91.37 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 91.37 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azoxymethane | 91.37 | 15824018 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 91.37 | 20064080 18569708 20869020 20464547 6695378 18520028 20135361 17053015 18816296 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 91.37 | 16885199 17163412 12117777 | |
| MESH:D008175 | Lung Neoplasms | Butylated Hydroxytoluene | 91.37 | 19925653 15390079 11696405 16337739 18597497 11246140 19359593 | |
| MESH:D008175 | Lung Neoplasms | ciglitazone | 91.37 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 91.37 | 6189445 17225452 11798837 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 91.37 | 18462866 16243823 19359593 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 91.37 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 91.37 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 91.37 | 6695378 20970405 20512841 21163286 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 91.37 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Drugs, Chinese Herbal | 91.37 | 18339527 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 91.37 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 91.37 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | Iron | 91.37 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 91.37 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | mangiferin | 91.37 | 18569708 18520028 18816296 | |
| MESH:D008175 | Lung Neoplasms | Melatonin | 91.37 | 17195641 | |
| MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 91.37 | 16337739 1399818 20970405 17909032 16271038 10545420 9230183 20512841 7750092 11893704 15390079 21163286 6695378 | |
| MESH:D008175 | Lung Neoplasms | Methylenebis(chloroaniline) | 91.37 | 512554 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 91.37 | 3148597 8781369 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 91.37 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Piroxicam | 91.37 | 11195469 15824018 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 91.37 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quartz | 91.37 | 11306444 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 91.37 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | silybin | 91.37 | 16788158 | |
| MESH:D008175 | Lung Neoplasms | Smoke | 91.37 | 11091918 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 91.37 | 16712894 15276417 17306315 17077188 19931552 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 91.37 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 91.37 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 91.37 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 91.37 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Tobacco Smoke Pollution | 91.37 | 11091918 12111688 16288123 3440675 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 91.37 | 12957351 11323394 15166089 11062179 15902970 11307925 16204055 10779650 11807781 16788158 12765245 10530776 12466968 16926031 11992545 15136453 11544531 10997738 17255336 11246140 11497255 17093202 6695378 16007126 11893704 16337739 10822126 17195641 16289808 12117781 16391232 11552296 14587096 7750092 11074608 | |
| MESH:D008175 | Lung Neoplasms | Vehicle Emissions | 91.37 | 9255578 | |
| MESH:D008175 | Lung Neoplasms | vinyl carbamate | 91.37 | 15824018 16885199 17363558 16247444 17361011 11195469 12117777 15172992 17163412 14755239 11134547 12438228 12765245 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 91.37 | 18800350 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.16 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Melatonin | 3.27 | 16373423 | |
| MESH:D008223 | Lymphoma | 9,10-Dimethyl-1,2-benzanthracene | 14.91 | 11376689 | |
| MESH:D008223 | Lymphoma | cannabidiol hydroxyquinone | 14.91 | 17478614 | |
| MESH:D008223 | Lymphoma | Curcumin | 14.91 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 14.91 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 14.91 | 19470736 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 14.91 | 16098063 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 14.91 | 16166326 | |
| MESH:D016393 | Lymphoma, B-Cell | marker/mechanism | 14654083 | ||
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 8.33 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 8.33 | 17088997 | |
| MESH:D016393 | Lymphoma, B-Cell | Sodium Selenite | 8.33 | 14737004 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 9.01 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 9.01 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 9.01 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 9.01 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 10.42 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 10.42 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 10.42 | 15621674 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.85 | 16640825 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 4.70 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 4.70 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,4-phenylenebis(methylene)selenocyanate | 55.37 | 12844480 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 55.37 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 9,10-Dimethyl-1,2-benzanthracene | 55.37 | 16082771 8985016 1500032 12844480 10697514 16153821 11807958 18840765 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Butylated Hydroxytoluene | 55.37 | 1500032 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 55.37 | 12104042 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 55.37 | 12807724 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 55.37 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Drugs, Chinese Herbal | 55.37 | 14758024 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 55.37 | 16891317 17203775 11807958 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 55.37 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | gefitinib | 55.37 | 18375820 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 55.37 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 55.37 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Iodine | 55.37 | 15922087 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 55.37 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 55.37 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 55.37 | 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 55.37 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 55.37 | 19196722 16827153 11731420 19196723 14580682 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 55.37 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Triclosan | 55.37 | 15358634 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 55.37 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 55.37 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 12.93 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 12.93 | 16551646 16568477 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 12.93 | 19453300 | |
| MESH:D008382 | Marfan Syndrome | Losartan | 4.46 | 19430350 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 1.88 | 17453147 | |
| MESH:D008545 | Melanoma | marker/mechanism | 17145863 17499752 | ||
| MESH:D008545 | Melanoma | Carboplatin | 36.73 | 12040289 16225601 16342250 11712820 | |
| MESH:D008545 | Melanoma | Cisplatin | 36.73 | 18505091 15577323 18332650 12374674 11135225 17023156 12883367 16432458 18176117 16248763 12393984 16809738 17761969 | |
| MESH:D008545 | Melanoma | Curcumin | 36.73 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | decitabine | 36.73 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | Disulfiram | 36.73 | 15367699 | |
| MESH:D008545 | Melanoma | docetaxel | 36.73 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 36.73 | 16827129 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 36.73 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | Fenretinide | 36.73 | 16270382 | |
| MESH:D008545 | Melanoma | Glucose | 36.73 | 14993021 | |
| MESH:D008545 | Melanoma | Isotretinoin | 36.73 | 17237267 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 36.73 | 16487513 | |
| MESH:D008545 | Melanoma | Paclitaxel | 36.73 | 16342250 12025231 12040289 | |
| MESH:D008545 | Melanoma | Platinum | 36.73 | 16814760 | |
| MESH:D008545 | Melanoma | Reactive Oxygen Species | 36.73 | 17992120 | |
| MESH:D008545 | Melanoma | resveratrol | 36.73 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 36.73 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Sulindac | 36.73 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 36.73 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | temozolomide | 36.73 | 12374674 16260697 18281670 12829675 10623706 17623835 16248763 16432458 17576461 15577323 16260693 16225601 | |
| MESH:D008545 | Melanoma | Thalidomide | 36.73 | 12829675 17089043 16098027 | |
| MESH:D008545 | Melanoma | Tretinoin | 36.73 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 36.73 | 16505122 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 6.13 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 6.13 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 9.31 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Acrolein | 9.31 | 10803710 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 9.31 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 7.20 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 7.20 | 18411066 15451040 | |
| MESH:D008569 | Memory Disorders | mangiferin | 7.20 | 19182383 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 2.82 | 16940565 | |
| MESH:D007706 | Menkes Kinky Hair Syndrome | Copper | 4.24 | 17268249 17109627 | |
| MESH:D001523 | Mental Disorders | Flupenthixol | 6.40 | 16856516 | |
| MESH:D001523 | Mental Disorders | Paroxetine | 6.40 | 16856516 | |
| MESH:D001523 | Mental Disorders | Sertraline | 6.40 | 16856516 | |
| MESH:D001523 | Mental Disorders | Trazodone | 6.40 | 16856516 | |
| MESH:D008654 | Mesothelioma | Asbestos, Crocidolite | 8.15 | 16966607 16166281 18303189 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 8.15 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 8.15 | 17638057 | |
| MESH:D008654 | Mesothelioma | Selenium | 8.15 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 8.15 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 2.86 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | Fructose | 5.23 | 17098227 18497449 16815490 17261469 19165636 | |
| MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 5.23 | 17261469 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.12 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.45 | 10496685 | |
| MESH:D008708 | Methemoglobinemia | 4-biphenylamine | 7.18 | 12030840 | |
| MESH:D008708 | Methemoglobinemia | Phenacetin | 7.18 | 4834387 16296465 1949026 3537620 | |
| MESH:D008708 | Methemoglobinemia | Phenetidine | 7.18 | 1949026 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.17 | 17358032 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 9.45 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 9.45 | 11903285 | |
| MESH:D008881 | Migraine Disorders | montelukast | 9.45 | 10759916 | |
| MESH:D008881 | Migraine Disorders | Naproxen | 9.45 | 18803445 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 9.45 | 11701602 | |
| MESH:D020326 | Migraine without Aura | 6-Ketoprostaglandin F1 alpha | 12.62 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Cyclic GMP | 12.62 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 12.62 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 12.62 | 14659530 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 2.97 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 3.89 | 15863610 | |
| MESH:D009041 | Motion Sickness | Dextroamphetamine | 3.87 | 1613127 | |
| MESH:D009062 | Mouth Neoplasms | Anti-Inflammatory Agents, Non-Steroidal | 19.22 | 15555568 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 19.22 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 19.22 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 19.22 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 19.22 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Plant Preparations | 19.22 | 17418620 | |
| MESH:D009062 | Mouth Neoplasms | Tobacco Smoke Pollution | 19.22 | 15006635 | |
| MESH:D009069 | Movement Disorders | Manganese | 6.63 | 16551646 | |
| MESH:D009069 | Movement Disorders | Trazodone | 6.63 | 4066620 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.16 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 33.07 | 14977855 11468182 15949261 19417148 19549372 | |
| MESH:D009101 | Multiple Myeloma | Capsaicin | 33.07 | 17505005 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 33.07 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 33.07 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 33.07 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 33.07 | 15867202 15744524 16118317 | |
| MESH:D009101 | Multiple Myeloma | lonafarnib | 33.07 | 16996129 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 33.07 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 33.07 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 33.07 | 16267019 17049120 14749477 17164350 16490592 17935668 | |
| MESH:D009101 | Multiple Myeloma | Thalidomide | 33.07 | 16445831 19112201 19112817 15939924 15867202 17168659 15920492 19372569 15741222 15744524 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 33.07 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 33.07 | 19621390 16996129 18089719 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.67 | 15259001 12879239 12130978 18160304 10479408 15241586 15213630 10890648 15834315 17724436 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Aluminum | 9.03 | 17086897 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 9.03 | 17086897 | |
| MESH:D020529 | Multiple Sclerosis, Relapsing-Remitting | Aluminum | 4.72 | 17086897 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 11.81 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 11.81 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 11.81 | 17962980 | |
| MESH:D009135 | Muscular Diseases | atorvastatin | 5.48 | 16239165 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 5.48 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 4.61 | 18694830 | |
| MESH:D009181 | Mycoses | Amiodarone | 7.67 | 17974566 12754197 | |
| MESH:D009181 | Mycoses | Iron | 7.67 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.02 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 10.16 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 10.16 | 18608210 16882708 19010910 19157545 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 10.16 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Thalidomide | 10.16 | 18720364 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 10.16 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | alpha-Tocopherol | 21.47 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 21.47 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 21.47 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 21.47 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Hydrochloric Acid | 21.47 | 18534312 | |
| MESH:D009203 | Myocardial Infarction | Losartan | 21.47 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | mangiferin | 21.47 | 16584858 17052832 19172585 16697266 16538859 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 21.47 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 21.47 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 21.47 | 16525036 16317513 17188708 16456233 17015251 17125593 | |
| MESH:D009203 | Myocardial Infarction | S-methylisothiopseudouronium | 21.47 | 10090345 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 10.24 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 10.24 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 10.24 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 10.24 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 11.97 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 11.97 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 11.97 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 11.97 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 11.97 | 19207477 | |
| MESH:D009205 | Myocarditis | Particulate Matter | 7.04 | 12563109 | |
| MESH:D009205 | Myocarditis | resveratrol | 7.04 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 2.85 | 17484760 | |
| MESH:D009216 | Myopia | Atropine | 3.78 | 12601066 | |
| MESH:D009232 | Myxoma | Raloxifene | 3.89 | 16343187 | |
| MESH:D009298 | Nasal Polyps | zileuton | 4.57 | 10665187 | |
| MESH:D009325 | Nausea | Aspirin | 3.58 | 15240983 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 5.60 | 18551238 7678174 | |
| MESH:D009336 | Necrosis | Melatonin | 5.60 | 12195237 | |
| MESH:D009361 | Neoplasm Invasiveness | Amiloride | 20.35 | 14644129 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 20.35 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 20.35 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 20.35 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 20.35 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 20.35 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 16.43 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | capecitabine | 16.43 | 12972520 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 16.43 | 9029167 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 16.43 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 16.43 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 16.43 | 11239499 16537180 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 16.43 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 16.43 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 16.43 | 15867366 17312309 19139120 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.76 | 19410462 | |
| MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 52.21 | 8820588 | |
| MESH:D009369 | Neoplasms | 4-phenylbutyric acid | 52.21 | 19116145 | |
| MESH:D009369 | Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 52.21 | 11544531 | |
| MESH:D009369 | Neoplasms | Acrolein | 52.21 | 17329238 | |
| MESH:D009369 | Neoplasms | alitretinoin | 52.21 | 16946489 | |
| MESH:D009369 | Neoplasms | Anti-Inflammatory Agents, Non-Steroidal | 52.21 | 16684565 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 52.21 | 11141357 | |
| MESH:D009369 | Neoplasms | capecitabine | 52.21 | 16374040 | |
| MESH:D009369 | Neoplasms | Carboplatin | 52.21 | 18854779 17925555 | |
| MESH:D009369 | Neoplasms | Cisplatin | 52.21 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 52.21 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 52.21 | 19470736 19116145 17925555 | |
| MESH:D009369 | Neoplasms | deguelin | 52.21 | 17764071 | |
| MESH:D009369 | Neoplasms | Disulfiram | 52.21 | 17079463 | |
| MESH:D009369 | Neoplasms | Epoprostenol | 52.21 | 17264769 | |
| MESH:D009369 | Neoplasms | Fenretinide | 52.21 | 17353921 15958647 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 52.21 | 18239605 18600527 16928823 | |
| MESH:D009369 | Neoplasms | meloxicam | 52.21 | 16684565 | |
| MESH:D009369 | Neoplasms | Oleanolic Acid | 52.21 | 8847885 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 52.21 | 17405874 | |
| MESH:D009369 | Neoplasms | Piroxicam | 52.21 | 16684565 | |
| MESH:D009369 | Neoplasms | Quercetin | 52.21 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 52.21 | 11559025 | |
| MESH:D009369 | Neoplasms | Tretinoin | 52.21 | 16594593 16946489 | |
| MESH:D009369 | Neoplasms | Urethane | 52.21 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 9.06 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 9.06 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 9.06 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 9.06 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 9.02 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 9.02 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 9.02 | 19200415 19196722 19189210 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 15.02 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | cannabidiol hydroxyquinone | 15.02 | 16571653 | |
| MESH:D009389 | Neovascularization, Pathologic | Copper | 15.02 | 17308104 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 15.02 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 15.02 | 17289903 | |
| MESH:D009393 | Nephritis | Acrolein | 4.62 | 12653641 | |
| MESH:D009395 | Nephritis, Interstitial | Anti-Inflammatory Agents, Non-Steroidal | 8.65 | 3291741 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 8.65 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 8.65 | 6375363 | |
| MESH:D009397 | Nephrocalcinosis | Furosemide | 4.22 | 15086907 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.16 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 2.78 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | atorvastatin | 10.58 | 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 10.58 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 10.58 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 10.58 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 11.62 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 11.62 | 16551646 | |
| MESH:D009410 | Nerve Degeneration | mangiferin | 11.62 | 17433543 | |
| MESH:D009410 | Nerve Degeneration | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 11.62 | 17356569 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 11.62 | 18619942 15790535 17356569 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 18.48 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 18.48 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 18.48 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 18.48 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Thalidomide | 18.48 | 16859833 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 18.48 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 3.97 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 11.85 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 11.85 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 11.85 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 11.85 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tetrahydrocannabinol | 11.85 | 19040278 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 11.85 | 9142499 | |
| OMIM:601634 | NEURAL TUBE DEFECTS, FOLATE-SENSITIVE | Methanol | 4.94 | 8946559 | |
| MESH:D019954 | Neurobehavioral Manifestations | 2,3',4,4',5-pentachlorobiphenyl | 7.41 | 19647017 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 7.41 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 11.62 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 11.62 | 16115947 15176712 8761367 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 11.62 | 15555623 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 11.62 | 17368321 | |
| MESH:D009447 | Neuroblastoma | Platinum | 11.62 | 16814760 | |
| MESH:D009447 | Neuroblastoma | temozolomide | 11.62 | 15176712 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 25.19 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Acrolein | 25.19 | 11342003 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 25.19 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 25.19 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 25.19 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | Oxidopamine | 25.19 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 25.19 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 25.19 | 17266991 16850258 | |
| MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 25.19 | 15081597 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 9.93 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 9.93 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 9.93 | 12837982 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 12.86 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Capsaicin | 12.86 | 17961222 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 12.86 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 12.86 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.45 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.04 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 4.16 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 4.16 | 16436463 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 4.50 | 8291058 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 4.50 | 16761898 7688884 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | Cholesterol | 4.10 | 20557099 9802331 | |
| MESH:D053206 | Nocturnal Enuresis | Furosemide | 4.22 | 17945291 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 7.12 | 17217161 | |
| MESH:D009765 | Obesity | Capsaicin | 7.12 | 19056576 | |
| MESH:D009765 | Obesity | Curcumin | 7.12 | 19297423 | |
| MESH:D009765 | Obesity | Fructose | 7.12 | 18585860 17707055 | |
| MESH:D009765 | Obesity | pirinixic acid | 7.12 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 7.12 | 19056576 20132043 | |
| MESH:D009771 | Obsessive-Compulsive Disorder | Paroxetine | 4.54 | 17503984 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.52 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 4.49 | 16049721 | |
| MESH:D009784 | Occupational Diseases | Hydrochloric Acid | 4.49 | 12378975 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.12 | 16517039 | |
| MESH:D053578 | Opsoclonus-Myoclonus Syndrome | Trazodone | 4.82 | 1318289 | |
| MESH:D009914 | Oral Submucous Fibrosis | marker/mechanism | 16311067 | ||
| MESH:D009914 | Oral Submucous Fibrosis | Arecoline | 4.67 | 16311067 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 19.37 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Diclofenac | 19.37 | 18287210 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 19.37 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 19.37 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 19.37 | 16640825 | |
| MESH:D010003 | Osteoarthritis | lumiracoxib | 19.37 | 20639878 | |
| MESH:D010003 | Osteoarthritis | N-((4-(5,9-diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo(3,4-g)quinolin-7-yl)-3-methylbenzyl)sulfonyl)-2-(2-methoxyphenyl)acetamide | 19.37 | 18287210 | |
| MESH:D010003 | Osteoarthritis | rofecoxib | 19.37 | 16690336 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 4.81 | 18500342 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 6.90 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 6.90 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 2.74 | 17016548 | |
| MESH:D010024 | Osteoporosis | Calcium | 14.28 | 17882678 | |
| MESH:D010024 | Osteoporosis | Curcumin | 14.28 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 14.28 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 14.28 | 16640825 16648989 | |
| MESH:D010024 | Osteoporosis | kaempferol | 14.28 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 14.28 | 15775268 19059307 17882678 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 14.28 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Drugs, Chinese Herbal | 15.41 | 16548355 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 15.41 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 15.41 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 15.41 | 17893378 17823083 15758505 15579764 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 15.41 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 5.57 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 5.57 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.35 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 42.97 | 16891317 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 42.97 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 42.97 | 16624393 12452020 19769630 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 42.97 | 6897625 15464296 19769630 17225452 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 42.97 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 42.97 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 42.97 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 42.97 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 42.97 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 42.97 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 42.97 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 42.97 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 42.97 | 16525653 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 42.97 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 42.97 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Thalidomide | 42.97 | 16288038 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 42.97 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 42.97 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 42.97 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 42.97 | 16391232 | |
| MESH:D010146 | Pain | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 53.62 | 16870215 | |
| MESH:D010146 | Pain | Acetaminophen | 53.62 | 16870215 | |
| MESH:D010146 | Pain | Anti-Inflammatory Agents, Non-Steroidal | 53.62 | 17440234 16684565 3291741 | |
| MESH:D010146 | Pain | Aspirin | 53.62 | 6995502 6363464 | |
| MESH:D010146 | Pain | Capsaicin | 53.62 | 18987195 17084039 16996476 17043245 17434803 19081190 | |
| MESH:D010146 | Pain | Cyclophosphamide | 53.62 | 18093676 12161096 | |
| MESH:D010146 | Pain | Diclofenac | 53.62 | 13679232 | |
| MESH:D010146 | Pain | DP 155 | 53.62 | 17627676 | |
| MESH:D010146 | Pain | Ibuprofen | 53.62 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 53.62 | 17627676 17440234 13679232 3291741 | |
| MESH:D010146 | Pain | lumiracoxib | 53.62 | 20639878 | |
| MESH:D010146 | Pain | Mangifera indica extract | 53.62 | 16273134 15177302 | |
| MESH:D010146 | Pain | montelukast | 53.62 | 15935457 | |
| MESH:D010146 | Pain | Morphine | 53.62 | 16273134 18699797 20225289 15275824 15215642 6776300 | |
| MESH:D010146 | Pain | Naproxen | 53.62 | 3291741 | |
| MESH:D010146 | Pain | nimesulide | 53.62 | 11438310 | |
| MESH:D010146 | Pain | Sulindac | 53.62 | 3291741 | |
| MESH:D010146 | Pain | Trazodone | 53.62 | 12790215 12798668 | |
| MESH:D010146 | Pain | Tretinoin | 53.62 | 16870215 | |
| MESH:D010146 | Pain | zileuton | 53.62 | 15935457 | |
| MESH:D010146 | Pain | zoledronic acid | 53.62 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Bupivacaine | 13.59 | 18165598 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 13.59 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 13.59 | 18702446 12538197 | |
| MESH:D010149 | Pain, Postoperative | rofecoxib | 13.59 | 18165598 16678543 | |
| MESH:D010190 | Pancreatic Neoplasms | marker/mechanism | 10485483 10657949 16820089 | ||
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 49.92 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 49.92 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 49.92 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 49.92 | 19196508 19401701 17440100 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 49.92 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 49.92 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 49.92 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 49.92 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 49.92 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 49.92 | 16500647 16929163 15113037 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 49.92 | 11504793 16929163 17440100 18992248 18383843 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 49.92 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 49.92 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 49.92 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 49.92 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 49.92 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Reactive Oxygen Species | 49.92 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 49.92 | 11504793 16820089 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 49.92 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 49.92 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 49.92 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 3.92 | 15028970 17883296 | |
| MESH:D010195 | Pancreatitis | Trinitrobenzenesulfonic Acid | 3.92 | 17698068 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.14 | 11578682 | |
| MESH:D010212 | Papilloma | 9,10-Dimethyl-1,2-benzanthracene | 23.63 | 15173996 16517061 17234724 | |
| MESH:D010212 | Papilloma | amarogentin | 23.63 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Benzoyl Peroxide | 23.63 | 12065085 8330346 | |
| MESH:D010212 | Papilloma | Croton Oil | 23.63 | 16517061 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 23.63 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 23.63 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 23.63 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 23.63 | 18922899 12065085 8330346 18404319 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.62 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.05 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.35 | 17352947 | |
| MESH:D010291 | Paresis | Thalidomide | 4.64 | 9200351 | |
| MESH:D010300 | Parkinson Disease | Acrolein | 7.69 | 17690948 | |
| MESH:D010300 | Parkinson Disease | Anti-Inflammatory Agents, Non-Steroidal | 7.69 | 12925360 | |
| MESH:D010300 | Parkinson Disease | Iron | 7.69 | 16640825 16563566 | |
| MESH:D010300 | Parkinson Disease | Manganese | 7.69 | 11181820 | |
| MESH:D010300 | Parkinson Disease | mangiferin | 7.69 | 17433543 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 7.69 | 11535288 16412576 19114014 18619942 16140633 19232380 11445065 18191903 15451049 | |
| MESH:D010302 | Parkinson Disease, Secondary | Oxidopamine | 6.59 | 15893579 11771942 | |
| MESH:D010302 | Parkinson Disease, Secondary | Trazodone | 6.59 | 3378227 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 12.88 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 12.88 | 16140633 | |
| MESH:D020734 | Parkinsonian Disorders | Melatonin | 12.88 | 15574749 | |
| MESH:D020734 | Parkinsonian Disorders | N-(1-methylethyl)-1,1,2-trimethylpropylamine | 12.88 | 15927086 15795934 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 12.88 | 15927086 15574749 15795934 18197244 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.05 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.59 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.52 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Anti-Inflammatory Agents, Non-Steroidal | 8.32 | 17681167 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 8.32 | 11156591 | |
| MESH:D010518 | Periodontitis | etoricoxib | 11.31 | 17225004 | |
| MESH:D010518 | Periodontitis | Indomethacin | 11.31 | 17225004 | |
| MESH:D010518 | Periodontitis | mangiferin | 11.31 | 19026997 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 4.91 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 4.91 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 7.68 | 16905509 6392382 15371236 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 7.68 | 15687053 | |
| MESH:D010538 | Peritonitis | Melatonin | 11.32 | 15707874 | |
| MESH:D010538 | Peritonitis | Ozone | 11.32 | 16369182 | |
| MESH:D010538 | Peritonitis | zileuton | 11.32 | 17371808 | |
| MESH:D010538 | Peritonitis | Zymosan | 11.32 | 18760300 18977430 14761945 19641140 17371808 17826846 19088179 18557954 11985352 15259001 15979727 | |
| MESH:D020795 | Photophobia | Aspirin | 4.10 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | Acrolein | 4.09 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.50 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Iron | 4.01 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 3.81 | 16391232 | |
| MESH:D010954 | Plasmacytoma | pristane | 9.08 | 15087411 | |
| MESH:D010954 | Plasmacytoma | Selenium | 9.08 | 15087411 | |
| MESH:D010995 | Pleural Diseases | Asbestos, Crocidolite | 3.29 | 10923243 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 8.46 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 8.46 | 17638057 | |
| MESH:D010998 | Pleurisy | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid | 9.74 | 19934399 | |
| MESH:D010998 | Pleurisy | Carrageenan | 9.74 | 19934399 | |
| MESH:D011014 | Pneumonia | Butylated Hydroxytoluene | 9.38 | 11893704 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 9.38 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 9.38 | 18007984 18929643 18381685 | |
| MESH:D011015 | Pneumonia, Aspiration | Hydrochloric Acid | 10.18 | 18497604 15970105 15607125 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 10.18 | 18573544 | |
| MESH:D011015 | Pneumonia, Aspiration | S-methylisothiopseudouronium | 10.18 | 18573544 | |
| MESH:D011041 | Poisoning | Atropine | 6.05 | 17849254 18072136 | |
| MESH:D011041 | Poisoning | Iron | 6.05 | 16604332 | |
| MESH:D011041 | Poisoning | Mustard Gas | 6.05 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 3.85 | 17105841 | |
| MESH:D011141 | Polyuria | Furosemide | 8.15 | 17945291 | |
| MESH:D011141 | Polyuria | Lithium Chloride | 8.15 | 19692487 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.34 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 5.80 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 5.80 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Azoxymethane | 13.40 | 14668109 19056647 12458338 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 13.40 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 13.40 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 13.40 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 13.40 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 5.61 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 5.61 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Thalidomide | 5.61 | 17031469 | |
| MESH:D011225 | Pre-Eclampsia | 8-epi-prostaglandin F2alpha | 10.49 | 17332518 | |
| MESH:D011225 | Pre-Eclampsia | Iloprost | 10.49 | 10329876 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 10.49 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 10.49 | 17114810 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.51 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 10.30 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 10.30 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 10.30 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 10.30 | 11118676 11896295 11399792 11222880 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 7.10 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 7.10 | 17616702 | |
| MESH:D011350 | Proctocolitis | Acetic Acid | 5.77 | 11561086 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.15 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 5.48 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 5.48 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 14754878 16506214 17609663 | ||
| MESH:D011471 | Prostatic Neoplasms | Anti-Inflammatory Agents, Non-Steroidal | 27.85 | 17609663 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 27.85 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 27.85 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 27.85 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 27.85 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 27.85 | 18487222 17914592 19011039 19240160 15638997 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 27.85 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 27.85 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 27.85 | 15754350 16644109 18247401 16289102 12479363 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 27.85 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 27.85 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Copper | 27.85 | 17079463 17308104 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 27.85 | 12497104 15129424 10851300 18769126 18226269 11398177 18156803 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 27.85 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 27.85 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 27.85 | 18824434 16644109 16520278 19103299 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 27.85 | 16888761 15897917 15749863 18437689 16868541 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | equol | 27.85 | 16898868 16925846 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 27.85 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 27.85 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 27.85 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Flurbiprofen | 27.85 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | gefitinib | 27.85 | 16685379 17914592 15651060 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 27.85 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 27.85 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Nordihydroguaiaretic Acid | 27.85 | 18491370 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 27.85 | 17172428 17136230 16729912 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 27.85 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 27.85 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 27.85 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 27.85 | 16220300 16536755 15731164 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 27.85 | 17804756 15767336 17636462 16731767 17675339 17718901 | |
| MESH:D011471 | Prostatic Neoplasms | Scutellaria baicalensis extract | 27.85 | 17516867 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 27.85 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Sodium Selenite | 27.85 | 18760546 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 27.85 | 15570007 17908994 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 27.85 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Thalidomide | 27.85 | 16729912 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 27.85 | 19789329 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | vinorelbine | 27.85 | 16888761 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 27.85 | 16606632 16517595 12429649 16700911 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 27.85 | 12438248 19103299 | |
| MESH:D011507 | Proteinuria | Arsenic | 20.11 | 21343184 | |
| MESH:D011507 | Proteinuria | Gentamicins | 20.11 | 15033597 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 20.11 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 20.11 | 11849393 | |
| MESH:D011507 | Proteinuria | pioglitazone | 20.11 | 16687628 | |
| MESH:D011507 | Proteinuria | Tretinoin | 20.11 | 16636307 | |
| MESH:D011507 | Proteinuria | valsartan | 20.11 | 17664856 18344623 12164870 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.35 | 16640825 | |
| MESH:D011536 | Prurigo | Thalidomide | 4.64 | 12755975 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 7.10 | 16919318 15861022 | |
| MESH:D011537 | Pruritus | Mustard Gas | 7.10 | 18058305 | |
| MESH:D011537 | Pruritus | zileuton | 7.10 | 19657356 17827870 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 2.85 | 12752131 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 1.45 | 16882103 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.28 | 18769834 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.15 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.15 | 10548101 | |
| MESH:D001261 | Pulmonary Atelectasis | Hydrochloric Acid | 4.36 | 20597076 | |
| MESH:D011654 | Pulmonary Edema | Hydrochloric Acid | 6.07 | 15090967 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 6.07 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.02 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | alpha-Tocopherol | 12.10 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 12.10 | 14606601 | |
| MESH:D011657 | Pulmonary Eosinophilia | Trazodone | 12.10 | 8520792 | |
| MESH:D011658 | Pulmonary Fibrosis | Amiodarone | 18.45 | 11597910 12832656 12490602 | |
| MESH:D011658 | Pulmonary Fibrosis | Asbestos, Crocidolite | 18.45 | 15814490 17322281 17975199 17365031 | |
| MESH:D011658 | Pulmonary Fibrosis | Cobalt | 18.45 | 6434250 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 18.45 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | Drugs, Chinese Herbal | 18.45 | 16987627 | |
| MESH:D011658 | Pulmonary Fibrosis | gefitinib | 18.45 | 18424623 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 18.45 | 17266442 17894541 17720292 10334151 17620002 | |
| MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 18.45 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | troglitazone | 18.45 | 18162602 | |
| MESH:D011658 | Pulmonary Fibrosis | valsartan | 18.45 | 17241526 | |
| MESH:D011693 | Purpura | Raloxifene | 3.89 | 15770314 | |
| MESH:D011833 | Radiation Injuries, Experimental | mangiferin | 4.74 | 15830843 | |
| MESH:D011928 | Raynaud Disease | Iloprost | 4.98 | 16363279 | |
| MESH:D012003 | Rectal Fistula | Drugs, Chinese Herbal | 4.31 | 15043669 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.55 | 15538739 18722050 18286688 16160472 | |
| MESH:D051437 | Renal Insufficiency | Acrolein | 15.47 | 12732208 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 15.47 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 15.47 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 15.47 | 17132701 15728788 | |
| MESH:D051437 | Renal Insufficiency | Losartan | 15.47 | 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 3.92 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Capsaicin | 11.01 | 19211983 18460982 | |
| MESH:D015427 | Reperfusion Injury | Furosemide | 11.01 | 16526316 | |
| MESH:D015427 | Reperfusion Injury | Morphine | 11.01 | 19211983 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 11.01 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 11.01 | 16317513 16314181 17520802 15827377 17058453 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 11.01 | 9865762 15266012 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 15.70 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 15.70 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 15.70 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Furosemide | 15.70 | 15912074 16096441 12394941 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Hydrochloric Acid | 15.70 | 17627322 16784557 16129981 18339021 18549715 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 15.70 | 16129981 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.49 | 10835634 | |
| MESH:D012131 | Respiratory Insufficiency | Trazodone | 4.22 | 8520792 | |
| MESH:D012133 | Respiratory Paralysis | Hydrochloric Acid | 4.70 | 11510729 | |
| MESH:D012135 | Respiratory Sounds | Tobacco Smoke Pollution | 5.16 | 18410779 | |
| MESH:D012135 | Respiratory Sounds | Vehicle Emissions | 5.16 | 18950799 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.25 | 18990726 | |
| MESH:D012140 | Respiratory Tract Diseases | Hydrochloric Acid | 3.56 | 20516732 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.17 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 4.79 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 4.79 | 16584753 | |
| MESH:D012173 | Retinitis | Gentamicins | 4.61 | 18644591 | |
| MESH:D012174 | Retinitis Pigmentosa | alpha-Tocopherol | 3.38 | 16849425 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 3.38 | 16849425 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 5.80 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 5.80 | 16116481 16283617 | |
| MESH:D012216 | Rheumatic Diseases | Auranofin | 5.77 | 17034761 | |
| MESH:D012220 | Rhinitis | Acetaldehyde | 8.69 | 17050345 | |
| MESH:D012220 | Rhinitis | Aspirin | 8.69 | 12372130 | |
| MESH:D012220 | Rhinitis | montelukast | 8.69 | 20332717 | |
| MESH:D012220 | Rhinitis | zileuton | 8.69 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Drugs, Chinese Herbal | 3.65 | 15015336 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.03 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 4.65 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 4.65 | 16767912 17203757 15625365 15675481 17710206 18313854 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 15.95 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 15.95 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 15.95 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 15.95 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 15.95 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.16 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 3.88 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 3.88 | 9673227 | |
| MESH:D012559 | Schizophrenia | Copper | 3.04 | 16842975 | |
| MESH:D012559 | Schizophrenia | Trazodone | 3.04 | 7868106 | |
| MESH:D019873 | Schnitzler Syndrome | Thalidomide | 4.30 | 16096327 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.28 | 16636934 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 7.03 | 18551238 | |
| MESH:D012640 | Seizures | Atropine | 7.03 | 17157343 12660363 11218047 | |
| MESH:D012640 | Seizures | Ethanol | 7.03 | 9754883 | |
| MESH:D012640 | Seizures | Kainic Acid | 7.03 | 16336964 18657176 1641125 19186208 19414003 17827730 15686955 14637104 10686065 | |
| MESH:D012640 | Seizures | nefiracetam | 7.03 | 15946322 | |
| MESH:D012640 | Seizures | Phenobarbital | 7.03 | 4039156 3137016 16876388 11442880 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.18 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 4.90 | 18389075 | |
| MESH:D018805 | Sepsis | Zymosan | 4.90 | 11441115 | |
| MESH:D020230 | Serotonin Syndrome | Trazodone | 4.48 | 7854515 8704074 9050436 | |
| MESH:D012772 | Shock, Septic | endotoxin, Escherichia coli | 9.10 | 18063050 | |
| MESH:D012772 | Shock, Septic | Mangifera indica extract | 9.10 | 15177305 | |
| MESH:D012772 | Shock, Septic | mangiferin | 9.10 | 15177305 | |
| OMIM:609620 | SHORT QT SYNDROME 1 | Amiodarone | 3.44 | 18724381 | |
| MESH:D012852 | Sinusitis | Ampicillin | 9.74 | 7327846 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 9.74 | 7327846 | |
| MESH:D012852 | Sinusitis | zileuton | 9.74 | 10665187 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.66 | 12269725 | |
| MESH:D012871 | Skin Diseases | marker/mechanism | 15451306 | ||
| MESH:D012871 | Skin Diseases | Arsenic | 4.56 | 19834688 18709164 17548696 17453740 16353154 6392382 16759981 17050553 17938729 16702368 15952646 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 4.56 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonous acid | 4.56 | 17431481 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 4.56 | 12880345 15451306 16961503 | |
| MESH:D012878 | Skin Neoplasms | marker/mechanism | 17499752 | ||
| MESH:D012878 | Skin Neoplasms | 9,10-Dimethyl-1,2-benzanthracene | 55.34 | 15173996 8985016 16517061 11376689 | |
| MESH:D012878 | Skin Neoplasms | amarogentin | 55.34 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 55.34 | 17976673 19538983 17029826 17050553 15504454 16251483 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 55.34 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Benzoyl Peroxide | 55.34 | 8532709 12065085 8330346 | |
| MESH:D012878 | Skin Neoplasms | Croton Oil | 55.34 | 16517061 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 55.34 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 55.34 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 55.34 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | gingerol | 55.34 | 19481070 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 55.34 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 55.34 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 55.34 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 55.34 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 55.34 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 55.34 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 55.34 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 55.34 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 55.34 | 12065085 8985016 18404319 11807781 8330346 | |
| MESH:D012878 | Skin Neoplasms | Tobacco Smoke Pollution | 55.34 | 18590791 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 55.34 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 55.34 | 11807781 | |
| MESH:D020181 | Sleep Apnea, Obstructive | montelukast | 7.84 | 19118273 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 7.84 | 19118273 | |
| MESH:D012892 | Sleep Deprivation | Trazodone | 4.62 | 19798453 | |
| MESH:D012893 | Sleep Disorders | Kainic Acid | 9.10 | 19414003 | |
| MESH:D012893 | Sleep Disorders | Melatonin | 9.10 | 16897403 18182647 16919138 | |
| MESH:D012893 | Sleep Disorders | Trazodone | 9.10 | 19395429 | |
| MESH:D020178 | Sleep Disorders, Circadian Rhythm | Melatonin | 4.97 | 19452292 18078449 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Melatonin | 5.52 | 18078449 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Trazodone | 5.52 | 15341891 17225163 15062207 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.68 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 2.97 | 17203757 15625365 16767912 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 6.11 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 6.11 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 3.87 | 16517039 | |
| MESH:D013119 | Spinal Cord Injuries | montelukast | 13.49 | 18059327 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 13.49 | 16503802 15862959 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 13.49 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 13.49 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 2.40 | 12854658 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 8.00 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 8.00 | 18545984 17207306 10192188 15038085 18209964 16113693 17638125 10486359 16184426 10215738 17160473 15472012 16280098 | |
| MESH:D013272 | Stomach Diseases | rebamipide | 8.00 | 16184426 | |
| MESH:D013274 | Stomach Neoplasms | marker/mechanism | 10404093 | ||
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 24.15 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 24.15 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 24.15 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 24.15 | 17522103 18396642 15958060 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 24.15 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 24.15 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 24.15 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Docosahexaenoic Acids | 24.15 | 19015929 | |
| MESH:D013274 | Stomach Neoplasms | Drugs, Chinese Herbal | 24.15 | 18339527 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 24.15 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 24.15 | 18567086 16424979 18396642 19084572 17522103 17498489 16951190 19015929 15786421 17172411 | |
| MESH:D013274 | Stomach Neoplasms | Folfox protocol | 24.15 | 18505590 | |
| MESH:D013274 | Stomach Neoplasms | Furosemide | 24.15 | 17052386 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 24.15 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 24.15 | 17575124 12958204 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 24.15 | 18506536 18396642 | |
| MESH:D013274 | Stomach Neoplasms | rebamipide | 24.15 | 15993841 | |
| MESH:D013274 | Stomach Neoplasms | Sodium Chloride | 24.15 | 16646055 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 24.15 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | troglitazone | 24.15 | 15930296 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 24.15 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | marker/mechanism | 12481160 9024292 | ||
| MESH:D013276 | Stomach Ulcer | 16,16-Dimethylprostaglandin E2 | 85.50 | 11595431 | |
| MESH:D013276 | Stomach Ulcer | Acetic Acid | 85.50 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 85.50 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | allylpyrocatechol | 85.50 | 18431645 | |
| MESH:D013276 | Stomach Ulcer | Amiodarone | 85.50 | 18087811 | |
| MESH:D013276 | Stomach Ulcer | Anti-Inflammatory Agents, Non-Steroidal | 85.50 | 17157122 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 85.50 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Atropine | 85.50 | 11595415 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 85.50 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 85.50 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 85.50 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 85.50 | 9562338 16755016 9211565 17918041 17189318 11906479 | |
| MESH:D013276 | Stomach Ulcer | Hydrochloric Acid | 85.50 | 17189318 15309881 16755016 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 85.50 | 12500499 15138204 11145282 17895592 17657623 15104355 16252198 16755016 11595415 17627676 16934674 11906479 12787963 12077510 18299717 10878458 12467913 10423059 16150113 17977527 17135157 17918041 17654042 18431645 18237397 1323529 10750652 16397915 18726076 18209962 15255614 16631530 18087811 18181030 14567935 11523592 11595431 18543354 18193104 12498302 11729361 16169175 | |
| MESH:D013276 | Stomach Ulcer | malabaricone B | 85.50 | 17977527 | |
| MESH:D013276 | Stomach Ulcer | malabaricone C | 85.50 | 17977527 | |
| MESH:D013276 | Stomach Ulcer | Mangifera indica extract | 85.50 | 19305363 | |
| MESH:D013276 | Stomach Ulcer | mangiferin | 85.50 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Melatonin | 85.50 | 16150113 12500499 11523592 | |
| MESH:D013276 | Stomach Ulcer | montelukast | 85.50 | 17895592 | |
| MESH:D013276 | Stomach Ulcer | Nifedipine | 85.50 | 14653237 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 85.50 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | olive oil | 85.50 | 12498302 16252198 | |
| MESH:D013276 | Stomach Ulcer | pimagedine | 85.50 | 18209962 | |
| MESH:D013276 | Stomach Ulcer | Piroxicam | 85.50 | 15309881 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 85.50 | 18193104 17135157 12787963 15255614 18237397 | |
| MESH:D013276 | Stomach Ulcer | Plant Oils | 85.50 | 16252198 | |
| MESH:D013276 | Stomach Ulcer | Thalidomide | 85.50 | 15138204 | |
| MESH:D020521 | Stroke | Acrolein | 12.06 | 16269634 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 12.06 | 16517955 16403987 | |
| MESH:D020521 | Stroke | Aspirin | 12.06 | 16403987 | |
| MESH:D020521 | Stroke | Raloxifene | 12.06 | 16837676 | |
| MESH:D020521 | Stroke | Trazodone | 12.06 | 810300 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 2.98 | 16321402 | |
| MESH:D013322 | Strongyloidiasis | Levamisole | 5.27 | 14651886 | |
| MESH:D013345 | Subarachnoid Hemorrhage | Drugs, Chinese Herbal | 4.11 | 17634840 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.42 | 16045194 16684133 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 5.47 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Trazodone | 5.47 | 12749364 393279 | |
| MESH:D013398 | Sudden Infant Death | Iron | 3.82 | 16640825 | |
| MESH:D013436 | Sulfhemoglobinemia | Phenacetin | 4.89 | 978859 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 7.09 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 7.09 | 12837982 | |
| MESH:D013610 | Tachycardia | Amiodarone | 5.97 | 11238279 | |
| MESH:D013610 | Tachycardia | Nitroprusside | 5.97 | 15306635 | |
| MESH:D017180 | Tachycardia, Ventricular | Amiodarone | 5.66 | 19225199 | |
| MESH:D017180 | Tachycardia, Ventricular | Trazodone | 5.66 | 2424891 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 3.20 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Capsaicin | 7.98 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 7.98 | 17997062 | |
| MESH:D013733 | Testicular Diseases | phenethyl isothiocyanate | 3.36 | 15864552 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.09 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 2.70 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.08 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 4.37 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 4.37 | 15669648 | |
| MESH:D013959 | Thyroid Diseases | Amiodarone | 17.55 | 19731979 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 17.55 | 12697716 | |
| MESH:D013959 | Thyroid Diseases | Thyroxine | 17.55 | 19910387 | |
| MESH:D013959 | Thyroid Diseases | Triclosan | 17.55 | 19910387 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 18.73 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 18.73 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 18.73 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 18.73 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 18.73 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | gefitinib | 18.73 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 18.73 | 11352223 14736730 18791128 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 18.73 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 18.73 | 16026305 17045167 | |
| MESH:D013971 | Thyrotoxicosis | Amiodarone | 3.25 | 18020914 19584973 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.23 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.23 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | marker/mechanism | 16543248 | ||
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 11.49 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 11.49 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 11.49 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 11.49 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | Amiodarone | 4.94 | 17467628 11989578 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 4.94 | 15213294 | |
| MESH:D014202 | Tremor | 2-cresol | 6.61 | 12820538 | |
| MESH:D014202 | Tremor | Atropine | 6.61 | 17594079 | |
| MESH:D014235 | Trichinellosis | Mangifera indica extract | 9.31 | 14669257 | |
| MESH:D014235 | Trichinellosis | mangiferin | 9.31 | 14669257 | |
| MESH:D014376 | Tuberculosis | Iron | 3.98 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 3.98 | 16040207 | |
| MESH:D014402 | Tuberous Sclerosis | everolimus | 4.94 | 18495876 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.27 | 10574470 17380554 | |
| MESH:D001749 | Urinary Bladder Neoplasms | marker/mechanism | 12664575 10873095 10582676 | ||
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 48.81 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4-biphenylamine | 48.81 | 12376482 17671175 6654951 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 48.81 | 19322015 17306315 11144890 17976673 15987713 19429237 18640142 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 48.81 | 11780464 20435036 12973940 12845720 | |
| MESH:D001749 | Urinary Bladder Neoplasms | benzidine | 48.81 | 16003747 12500666 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 48.81 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 48.81 | 12973940 17225452 15464296 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 48.81 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 48.81 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 48.81 | 19087683 17616700 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 48.81 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 48.81 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Methylenebis(chloroaniline) | 48.81 | 15929884 722185 3189344 | |
| MESH:D001749 | Urinary Bladder Neoplasms | monomethylarsonous acid | 48.81 | 20375083 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Phenacetin | 48.81 | 11144890 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 48.81 | 11251952 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 48.81 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 48.81 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 48.81 | 16712894 16452187 17306315 11723127 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 48.81 | 16712894 17572228 8653321 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tobacco Smoke Pollution | 48.81 | 12846360 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Vehicle Emissions | 48.81 | 11144890 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.62 | 18462866 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 2.69 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 11.67 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 11.67 | 20485159 10982225 | |
| MESH:D014581 | Urticaria | montelukast | 11.67 | 10982225 | |
| MESH:D014581 | Urticaria | nimesulide | 11.67 | 10982225 | |
| MESH:D014581 | Urticaria | Piroxicam | 11.67 | 10982225 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 22.08 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 22.08 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 22.08 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 22.08 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 22.08 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 22.08 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 22.08 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 3.35 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 13.79 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 13.79 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 13.79 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 13.79 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 13.79 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 7.36 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 7.36 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 10.87 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 10.87 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 10.87 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 9.55 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | temozolomide | 9.55 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 9.55 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 10.93 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 10.93 | 17056641 | |
| MESH:D014652 | Vascular Diseases | Thalidomide | 10.93 | 15741222 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 2.93 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.25 | 10620525 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 3.58 | 19057314 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.55 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.03 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 8.12 | 17678736 16364871 17638931 17334414 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 8.12 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 8.12 | 17488730 | |
| MESH:D018879 | Ventricular Premature Complexes | Trazodone | 5.16 | 2424891 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 7.47 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | valsartan | 7.47 | 19027736 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 3.93 | 18776599 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.50 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 10.05 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 10.05 | 11897121 | |
| MESH:D014839 | Vomiting | meloxicam | 10.05 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 3.89 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.59 | 15886252 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.49 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Drugs, Chinese Herbal | 6.40 | 16313111 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 6.40 | 19894650 20213670 | |
| MESH:D014947 | Wounds and Injuries | Plant Oils | 6.40 | 16313111 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 2.78 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:00590 | Arachidonic acid metabolism |
| REACT:13433 | Biological oxidations |
| REACT:15314 | Hormone biosynthesis |
| KEGG:05140 | Leishmaniasis |
| KEGG:01100 | Metabolic pathways |
| REACT:22258 | Metabolism of lipids and lipoproteins |
| KEGG:05200 | Pathways in cancer |
| KEGG:05222 | Small cell lung cancer |
| KEGG:04370 | VEGF signaling pathway |
| Releated gene ID | Related gene Name |
|---|---|
| PA27740 | ELAVL1 |
| PA30621 | MAPK14 |
| PA27046 | CUGBP2 |
| PA28126 | FGF9 |
| PA30616 | MAPK1 |
| PA31345 | MYB |
| PA31712 | NPM1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA443624 | Carcinoma, Renal Cell |
| PA445019 | Myocardial Infarction |
| PA447054 | Stroke |
| PA443319 | Alzheimer Disease |
| PA445058 | Neoplasm Metastasis |
| PA443450 | Asthma |
| PA443756 | Colonic Neoplasms |
| PA445208 | Pain |
| PA444552 | Hypertension |
| PA445062 | Neoplasms |
| PA447278 | Depression |
| PA444620 | Inflammation |
| PA445174 | Osteoarthritis |
| PA447021 | Osteoarthritis, Knee |
| PA446108 | Colorectal Neoplasms |
| PA443635 | Cardiovascular Diseases |
| PA443797 | Coronary Disease |
| PA443560 | Breast Neoplasms |
| PA152132901 | Hereditary Breast/Ovarian Cancer Syndrome |
| PA445204 | Ovarian Neoplasms |
| PA444101 | Esophageal Neoplasms |
| PA445218 | Pancreatic Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA164749376 | interferon alfacon-1 |
| PA10040 | cetuximab |
| PA131301952 | gefitinib |
| PA164712669 | Coxibs |
| PA449247 | dexamethasone |
| PA451578 | tacrolimus |
| PA449293 | diclofenac |
| PA449957 | ibuprofen |
| PA133950441 | hmg coa reductase inhibitors |
| PA449048 | clomipramine |
| PA452363 | prostaglandins |
| PA10226 | valdecoxib |
| PA448871 | celecoxib |
| PA448497 | aspirin |
| PA451268 | rofecoxib |
| PA452347 | glucocorticoids |
| PA137179528 | nimesulide |
| PA450702 | omega-3 polyunsaturated fatty acids |
| PA165291474 | BSI-201 |
| PA164920420 | Olaparib |
| PA448771 | capecitabine |
| PA131285527 | oxaliplatin |
| PA164712462 | Antiinflammatory agents, non-steroids |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00154 | - | gamma-Homolinolenic acid | Dietary supplement;Micronutrient |
| DB00159 | antagonist | Icosapent | Dietary supplement;Micronutrient |
| DB00233 | antagonist | Aminosalicylic Acid | Antituberculosis Agents;Antitubercular Agents |
| DB00244 | inhibitor | Mesalazine | |
| DB00316 | antagonist | Zydone | Analgesics, Non-Narcotic;Antipyretics |
| DB00328 | inhibitor | Indomethacin | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Tocolytic Agents;Cardiovascular Agents;Nonsteroidal Anti-inflammatory Agents (NSAIAs);Gout Suppressants |
| DB00461 | inhibitor | Nabumetone | Antineoplastic Agents |
| DB00465 | inhibitor | Ketorolac | Cyclooxygenase Inhibitors |
| DB00469 | inhibitor | Tenoxicam | Cyclooxygenase Inhibitors |
| DB00480 | negative modulator | Lenalidomide | Antineoplastic Agents |
| DB00482 | antagonist | Celecoxib | Cyclooxygenase Inhibitors |
| DB00500 | inhibitor | Tolmetin | Cyclooxygenase Inhibitors |
| DB00533 | antagonist | Rofecoxib | Cyclooxygenase Inhibitors;Cyclooxygenase 2 Inhibitors |
| DB00554 | antagonist | Piroxicam | Cyclooxygenase Inhibitors |
| DB00573 | antagonist | Fenoprofen | Cyclooxygenase Inhibitors;Propionic acid derivatives |
| DB00580 | inhibitor | Valdecoxib | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00586 | antagonist | Diclofenac | Cyclooxygenase Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00605 | inhibitor | Sulindac | Antineoplastic Agents;Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00712 | antagonist | Flurbiprofen | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00749 | inhibitor | Etodolac | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00784 | inhibitor | Mefenamic acid | Cyclooxygenase Inhibitors |
| DB00788 | inhibitor | Naproxen | Cyclooxygenase Inhibitors;Gout Suppressants |
| DB00795 | inhibitor | Sulfasalazine | Antirheumatic Agents;Anti-Infective Agents;Sulfonamides;Gastrointestinal Agents |
| DB00812 | antagonist | Phenylone Plus Tab | Anti-inflammatory Agents;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00814 | antagonist | Meloxicam | Antineoplastic Agents;Cyclooxygenase Inhibitors;Antiemetics;Analgesics;Growth Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00821 | antagonist | Carprofen | Photosensitizing Agents |
| DB00861 | inhibitor | Diflunisal | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00870 | antagonist | Suprofen | Cyclooxygenase Inhibitors |
| DB00936 | antagonist | Mobilat | Anti-Infective Agents;Keratolytic Agents;Antifungal Agents |
| DB00939 | antagonist | Meclofenamic acid | Cyclooxygenase Inhibitors |
| DB00945 | antagonist | Extra Strength Aspirin Backache | Anticoagulants;Cyclooxygenase Inhibitors;Platelet Aggregation Inhibitors;Fibrinolytic Agents;Salicylates |
| DB00963 | inhibitor | Bromfenac | Analgesics |
| DB00991 | inhibitor | Oxaprozin | Anti-inflammatory Agents;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB01009 | inhibitor | Ketoprofen | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB01014 | antagonist | Balsalazide | Anti-Ulcer Agents;Gastrointestinal Agents |
| DB01041 | antagonist | Thalidomide | Immunosuppressive Agents;Leprostatic Agents;Teratogens;Angiogenesis Inhibitors |
| DB01050 | inhibitor | Vicoprofen® | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB01283 | antagonist | Lumiracoxib | Cyclooxygenase Inhibitors;Cyclooxygenase 2 Inhibitors |
| DB01294 | antagonist | Watkins Settelz | Antidiarrheals |
| DB01397 | antagonist | Magnesium salicylate | |
| DB01398 | antagonist | Salicylate-sodium | Nonsteroidal Anti-inflammatory Agents (NSAIAs);Salicylates |
| DB01399 | antagonist | Salsalate | |
| DB01401 | antagonist | Trisalicylate-choline | |
| DB01404 | antagonist | Ginseng | |
| DB01419 | antagonist | Antrafenine | |
| DB01435 | antagonist | Formule L2 | |
| DB01600 | antagonist | Tiaprofenic acid | |
| DB01628 | inhibitor | Etoricoxib | Cyclooxygenase Inhibitors |
| DB02266 | - | Flufenamic Acid | Anti-inflammatory Agents |
| DB02709 | inhibitor | Resveratrol | Antioxidants;Platelet Aggregation Inhibitors;Enzyme Inhibitors;Anticarcinogenic Agents;Antineoplastic Agents, Phytogenic;Antimutagenic Agents |
| DB03014 | - | Heme | |
| DB03122 | - | B-Octylglucoside | Detergents |
| DB03477 | - | 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole | |
| DB03866 | - | Prostaglandin G2 | |
| DB04552 | antagonist | Niflumic Acid | Cyclooxygenase Inhibitors |
| DB04743 | inhibitor | Nimesulide | Cyclooxygenase Inhibitors |
| DB06725 | antagonist | Lornoxicam | Analgesics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB06802 | antagonist | Nepafenac | Nonsteroidal Anti-inflammatory Agents (NSAIAs);Prodrugs;Anti-inflammatory Agents, Locally Applied |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00250 | substrate | Dapsone | Anti-Infective Agents;Anti-Infectives;Anti-inflammatory Agents;Antimalarials;Folic Acid Antagonists;Leprostatic Agents;Antimycobacterials |
| DB01041 | substrate | Thalidomide | Immunosuppressive Agents;Leprostatic Agents;Teratogens;Angiogenesis Inhibitors |
| No data |
| No data |